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Abstract 
Papua New Guineans have medicinal knowledge based on thousands of years of using 
flora, fauna and fungi as medicines. However, factors such as poor documentation and 
an increase in the use of allopathic medicine within the island have promoted the rapid 
loss of such medicinal knowledge. Thus the work presented in this thesis has been 
directed towards the preservation of first hand traditional knowledge, as it pertains to 
the use of mushrooms by indigenous inhabitants of Papua New Guinea, in particular 
those mushrooms with medicinal potential. 
 
A compilation of biologically active secondary metabolites isolated from terrestrial and 
marine fungi from Papua New Guinea under ethnomycology is presented in chapter 
one. A brief account of ethnomycology by early Europeans and inhabitants of the new 
world in pre-Columbian times is also presented. 
 
Chapter two describes the in vitro biological testing of mushrooms used by the Kiovi, 
Waefo and Kopanka clans. Turbidity-MTT microdilution assay was used to determine 
the susceptibility of Gram (+) and Gram (-) bacteria against 52 crude mushroom 
extracts resulting in approximately 31% of the samples tested active against at least one 
of the organisms used. Ethnomycological comparisons between the Kiovi, Waefo and 
Kopanka are also presented. 
 
The work described in chapter three includes ethnomycological and taxonomical 
background of Fulaga dive, common name given to a mushroom member of the 
Amanitaceae family and used by the Kiovi tribe for its edibility and because it makes 
them “feel well”. Bioassay guided isolation, purification and structural elucidation of 
two novel furan fatty acids is detailed. 
 
Chapter four details the synthetic route of the two novel furan fatty acids isolated from 
Fulaga dive. The synthesis was achieved from commercially available furan. 
Degradation of this class of compounds is also discussed, where (Z)-9-(5-pentylfuran-2-
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yl)-non-8-enoic acid isomerises to the more stable (E)-diastereoisomer followed by 
olefinic cleavage producing 5-pentyl-2-furaldehyde. 
Chapter five reports the synthesis of 26 compounds, that are furan based homologues 
and thiophene based analogues of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid. 
Homologues and analogues were assayed for their antibacterial potential against a panel 
of bacterial human pathogens using the turbidity-MTT assay and their radical 
scavenging properties using the DPPH assay. 
 
Finally, chapter six includes ethnomycological and taxonomical background of Igura 
hivi, a mushroom also used by the Kiovi tribe for its edibility and treat stomach 
complaints. Bioassay guided isolation, purification and structural elucidation of the 
known antibiotic grifolin is presented. The spectroscopic data obtained for the isolated 
fungal metabolite matched that reported in the literature. 
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Chapter One 
Natural products in  
drug discovery: 
an ethnomycological 
approach 
 
 
Roadside market Kiovi village, PNG (2012). Family selling mushrooms. Photograph by Anson 
Barish (UoG). Reproduced with permission. 
 
This chapter defines ethnomycology and entails a review of secondary metabolites 
isolated from fungi collected from the highalnds of Papua New Guinea (PNG).
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Chapter 1 : Natural products in drug discovery 
1.1 Ethnomycology 
Ethnomycology (Gr. ethno = nation + mykes = mushroom + logos = discourse), 
etymologically, is the study of historical, cultural and sociological uses of fungi by 
humans.
1,2
 As a field of study, ethnomycology began sometimes between the 1950s and 
‘60s through the studies of Wasson and Heim in the use of mushrooms for religious 
purposes in different cultures around the world.
3
 However, the degree of popularity 
ethnomycology has achieved is recent, despite evidence suggesting that mushrooms 
have been utilised by humans as a source of food, tinder and medicine for thousands of 
years.
1
 
 
Carbon-14 dating analysis of a painting of 13 objects with mushroom appearance found 
in a cave closed to Villar del Humo (smoking villages) in Spain, and reports of 
mycologist Gastón Guzmán, who suggested that the paintings could be of the 
hallucinogenic fungus Psilocybe hispanica Guzmán, were indicative that early 
Europeans may have used hallucinogenic mushrooms for religious purposes about 6000 
years ago.
4
 Figure 1.1 shows the mural of a bull and bottom right objects with 
mushroom appearance. 
 
 
Figure 1.1: Earliest evidence for magic mushrooms use in Europe.
4
 Photograph retrieved 
December 2015. 
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Stories of the interrelationships between fungi and early Europeans do not end in Spain. 
Ötzi – the iceman (Figure 1.2), a mummy that is on display at the South Tyrol Museum 
of Archaeology in Bolzano, Italy, is also evidence of the ethnological linkages between 
humans and fungi. Ötzi was found in the Italian Alps close to the border with Austria. 
Carbon-14 dating analysis of Ötzi and his belongings revealed that the iceman lived 
between 3350 and 3100 BC (Before Common Era). Therefore he was alive around 5000 
years ago. Amongst his implements, Ötzi carried attached to a string the bracket fungus 
birch polypore (Piptoporus betulinus (Bull.) P. Karst), which is known for its antibiotic 
potential. It is very likely that Ötzi used the birch polypore as medicine to treat 
intestinal parasites that he suffered from.
5
 
 
 
Figure 1.2: Top left, Ötzi – mummy on display. Bottom left, birch polypore found amongst 
Ötzi’s belongings. Picture on the right, representation of what Ötzi’s appearance might have 
been. Photographs retrieved December 2015 from South Tyrol Museum of Archaeology’s 
website.
5
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In 2000, Schlegel and co-workers
6
 isolated piptamine (1.1), shown in Figure 1.3, from 
the fungus birch polypore (P. betulinus (Bull.) P. Karst, strain Lu9-1) collected in 
Thuringia, Germany. Schlegel confirmed that this birch polypore was active against a 
number of Gram (+) bacteria and fungi, especially against Staphylococcus aureus 
Rosenbach (strain SG511) (MIC 0.78 µg.mL
-1
) and Enterococcus faecalis (Andrewes 
and Horder) Schleifer and Kilpper-Baeiz (strain 1528) (MIC 1.56 µg.mL
-1
).
6
 
 
 
Figure 1.3: Piptamine (1.1) isolated from P. betulinus (Bull.) P. Karst (Germany) 
 
In Mesoamerica several sculptures with mushroom appearance were unearthed in the 
late 1800s.
7
 However, in early 1960s archaeological investigations were performed on 
the “enigmatic” objects. Figure 1.4 shows miniature mushroom stones found in 
Guatemala, which based on their morphology all stones were dated back to pre-
Columbian times in a Late Preclassic 1000 – 500 BC.8 
 
 
Figure 1.4: Miniature mushroom stones from Guatemala.
8
 Retrieved December 2015 
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Since the discovery of such sculptures there was controversy whether Mayans in the 
south part of Mexico and Guatemala had any cultural or sociological linkages to 
mushrooms.
7
 The controversy was due to the absence of documentation linking the 
sculptures to the Mayans of that time. However, there was evidence suggesting that 
Mayans used the hallucinogenic mushroom Psilocybe cubensis (Earle) Singer, as part of 
their religious rituals, hence it was plausible that the sculptures with mushroom 
appearance found in Mesoamerica were in fact associated with the uses of mushrooms 
by the Mayans.
7,9
 
 
Papua New Guinea (PNG) is not the exception. Mushrooms have been an important part 
of everyday lives of Papua New Guineans for thousands of years for their edibility, 
medicine and economical livelihood. However, very little has been done to preserve 
firsthand information as it pertains to the use of mushrooms by Papua New Guineans 
and therefore, that knowledge is getting rapidly lost. Figure 1.5 shows local villagers in 
the highlands of PNG selling mushrooms in support of their livelihood. 
 
 
Figure 1.5: Roadside market Kiovi village, PNG (2012). Men selling mushrooms. 
Photograph by Anson Barish (UoG). Reproduced with permission. 
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Ethnomycological studies in PNG have been carried out previously. However, such 
studies have mostly focused on the use of psychotropic mushrooms in particular the so-
called “mushroom madness” excluding hundreds and possibly thousands of mushroom 
species with medicinal potential that could lead to the discovery of new drugs.
3
 In 2001, 
Hawksworth
10
 re-estimated the number of fungal species in the world to be of 1.5 
million species. Although new evidence indicated that Hawksworth’s estimation was 
too low, he thought prudent to retain his estimations until a consensus was created to 
decide whether to increase the number or not.
10
 The consensus came and new evidence 
indicated that Hawksworth did underestimate the number of fungal species in the world 
with 3.5 million species now thought to be conservative.
11
 
 
The purpose of this chapter is to present secondary metabolites that have been isolated 
from macro and/or microfungi from terrestrial and/or marine origins, specifically from 
PNG. Although there exist several reviews covering secondary metabolites from marine 
sources,
12,13
 or fungal metabolites as pharmaceuticals,
14
 to the best of my knowledge, 
this is the first attempt at listing natural products isolated from fungi from PNG. 
 
1.2 Secondary metabolites isolated from fungi 
This review is of the literature from 2002 to present, and it describes 43 compounds 
from 14 articles and a personal communication. The chemical structures of the 43 
natural products isolated from fungi from PNG are shown. Structures of synthetic 
bioactive homologues or analogues are not shown in this review. 
 
In 2002, Strobel and co-workers
15
 obtained the endophyte Pestalotiopsis microspora 
(Speg.) G.C. Zhao & N. Li, from the stem of the plant Terminalia morobensis L. that 
grows in the outflowing part of the Sepik river in PNG. Upon bioassay guided 
purification these authors isolated an isobenzofuranone and with X-ray crystallography 
for structural elucidation, they named the isolated compound isopestacin (1.2), shown in 
Figure 1.6. It is worth noting that isopestacin (1.2) was crystallised as two molecules in 
an asymmetric unit, suggesting its natural existence as a racemic mixture.
15
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Figure 1.6: Isopestacin (1.2) isolated from P. microspora (Speg.) G.C. Zhao & N. Li. 
 
In vitro biological testings of the isolated isobenzofuranone showed moderate antifungal 
activity (40 µg.mL
-1
) against the plant pathogen oomycete Pythium ultimum Trow. In 
addition, due to structural similarities of the isolated compound to flavonoids, these 
authors investigated its antioxidant potential. The radical scavenging activity of 
isopestacin (1.2) was similar to that of ascorbic acid (positive control), as isopestacin 
(1.2) was able to scavenge hydroxyl free radicals (EC50 = 0.22 mM) based on results by 
electron spin resonance measurements.
15
 
 
The following year, Harper and co-workers,
16
 while working with the endophyte P. 
microspora (Speg.) G.C. Zhao & N. Li extracted from T. morobensis L., isolated a 1,3-
dihydro-isobenzofuran, and by X-ray crystallography and NMR spectroscopy analysis, 
these authors named the isolated compound as pestacin (1.3) (Figure 1.7).
16
 
 
 
Figure 1.7: Pestacin (1.3) isolated from P. microspora (Speg.) G.C. Zhao & N. Li. 
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Pestacin (1.3) was found to crystallise as one molecule per asymmetric unit, suggesting 
its natural existence as a mixture of enantiomers. Harper and co-workers
16
 proposed a 
racemisation mechanism, which proceeded via a cationic intermediate stabilised by 
seven resonance structures and able to be further stabilise via tautomerisation to the 
neutral ortho-quinone methide-like structures, as shown in Figure 1.8. 
 
 
Figure 1.8: A: proposed racemisation mechanism of pestacin (1.3) and B: postulated 
resonance stabilised structures of cataionic intermediate of pestacin (1.3) by Harper and co-
workers
16
 
 
  
9 
Chapter one: Natural products in drug discovery 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
Pestacin (1.3) showed antifungal and antioxidant activities similar to that of isopestacin 
(1.2). This was not at all surprising because they were related compounds. Pestacin (1.3) 
exhibited an EC50 of 1.7 ± 0.1 mM according to total oxyradical scavenging capacity 
method, and when compared to trolox (vitamin E derivative) used as a control (EC50 
18.8 ± 0.9 mM), pestacin (1.3) appeared to be more effective as an antioxidant. 
 
Pestacin (1.3) was also evaluated for its antimycotic activity. Thus, pestacin (1.3) 
showed a MIC of 10 µg.mL
-1
 against Pythium ultimum Trow. These results appeared 
relatively similar to those reported for isopestacin (1.2).
16
 
 
In 2003, Garo and co-workers
17
 isolated the fungus Trichoderma virens Persoon (strains 
CNL910 and CNK266), identified following morphological and phylogenetic analyses, 
from the marine ascidian Didemnum molle and the green alga Halimeda sp. J. V. 
Lamouroux respectively.  
 
The marine invertebrate and alga used for the extraction of T. virens Persoon were 
collected in the Bismarck Sea off the coast of Madang in PNG.
17
 These authors reported 
the isolation of dipeptides trichodermamides A and B (1.4 and 1.5) and two known 
antibiotics gliovirin (1.6) and heptelidic acid chlorohydrin (1.7) in small quantities 
(Figure 1.9).
17
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Figure 1.9: Trichodermamides A and B (1.4 and 1.5), gliovirin (1.6) and heptelidic acid 
chlorohydrin (1.7) 
 
Trichodermamide A (1.4) was shown to possess (R) stereochemistry at C-8 position by 
esterification with Mosher’s acid chloride, which resulted in (R)- and (S)-MTPA esters 
(1.4a and 1.4b) respectively. Analysis of the 
1
H NMR spectra of both esters helped to 
support those results, as there was evidence for the (R)-MTPA ester (1.4a) olefinic 
protons at positions C-6 and C-7 were shifted upfield, while the proton at position C-9 
moved downfield, while for the (S)-MTPA ester (1.4b) the opposite was observed. 
 
These authors suggested that the total absolute stereochemistry of trichodermamide B 
(1.4) was 4S, 5R, 8R and 9S. In addition, the absolute stereochemistry of 
trichodermamide B (1.5) could be determined based on the relative stereochemistry 
obtained from X-ray analysis and Mosher’s method in the same manner as for 
trichodermamide A (1.4). 
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Trichodermamide B (1.5) exhibited in vitro antibacterial activity against amphotericin-
resistant Candida albicans (C.P.Robin) Berkhout, methicillin-resistant S. aureus 
(MRSA), and vancomycin-resistant Enterococcus faecium (Orla-Jensen) Schleifer & 
Kilpper-Baeiz (MIC 15 µg.mL
-1
). In addition, trichodermamide B (1.5) showed activity 
against HCT-116 human colon carcinoma (IC50 0.32 µg.mL
-1
). 
 
Trichodermamide A (1.4) did not show any antibacterial or anticancer activity against 
the organisms tested.
17
 With regards to gliovirin (1.6) and heptelidic acid chlorohydrin 
(1.7), these authors did not report any experimental data, as they were known 
compounds. Chemical structures of gliovirin (1.6) and heptelidic acid chlorohydrin 
(1.7), shown in this review, were reported by other authors.
18,19
 
 
The same year, Amagata and co-workers
20
 extracted the fungus Penicillium citrinum 
Thom, C. from the sponge, Axinella sp. Schmidt from PNG, and reported the discovery 
of two novel rearranged steroids, isocyclocitrinol A (1.8) and 22-acetylisocyclocitrinol 
A (1.9) (Figure 1.10).
20
 
 
 
Figure 1.10: Isocyclocitrinol A (1.8) and 22-acetylisocyclocitrinol A (1.9) 
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It was firstly suggested that isocyclocitrinol A (1.8) was an analogue of the known 
sesterterpenoid cyclocitrinol (1.8a) shown in Figure 1.11 because of the similarities in 
the 
13
C NMR spectrum. Although extensive NMR experiments were performed, these 
authors were unable to match the core of cyclocitrinol (1.8a).  
 
The structure of cyclocitrinol (1.8a) was revised by these authors based on comparisons 
of the 
13
C spectra between isocyclocitrinol A (1.8) and cyclocitrinol (1.8a), concluding 
with the rearranged steroid cyclocitrinol (1.8b), as shown in Figure 1.11. 
 
 
Figure 1.11: Cyclocitrinol (1.8a, originally reported) and cyclocitrinol (1.8b, revised) 
 
The chemical structure of isocyclocitrinol A (1.8) was elucidated by X-ray analysis of 
22-acetylisocyclocitrinol A (1.9), which consisted of a five, six and two-seven 
membered ring systems. 
 
X-ray analysis provided guidance for the relative configurations of all asymmetric 
centres in 22-acetylisocyclocitrinol A (1.9) and the absolute stereochemistry was 
determined by Mosher’s method. The absolute stereochemistry of isocyclocitrinol A 
(1.8) and 22-acetylisocyclocitrinol A (1.9) was 3S, 5S, 9R, 14R, 17S, 19S, 20R and 22S 
in accordance with comparisons between the spectral data of isocyclocitrinol A (1.8) 
and Mosher products of 22-acetylisocyclocitrinol A (1.9).  
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In vitro biological testings indicated weak antibacterial activity of isocyclocitrinol A 
(1.8) and 22-acetylisocyclocitrinol A (1.9) against S. epidermidis and Enterococcus 
durans Schleifer & Kilpper-Baeiz.  
 
In 2006, Amagata and colleagues
20
 obtained a fungus (strain 001314c) from a yellow 
fan-shaped sponge (collection no. 00314, Ianthella sp. Pallas) from PNG. Based on 
DNA sequencing analyses, the closest relative of strain 001314c was Fusarium 
graminearum (Schwein.) Petch. However, due to a genetic distance of 9.75%, these 
authors were unable to establish the taxonomy of strain 001314c.  
 
Bioassay guided purifications and LC-MS experiments helped Amagata and co-
workers
20
 in the discovery of three novel cyclic depsipeptides: guangomides A and B 
(1.10 and 1.11) and homodestcardin (1.12) shown in Figure 1.12. 
 
 
Figure 1.12: Guangomides A and B (1.10 and 1.11), homodestcardin (1.12) 
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In general, assignments of the absolute stereochemistry for the three compounds were 
on the basis of results compiled from HPLC analysis of products derived from Marfey’s 
acid hydrolysis, NMR experiments, X-ray analysis and observations of optical rotation. 
 
Thus, these authors concluded that guangomide A (1.10) possessed the absolute 
stereostructure 2S, 9S, 13S, 19S, 24R and 28R. In addition, the absolute stereostructure 
of guangomide B (1.11) was determined to be the same as that for guangomide A (1.10) 
according to comparisons between observations of the optical rotations and NMR data 
for each asymmetric centre.  
 
With regards to the absolute stereostructure of homodestcardin (1.12), this was achieved 
by comparisons of NMR experimental data and analogy between homodestcardin (1.12) 
and known compounds homodestruxin B and roseocardin, not shown in this review. In 
vitro examination of guangomides A and B (1.10 and 1.11) indicated weak antibacterial 
activity against S. epidermidis and E. durans.
21
 
 
In 2006, Boot and co-workers
22
 obtained the fungus Acremonium sp. Link (collection 
no. 021172cKZ) from cultures of a sponge (Teichaxinella sp. collection no. 02172) 
collected in Milne Bay, PNG.  
 
The fungus Acremonium sp. Link (collection no. 021172cKZ) was submitted further 
purifitcation via a bioassay guided fractionation. Upon fractionation, these authors 
isolated two novel N-methylated linear octapeptides RHM1 and RHM2 (1.13 and 1.14) 
together with the known efrapeptin G (1.15), shown in Figure 1.13. 
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Figure 1.13: RHM1 and RHM2 (1.13 and 1.14) and efrapeptin G (1.15) 
 
Although the analysis of amino acids was not an easy task, these authors used extensive 
NMR and ESIMS experiments to elucidate the structure of the compounds isolated. 
Regarding RHM1 (1.13), the configuration was found to be Ac-(R)-Gln-(2S,3S)-Ile-(S)-
N-Me-Leu-(2S,3S)-Ile-(S)-N-Me-Val-(2S,3S)-N-Me-Ile-(2S,3S)-N-Me-Ile-(2S,3S)-N-
Me-Ile-OH, as determined by Marfey’s method.22 
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With regards to the configuration of RHM2 (1.14), these authors reported: Ac-(R)-Glu-
(S)-Val-(S)-N-Me-Leu-(S)-N-Me-Val-(2S,3S)-Ile-(2S,3S)-N-Me-Ile-(2S,3S)-N-Me-Ile-
(2S,3S)-N-Me-Ile-OH. This sequence was postulated based on the similarities of 
biosynthetic origins of RHM1 and RHM2 (1.13 and 1.14).
22
 
 
Finally, in vitro antibacterial testings indicated that S. epidermidis was susceptible to 
RHM1 (1.13) (MIC 50 µg.mL
-1
) and efrapeptin G (1.15) (MIC 80 µg.mL
-1
) with RHM2 
(1.14) being the least active of the three compounds (MIC > 400 µg.mL
-1
). It is worth 
noting that RHM1 (1.13) and RHM2 (1.14) showed weak cytotoxicity (potency < 16) 
relative to that shown by efrapeptin G (1.15) (potency 3300) against solid tumour 
murine cancer cells. It should also be noted that no controls were used in toxicity test.
22
 
 
The following year Boot and co-workers
23
 re-assayed the Acremonium sp. Link (strain 
021172c) and isolated two novel efrapeptins Eα and H (1.16 and 1.17) as well as the 
known efrapeptin F (1.18), all shown in Figure 1.14. In addition, the previously reported 
efrapeptin G (1.15) was also isolated. 
 
Similarly to efrapeptin G (1.15) the elucidation of efrapeptins Eα and H (1.16 and 1.17) 
was based on NMR and extensive MS data analyses. With regards to the 
stereostructures of efrapeptins Eα and H (1.16 and 1.17) these authors suggested L 
stereochemistry for each of their amino acids. In vitro biological testings of efrapeptin 
G, Eα and F (1.15, 1.16 and 1.18) against H125 human lung carcinoma cells exhibited 
IC50 of 1.3 nM across the three compounds.
23
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Figure 1.14: Efrapeptins Eα, H and F(1.16, 1.17and 1.18)  
 
Boot and colleagues
23
 isolated two novel N-methylated linear octapeptides, RHM3 and 
RHM4 (1.19 and 1.20), from an Acremonium sp. Link (strain 021172c). The 
stereostructures of RHM3 and RHM4 (1.19 and 1.20) shown in Figure 1.15, were 
relative to that determined for RHM1 (1.13). In addition, two known N-methylated 
scytalidamides A and B (1.21 and 1.22) ), shown in Figure 1.15, commonly found in 
Scytalidium sp. fungal strains, were also isolated from an Acremonium sp. Link (strain 
021172c). 
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These authors did not report any information regarding 1.21 and 1.22 stereostructures, 
as both were known compounds. Structures of 1.21 and 1.22 shown in Figure 1.15 were 
reported by other authors.
24
 In vitro antibacterial testing for novel RHM3 and RHM4 
(1.19 and 1.20) were not performed.
23
 
 
 
 
Figure 1.15: Octapeptides RHM3 and RHM4 (1.19 and 1.20) and scytalidamides A and B 
(1.21 and 1.22) 
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Also in 2007, Oh and co-workers
25
 prepared co-cultures of two different 
microorganisms, as a way to induce the production of novel chemotypes. These authors 
cultured the marine-derived fungus, Emericella sp. (strain CNL-878, isolated from 
green algae Halimeda sp. J. V. Lamouroux Madang Bay, PNG) and the actinomycete, 
Salinispora arenicola Maldonado et al. (strain CNH-665) in a single vessel to replicate 
microorganism interactions, as it would occur in a natural environment, to induce the 
production of new natural products. Oh and co-workers
25
 isolated two novel cyclic 
depsipeptides emericellamides A and B (1.23 and 1.24) shown in Figure 1.16. 
 
 
Figure 1.16: Emericellamides A and B (1.23 and 1.24) 
 
Relative configurations were assigned for emericellamide A (1.23), as 21R*, 22R* and 
23S*, based on J-based configurational analyses, using 
3
JHH, 
3
JCH and NOE 
correlations.
25, 26
 In addition, the absolute stereochemistry was reported as C-21 R , C-
22 R and C-23 S according to Mosher’s derivatisation method.  
 
Oh and co-workers
25
 also found that the amino acid residues in emericellamide A (1.23) 
possessed L stereochemistry, according to comparisons between Marfey standards of L- 
and D- Ala, Val and Leu and hydrolysis products of emericellamide A (1.23). The 
stereostructure of emericellamide B (1.24) was based on comparisons with 
emericellamide A (1.23) data resulting in 21R, 22R, 23S and 25S. 
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In vitro antibacterial assessment of the two depsipeptides showed that emericellamide A 
(1.23) exhibited moderate activity against MRSA (MIC 3.8 µM) and weak cytotoxicity 
against HCT-116 human colon carcinoma cells (IC50 23 µM). In vitro biological activity 
of emericellamide B (1.24) was weaker than that shown by emericellamide A (1.23) 
showing an MIC of 6.0 µM against MRSA strains and IC50 of 40 µM against HCT-116 
human colon carcinoma cells. 
 
In 2008 Hoffman and co-workers
27
 isolated the endophyte Phoma sp. Saccardo (strain 
NG-25) from the lower crown of Saurauia scaberrinae Willd. found near Goroka in the 
Eastern Highlands Province of PNG. These authors isolated two natural products, usnic 
acid (1.25) and cercosporamide (1.26), known in the literature for their phytotoxic and 
antifungal properties.
27
 In addition, Hoffman and co-workers also isolated a new natural 
product named phomodione (1.27), which is an analogue of usnic acid (1.25). Their 
structures are shown in Figure 1.17.  
 
 
Figure 1.17: Usnic acid (1.25), cercosporamide (1.26) and phomodione (1.27) 
 
Phomodione (1.27) was characterised using HRMS, 1D and 2D NMR experiments and 
X-ray crystallography analyses. Relative abundances of fragment ions of phomodione 
(1.27) suggested close relation to usnic acid (1.25). In addition, phomodione (1.27) 
possess a relative stereochemistry C-4a S* and C-9b R* and it was determined by X-ray 
crystallography, NMR, IR and Raman spectroscopy. 
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In vitro antibacterial activity of the three compounds indicated selectivity and similar 
biological activity against S. aureus according to the diameter of the zone of inhibition 
(5 mm), as per the disc diffusion assay. 
 
Furthermore, cercosporamide (1.26) and phomodione (1.27) exhibited similar 
antimycotic activity against the plant pathogens Pythium ultimum Trow (MIC 3 – 5 
µg.mL
-1
), Sclerotinia sclerotiorum (Lib.) de Bary (MIC 3 - 8 µg.mL
-1
) and Rhizoctonia 
solani J. G. Kühn (MIC 5 – 10 µg.mL-1), while usnic acid (1.25) was less effective to 
inhibit the growth of the fungal species tested (MIC > 10 µg.mL
-1
).
27
 
 
In 2013 Wijeratne and co-workers
28
 also isolated phomodione (1.27) from the 
endophyte Phoma sp. Saccardo (strain NRRL-46751), as Hoffman and colleagues
27
 did, 
from the lower crown of the plant Saurauia scaberrinae Willd. in the Eastern Highlands 
Province in PNG. Phomapyrrolidones A, B and C (1.28, 1.29 and 1.30), shown in 
Figure 1.18, were isolated in an effort to discover novel antitubercular agents. 
 
 
Figure 1.18: Phomapyrrolidones A - C (1.28 – 1.30) 
 
Extensive NMR spectroscopy and X-ray crystallography analyses were crucial for the 
elucidation of the structures of the three alkaloids. 
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The total relative configuration of phomapyrrolidone A (1.28) was depicted as 1S*, 
4R*,7S*, 8R*, 10S*, 12R*, 13S*, 14S*, 15R*, 16S*, 1’S* and 18R* on the basis of 
comparisons between NMR analyses and relative stereochemistry of related alkaloids 
embellicines A and B, not shown in this review.  
 
NMR data suggested that phomapyrrolidone B (1.29) was a stereoisomer of 
phomapyrrolidone A (1.28) with its relative stereochemistry as depicted in Figure 1.18. 
Phomapyrrolidone C (1.30) was found to be related to phomapyrrolidones A and B 
(1.28 and 1.29). However, the main differences appeared to be around the succinimide 
moiety, where resonances such as the imide carbonyl carbon and a methine carbon were 
absent and replaced by a hemiaminal carbon and oxygenated quaternary carbon. The 
relative configuration was based on comparisons to phomapyrrolidones A and B (1.28 
and 1.29), as depicted in Figure 1.18.
28
 
 
Phomapyrrolidones B and C (1.29 and 1.30) showed weak in vitro antitubercular 
activity for replicating cultures of Mycobacterium tuberculosis Zopf (H37Pv, MIC 5.2 – 
5.9 µg.mL
-1
) according to microplate Alamar Blue assay method and weak in vitro low 
oxygen recovery for non-replicating cultures of M. tuberculosis (H37Pv, 13.4 – 15.4 
µg.mL
-1
) according to low oxygen recovery assay. 
 
Phomapyrrolidone A (1.28) appeared less active when compared to phomapyrrolidones 
B and C (1.29 and 1.30) in both assays (MIC 20.1 and 41.1 µg.mL
-1
). The three 
alkaloids were also tested against vero cells showing very similar IC50 (32.4 – 35.7 µM). 
In addition, all three alkaloids showed no activity against cancer cells tested at 
concentrations of 5 µM.
28
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In 2013, Wossa and co-workers
29
 isolated boleptosins 11 and 12 (1.31 and 1.32), as well 
as the previously described boleptosins 4 and 7 (1.33 and 1.34) and cycloleucomelone 
(1.35), from the fruiting bodies of a Boletopsis sp. Fayod used traditionally by the Kiovi 
clan of the Lufa district in the Eastern Highlands Province of PNG for its edibility and 
to treat gastrointestinal complaints.
29
 The corresponding chemical structures are shown 
in Figure 1.19. 
 
 
Figure 1.19: Boletopsins 11 and 12 (1.31, 1.32), known boletopsin 4, 7 (1.33, 1.34) and 
cycloleucomelone (1.35) 
 
In vitro antibacterial testings of the isolated compounds revealed some degree of 
activity against Gram (+) and Gram (-) bacteria, with all compounds tested being 
moderately active against S. epidermidis IC50 = 242 – 500 µg.mL
-1
. 
 
In 2014, as part of an international cooperative biodiversity group program, Jadulco and 
co-workers
30
 screened extracts of endophytic fungi isolated from terrestrial and marine 
sources in PNG. Tuberculosis-active pyrrolocin A (1.36) was isolated from a novel 
fungal strain (NRRL-50135) of a taxonomically unclassified endophyte isolated from 
the stem of an Asplenium sp. L. fern in Watunou, Milne Bay, PNG.
30
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NRRL-50135 was subjected to a recombinant expression platform with Fusarium 
heterosporus Link in order to induce the production of more pyrrolocin A (1.36), once 
NRRL-50135 ceased to produce it naturally. Co-cultures of the two organisms was 
successful and these authors also isolated two new decalin analogues, pyrrolocin B and 
C (1.37 and 1.38) shown in Figure 1.20.
30
 
 
 
Figure 1.20: Pyrrolocin A - C (1.36 – 1.38) 
 
The desmethyl analogue pyrrolocin B (1.37) having the cis-decalin configuration, 
according to NMR spectroscopic analysis and absolute configuration of 2R, 3S, 6S, 8S, 
11R, 17R and 5’R, based on Mosher’s approach, was found less active (IC50 112.9 µM) 
against M. tuberculosis than pyrrolocin A (1.36) (IC50 26.3 µM). 
 
In addition, pyrrolocin A (1.36) and the desmethyl analogue pyrrolocin C (1.38) (IC50 
56.4 µM), both containing a trans-decalin configuration, was suggestive that the trans 
configuration and the N-methylation could increase the antimicrobial activity of this 
class of compounds.
30
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In 2015 Beekman and co-workers
31
 isolated boleptosins 13 and 14 (1.39 and 1.40), 
shown in Figure 1.21, from the fruiting bodies of a Boleptosis sp. collected in the forest 
that surrounds the Kiovi clan in the Lufa district in the Eastern Highlands Province of 
PNG.
31
 
 
 
Figure 1.21: Boleptosins 13 and 14 (1.39 and 1.40) 
 
These polybrominated compounds represented the first example naturally produced by a 
terrestrial macrofungi. In addition, due to insufficient amounts obtained upon isolation 
from the natural source, these authors used a combination of synthetic work, 
chromatography and NMR and mass spectrometry. 
 
In vitro antibacterial activity of both polybrominated metabolites indicated that 
boletopsins 13 and 14 (1.39 and 1.40) exhibited weak antibacterial activity against E. 
coli and S. epidermidis (MIC greater than 650 µg.mL
-1
).
31
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Lin and co-workers
32
 isolated racemic oxazonin A (1.41), shown in Figure 1.22, from a 
filamentous fungus (class Eurotiomycetes O. E. Erikss. & Winka, strain 110162) 
isolated from the ascidian Lissoclinum patella from PNG.
32
  
 
 
Figure 1.22: Oxazinin A (1.41) (racemic)  
 
The chemical structure of oxazonin A (1.41) was elucidated following 1D and 2D NMR 
experiments and its relative configuration was proposed to be 3S*, 11R*, 12S*, 24S*, 
3’R*, 24’R* determined by a combination of ROESY correlation analyses, Chem3D 
and molecular dynamics simulation modelling tools.
33
 
 
In addition, oxazonin A (1.41) was found to be present, as a racemic mixture, according 
to CD spectroscopy analysis. Oxazonin A (1.41) was tested for inhibitory activity 
against a panel of bacteria showing growth inhibitory activity against M. tuberculosis 
(IC50 2.9 µM), as well as activity against human CEm-TART T-cell leukaemia line 
showing a LC50 = 4.7 µM.
32
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Also in 2015 in a personal communication, Janso J.,
34
 the scientist responsible for 
screening more than 600 extracts of fungi obtained from terrestrial and marine sources 
in PNG, isolated three known compounds named: regulotrosin A (1.42), cordypyridone 
A (1.43) and blennin A (1.44) (Figure 1.23).
34
 
 
 
Figure 1.23: Regulotrosin A (1.42), cordypyridone A (1.43), blennin A (1.44) 
 
Janso J.
34
 communicated that regulotrosin A (1.42) was isolated from the endophyte 
Bipolaris sp. Shoemaker (culture ENDO-0489) and isolated from the roots of a 
Rottboellia sp. L. in Watunou village in PNG. No further characterisation information 
was provided to us for regulotrosin A (1.42), as it was a known compound. It should be 
noted that the structure depicted in Figure 1.23 was reported by Stewart and co-
workers.
35
  
 
With regards to cordypyridone A (1.43), this secondary metabolite was isolated from 
the endophyte Phomopsis sp. Sacc. & Roum. (culture ENDO-0539), which was 
extracted from the roots of an Areca sp. L. in Deka Deka island in PNG. No further 
characterisation information was provided to us for cordypyridone A (1.43), as it was a 
known compound. It should be noted that the structure depicted in Figure 1.23 was 
reported by Isaka and co-workers.
36
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Finally, blennin A (1.44) was isolated from an unidentified basidiomycete (PNG-03S-
018), which was isolated from the interior of the sponge Haliclona sp. Grant in 
Bagabag, PNG. Similar to regulotrosin A (1.42) and cordypyridone A (1.43), no further 
characterisation was communicated to us, as the chemical structure depicted in Figure 
1.23 was reported by De Bernardi and co-workers.
37
 
 
1.3 Conclusion 
A total of 43 secondary metabolites have been isolated from marine and terrestrial fungi 
from Papua New Guinea (PNG). In addition, approximately 60% (n = 25) of the 
secondary metabolites isolated were found to be novel compounds exhibiting a wide 
range of biological activities. Figure 1.24 shows the number of secondary metabolites 
isolated from fungi from PNG on a yearly basis across a 15-year period. 
 
 
Figure 1.24: Number of secondary metabolites isolated from marine and terrestrial fungi 
from Papua New Guinea across a 15-year period from 2000. 
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A total of 14 fungal species were used in the isolation of secondary metabolites reported 
in this review. Marine derived fungi have been the most commonly selected fungal 
types for the discovery of novel compounds (50%, n = 7) followed by endophytes (36%, 
n = 5) and macrofungi (14%, n = 2). 
 
Marine derived fungi were sourced from sponges (29%, n = 4), ascidians (14% n = 2) 
and algae (7%, n = 1), while the macrofungi reported herein were collected from the 
forest that surrounds the Kiovi village in the Eastern Highlands Province of PNG. 
 
Interestingly, of the 25 novel compounds isolated, 15 secondary metabolites were 
obtained from seven marine derived fungal species resulting in a ratio of approximately 
2 new compounds per marine derived fungi isolated. It is also interesting that four novel 
secondary metabolites were obtained from two species of macrofungi of the same 
genus, resulting in a ratio of two new compounds per macrofungi tested. 
 
PNG is described in the literature as one of the most biodiverse places in the world.
38
 
Considering that out of the 3.5 million fungal species present in the world,
11
 90,000 are 
located in PNG,
29
 it can be expected that an enormous number of macrofungi from PNG 
are waiting to be evaluated for the discovery of new bioactive compounds. 
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Chapter Two 
Mushrooms from Papua 
New Guinea and their 
antimicrobial potential 
 
Antimicrobial screening of mushrooms. Pictures from left to right: excerpt of MTT testing 
(author’s photograph), photograph of a Boletus sp. L. by Anson Barish (UoG) (edited and 
reproduced with permission) and disc diffusion assay (author’s photograph). 
 
This section examines the mushrooms used by indigenous communities in three 
provinces of Papua New Guinea (PNG), on the basis of ethnomycology, namely; a) 
Eastern Highlands Province, b) Simbu Province and c) Jiwaka Province. In vitro 
antibacterial testing of mushrooms used is also reported.  
  
32 
Chapter two: Mushrooms from Papua New Guinea 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
Chapter 2 : Antimicrobial screening of mushrooms 
2.1 Introduction 
Medicinal plants are the oldest source of biologically active agents and they have for 
centuries represented an alternative to allopathic medicine or the orthodox system, in 
which the use of drugs is used for the treatment of various medical conditions.
39
 Papua 
New Guinea (PNG) possesses one of the most biodiverse ecosystems in the world, and 
the use of plants, as medicines, has been commonly practised.
40
 
 
The government of PNG has worked with an International Cooperative Biodiversity 
Group (ICBG) to evaluate the use of plants as medicines by exploring their antibacterial 
activities and to identify chemicals responsible for the biological activities.
41
 Papua 
New Guineans have included the use of mushrooms in their medical traditions, as 
ethnomycology has been commonly practised for thousands of years.
42
 However, the 
use of mushrooms as food, medicine or for cultural rituals has been poorly documented. 
 
As part of an ongoing study to preserve first-hand knowledge, as it pertains to the use of 
mushrooms by indigenous tribes in PNG, initial contact was established with one 
ethnolinguistic group in the Easter Highlands Province. Subsequently, contact was also 
established with two other groups in the surrounding area. 
 
Therefore, we examined the mushrooms used by the Kiovi tribe from the Eastern 
Highlands Province, the Waefo tribe from the Simbu Province and the Kopanka clan 
from the recently created Jiwaka Province (Figure 2.1; numbers on map: 3, 2 and 22 
respectively). An emphasis on ethnomycology pertaining to mushrooms' antibacterial 
potential has been placed. 
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Figure 2.1: Study areas: Eastern Highlands Province (3), Simbu Province (2) and Jiwaka 
Province (22). Image source available under Creative Commons Licence.
43
 
 
2.2 Study area and population 
Kiovi, Waefo and Kopanka are ethnolinguistic groups living in mountainous regions of 
PNG. The Kiovi are inhabitants of the Lufa District, which area is at latitude 6˚20’57’’S 
and longitude 145˚20’31’’E in the Eastern Highlands Province (No. 3 on map, Figure 
2.1). The 2011 census gave the population of 579 825 inhabitants of Eastern Highlands 
Province with approximately 61 057 people in Lufa District.
44
 
 
The Waefo are based in the Siane area in Chuave District, which area is at latitude 
6˚7’12’’S and longitude 145˚7’36’’E in Simbu Province (No. 2 on map, Figure 2.1). 
The 2011 population count suggested a total of 376 473 inhabitants of Simbu Province 
with approximately 39 021 people in Chuave District.
44
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The Kopanka inhabit the hilltop of Tapiaku village within the Anglimp-South Waghi 
District, which area is at latitude 5˚52’38’’S and longitude 144˚41’11’’E, with a total 
area of about 1 970 km
2
, in the central highlands region of Papua New Guinea’s newly 
created Jiwaka Province (No. 22 on map, Figure 2.1). The 2011 population count 
suggested a total of 343 987 inhabitants of Jiwaka Province with approximately 194 109 
people in the Anglimp-South Waghi District.
44
 Although no ethnographic studies have 
been performed on the Kopanka, their village is on the rocky highlands overlooking the 
Wahgi river and hence the name Tapiaku, which means “on the rocks”. 
 
Similar to other clans in PNG, the Kiovi, Waefo and Kopanka reside in small villages 
and due to the difficult access to and from the mountainous areas they inhabit, the three 
ethnolinguistic groups studied herein rely heavily on their land for their livelihood. 
Therefore, the study areas include the forest that surrounds the Kiovi village, Waefo 
from the Siane area and Kopanka from the Tapiaku village. 
 
2.3 Ethnomycological data collection 
The traditional forest owners and councillors representing the Kiovi, Waefo and 
Kopanka granted our research team with permission to utilise their local forest for the 
collection of mushrooms traditionally used by their inhabitants. Formal consent letters 
signed by the forest owners to conduct research in the area are kept at the University of 
Goroka (UoG). 
 
Ethnomycological information was gathered using a combination of informal focus 
groups through semi-structured interviews and forest walks. Focus groups were 
composed by members of the community 30 years of age or older capable of identifying 
mushrooms by local names. 
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Local names and uses of mushrooms were cross-checked with at least two elders and 
the village chief. Interviews were carried out by Mr Stewart Wossa for the Kiovi and Mr 
John Nema for the Waefo, as they are both fluent in the Tok Pisin language. Interviews 
for the Kopanka tribe were carried out by the author of this thesis in English and Mr 
Stewart Wossa as a translator, also in Tok Pisin language. 
 
2.4 Collection of mushroom material 
Only mushrooms traditionally used as foods, medicines or in rituals according to the 
local inhabitants cultural believes, including those that were regarded as potentially 
poisonous were collected. 
 
Photographic evidence was kept to record habitat and morphological characteristics of 
the mushrooms and an identity code was assigned on collection. For instance, Kiovi-
MSp1; where “Kiovi” represents the name of the village where samples were collected, 
“M” represents mushroom, “Sp1” indicates sample number one, as the specimen tally 
from that village. The same is true for the Waefo (e.g. Waefo-MSp1) and Kopanka from 
Tapiaku (e.g. Tapiaku-MSp1). 
 
For the Kiovi, collections were conducted during the wet season (August to December 
2012), as this period presents ideal conditions for wild mushroom harvest. For the 
Waefo clan, collections were performed during the fruiting season in the area of Siane 
(November 2012 to February 2013) and finally, for the Kopanka, collections were 
performed in February 2014. Figure 2.2 shows the collection team from Kopanka clan 
in Tapiaku village. 
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Figure 2.2: Collection group from Kopanka clan. Two men on the left contributed greatly 
(from left to right; elder, clan leader). Author’s photograph (February 2014) 
 
Mushroom samples were identified based on morphological comparisons with 
mushroom specimens published in the literature and voucher samples of all species kept 
at UoG. Thus far, a total of 79 mushroom samples have been collected amongst the 
three tribes. There were 26 mushroom samples identified as having ethnological 
linkages with the Kiovi, 18 mushrooms for the Waefo and 35 mushroom specimens 
were collected from the Tapiaku under the direction of the custodians of the traditional 
knowledge and/or landowners of their respective areas. Table 2.1 - Table 2.3 below 
show an excerpt of the specimens collected from the three tribes. For complete tables 
showing specimens collected from both groups refer to appendix 1 - 3. 
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Table 2.1: Mushrooms used by the Kiovi, Eastern Highlands Province, PNG. 
Specimens 
collection code 
Species 
(Family) 
Local name 
 
Field notes 
 
Kiovi-MSp6 
Lactarius sp. 
Pers. 
(Russulaceae) 
Dagaidy  Large fleshy mushroom 
 Could be edible if 
marinated before 
cooking 
 
Kiovi-MSp7 
Russula sp. Pers. 
(Russulaceae) 
Kokai  Strong red coloured cap 
and white gills 
 Hot in taste 
 Regarded as potentially 
poisonous 
 
Kiovi-MSp11 
Ramaria sp. Fr. 
Ex Bonord. 
(Ramariaceae) 
Dekeja-hava  Edible mushroom 
 Club shape 
 Grows on grounds 
 Used to treat stomach 
complaints 
 
Kiovi-MSp15 
Amanita sp. Pers. 
(Amanitaceae) 
Fulaga-dive  Edible mushroom 
 Grows on soil 
 Used as a food source 
 Kiovi people 
particularly reported 
that eating this 
mushroom makes them 
feel well 
 
Kiovi-MSp43 
Albatrellus sp. 
Gray 
(Albatrellaceae) 
Igura hivi  Edible mushroom 
 Grows on dead trunks 
 Kiovi people use this 
mushroom medicinally 
to treat stomach upset 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
  
38 
Chapter two: Mushrooms from Papua New Guinea 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
 
Table 2.2: Mushrooms used by the Waefo, Simbu Province, PNG. 
Specimens 
collection code 
Species 
(Family) 
Local name 
 
Field notes 
 
Waefo-MSp1 
(Polyporaceae) Holipa lua 
hefola 
 
 Edible mushroom 
 Grows on dead trunks 
 Associated with 
mosses under moist 
conditions 
 Cooked in wooden 
drums before eating 
 
Waefo-MSp4 
(Polyporaceae) Heleme lua 
 
 Edible mushroom 
 Grows on soil 
 Waefo made emphasis 
on the good taste of 
this mushroom 
 
Waefo-MSp5 
(Bracket fungus) He lua 
 
 Edible mushroom 
 Grows on the bark of 
specific living trees 
 Culturally of great 
value as it is specially 
given to pigs to fatten 
them 
 
Waefo-MSp6 
(Polyporaceae) Mamona lua 
homulege 
 
 Edible mushroom  
 Grows on dead trunks 
 Associated with high 
moisture 
 Raw mushroom 
induces vomiting 
 Mushroom is cooked 
before eating 
 
Waefo-MSp7 
(Amanitaceae) 
 
Fiona fululu lua 
(slippery/waxy) 
 
 Edible mushroom 
 Grows on soil and on 
dead trunks 
 Mushroom is cooked 
before eating 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
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Table 2.3: Mushrooms used by the Kopanka, Jiwaka Province, PNG. 
Specimens 
collection code 
Species 
(Family) 
Local name 
 
Field notes 
 
Tapiaku-MSp9 
Auricularia sp. 
(Dicks.) Pers. 
(Auriculariaceae) 
Koikamuk 
(rat ears) 
 Edible mushroom 
 Eaten cooked or 
boiled 
 Given to mothers 
post-partum for womb 
healing 
 
Tapiaku-MSp12 
Echinoderma sp. 
(Pers.) Bon 
(Agaricaceae) 
Nakents 
(baby faeces) 
 Edible mushroom 
 Grows on soil 
 Given to babies as 
anti-diarrhoeal 
 
Tapiaku-MSp18 
Microporus sp. 
P. Beauv. 
(Polyporaceae) 
Willikimik  Edible mushroom 
 Grows on dead trunks 
 Used for the treatment 
of pimples and scar 
removal 
 
Tapiaku-MSp21 
Morchella sp. 
(L.) Pers 
(Morchellaceae) 
Kipenembik 
(devil’s penis) 
 
 Edible mushroom 
 Grows on garden soil 
 Eaten cooked and 
used as a food source 
 
Tapiaku-MSp27 
Missing data Bongnengs 
(no English 
translation) 
 Edible mushroom 
 Grows on soil 
 Eaten cooked 
 Given to babies to 
prevent diseases and 
to grow healthy 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
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2.5 Mushroom uses amongst the Kiovi, Waefo and Kopanka 
Twenty six mushrooms have been collected from the forest that surrounds the Kiovi 
people under the leadership of Mr Stewart Wossa. Fulaga dive is one of the mushrooms 
used by the Kiovi for its edibility and because it makes them “feel well”. 
 
The Fulaga dive mushroom (Amanita sp. Pers.) is discussed in Chapter 3. Igura hivi 
(Albatrellus sp. Gray) is another mushroom used by the Kiovi to treat stomach 
complaints, and it is briefly discussed in Chapter 6. Furthermore, 18 mushroom species 
were identified as having ethnological linkages to the Waefo and 35 mushroom species 
to the Kopanka. For complete tables outlining ethnomycological data for the three tribes 
refer to appendices 1 - 3. Figure 2.3 shows ethnomycological comparisons between the 
three tribes. 
 
 
Figure 2.3: Mushroom uses by the Waefo and Kopanka 
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It is not surprising that amongst the three clans, mushrooms are predominantly used as a 
source of food. Difficult access to provincial areas forces inhabitants of remote 
communities to live of the forest and hence using mushrooms as foods become common 
practice. In addition, the three clans utilise mushrooms to feed and fatten pigs. This is 
not surprising, as pigs are considered highly valuable livestock in PNG. As well as 
using pigs for food, pigs represent social status. Pigs are mostly used for very important 
events, such as funerals, weddings, initiation rituals. In addition, the use of pigs is still 
used as the main dowry in exchange for women.
45
 
 
Mushrooms used to treat pain amongst the Kopanka appeared in second place after 
those species used mainly as a food source. However, it should be noted that the 
Kopanka were unable to differentiate amongst Ombnantskim species (sugar cane skin) 
and hence based on the Kopanka’s communications, mushrooms species used as 
analgesics would be reduced to one. 
 
Interestingly, the number of mushrooms considered as potentially toxic by the Waefo 
surpassed even those that were identified as good to eat and it is followed by the Kiovi 
with five mushrooms species reported as potentially toxic (see Appendix 1 for complete 
table). Contrastingly, potential toxic mushrooms identified by the Kopanka clan were 
reduced to two species referred by the common name “Mos” and recorded as Mos-1 and 
Mos-2 under the codes Tapiaku-MSp33 and Tapiaku-MSp34 respectively (Appendix 3). 
It should be noted that Mos-2 was reported to be edible. However, the Kopanka 
reported that gills must be removed before cooking, due to potential toxicity.  
 
Other mushroom species such as Binge bang, Dukdedek and Kalap were reported as 
inedible species. However, they were used to treat different medical conditions. For 
complete tables outlining field notes and common names of mushrooms collected 
amonst the three clans, see Appendices 1 – 3. 
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It might be plausible that ethnomycology amongst the Kopanka have enable them to 
identify mushrooms used as stimulants, analgesics, to treat skin conditions or to boost 
their immune system and prevent diseases, including those with spiritual uses, for 
example Kombsar (Tapiaku-MSp10, Appendix 3), which means lightning and the 
Kopanka believes that Kombsar provides them with protection from lightning strikes 
during the wet season, as it appears after a heavy thunderstorm. Further research should 
be done to determine why the Kiovi and Waefo people do not possess the same 
mushroom knowledge when compared to their neighbours the Kopanka. 
 
2.6 Methodology 
Previous work within our research group has focused on the antimicrobial screening of 
ethanolic extracts of mushrooms used by Papua New Guineans employing a paper disc 
diffusion assay, which relies on the ability of a test sample to diffuse into an agar 
medium containing a lawn of microorganisms as an indication of biological activity (see 
section 2.6.2).
46
 
 
Preliminary testings of mushrooms collected found ‘good’ (>16 mm), ‘moderate’ (10-
15 mm) or ‘low’ (<10 mm) levels of activity against microorganisms tested. While the 
paper disc diffusion assay is a useful tool for the analysis of antimicrobial activity due 
to its low cost and its ability to be used to test several samples simultaneously, it is 
limited by the capacity of lipophilic active compounds to diffuse through an aqueous 
agar medium. 
 
Low levels of activity observed in preliminary testings of pure isolated compounds from 
extracts of mushrooms of reputed medicinal significance led us to suspect that poor 
diffusion of the purified compounds was to blame causing uncertainty in the results of 
preliminary testings. 
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Such uncertainty prompted us to implement a more reliable and reproducible method 
for the screening of pure isolated compounds and crude mushroom extracts. Two 
methods were chosen for this task; a) thiazolyl blue tetrazolium bromide (MTT) assay, 
for cell proliferation, which relies on a biochemical reaction between blue tetrazolium 
and living cells of a microorganism to induce a colour change and therefore suggest 
whether the test sample is active or not (see section 2.6.3);
47,48
 and b) a turbidity assay, 
which relies on measuring the optical density (OD) at 600 nm of a bacterial suspension 
to determine activity of a test sample (see section 2.6.4).
49,50
 
 
2.6.1 Preparation of mushroom extracts 
Because of Australian Quarantine restrictions in the import of organic materials, the 
following extraction protocol was performed at UoG prior to shipping to Australia. 
Specimens were thoroughly washed with water and cut into small pieces. Mushroom 
material (500 – 1000 g) was macerated in 95% EtOH for a week in a 1:3 ratio of solid 
matter and solvent. The resulting fluid extract (approx. 1500 – 3000 mL) was filtered to 
remove any residues and concentrated under reduced pressure to obtain approximately 
50 - 100 mL of concentrated extract. Samples were stored in plastic bottles labelled with 
the assigned code during collection and shipped to the ANU for further work in the 
laboratory. 
 
2.6.2 Paper disc diffusion assay 
The disc diffusion assay explained herein is based on the antibiotic susceptibility testing 
by a standardised single disc method or the Kirby-Bauer method.
46
 In brief, this assay 
uses 6 mm filter paper discs impregnated with a known concentration of the test sample 
to be screened (e.g. mushroom extracts, antibiotics, controls) and placed onto a lawn of 
bacteria in an agar petri dish. The test sample will diffuse out of the paper disk into the 
media, which was previously covered by a layer of bacteria. Bacteria will be culled or 
its growth will be interrupted if susceptible to the test sample. 
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The area with no bacterial growth around the paper disc is referred to as the zone of 
inhibition (ZoI). The diameter of the ZoI is measured in millimetres (mm) and its size 
gives an indication whether the bacteria is resistant or susceptible against the test 
samples.
46
 Figure 2.4 shows an example of an active sample with a clear ZoI (right hand 
side). 
 
 
Figure 2.4: Zone of inhibition for active sample (right hand side). Author’s photograph. 
 
A bacterial suspension is prepared from a single colony of the organism to be tested. 
The suspension is then incubated overnight and diluted to achieve an OD of 0.5 
McFarland standard and further diluted 100-fold with a non-specific broth medium. 
Turbidity could be adjusted visually with the aid of a Wickerham card (Figure 2.5), or 
by measuring the OD600 of the suspension.  
 
The resulting bacterial suspension is subsequently streaked evenly onto the previously 
prepared agar petri dish with the help of a cotton swab or a glass rod in the shape of a 
hockey stick.
51
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Figure 2.5: Visual comparison of OD of bacterial suspension using a Wickerham card. 
Author’s photograph. 
 
Paper discs containing a known concentration of the test sample and appropriate 
controls are placed on the agar with sterile tweezers and gently pressed down to ensure 
contact with the agar. Petri dishes are subsequently incubated for 18h and the activity of 
the test samples is determined by measuring the diameter of the ZoI with a ruler. 
 
A measurement of 6 mm indicates the absence of a ZoI and therefore the organism 
tested could be considered resistant to the test sample. Complete bacterial growth 
inhibition is determined by the naked eye. However, test sample with a ZoI of equal or 
more than 16 mm are considered to have ‘good’ inhibition properties, those with a 
measurement of 10-15 mm are ‘moderate’ and those with a measurement below 10 mm 
are said to have ‘low’ levels of bacterial growth inhibition.  
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Although the paper disc assay is very popular due its low cost and its ability to screen 
several test samples in a time efficient manner, it relies on the ability of the test sample 
to diffuse from the paper disc into the agar and hence prevent the growth of the 
microorganism.  
 
This dependence of the test sample to diffuse is a major disadvantage of the paper disc 
diffusion assay especially when test samples assayed are of high hydrophobicity and 
hence diffusion into aqueous media could be non-existent resulting in false negatives.
19
 
As per the aforementioned reasons, a new test was selected for the antimicrobial 
screening of mushrooms. 
 
2.6.3 MTT colourimetric assay 
The modified MTT colourimetric method explained herein is based on a method for 
drug susceptibility testings as described by Mengatto et al.
47
 and Caviedes et al.
48
 In 
brief, this method uses a yellow MTT-tetrazolium salt as an indicator for cell 
proliferation. Yellow MTT-tetrazolium is added to a mixture of bacterial suspension 
and test sample (e.g. mushroom extracts, antibiotics, and controls) and incubated for 60 
min. 
 
The water soluble yellow tetrazolium salt undergoes reduction with hydride from 
reductases of living cells. This cleavage leads to the development of a blue-purple 
colour, characteristic of the water-insoluble MTT-formazan. A blue-purple colour 
suggests that the organism of interest is resistant to the test sample, while a yellow 
colour is an indication of bacterial susceptibility to the test sample.
47,48 
Figure 2.6 shows 
reduction of yellow tetrazolium to blue formazan. 
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Figure 2.6 Reductive cleavage of the yellow tetrazolium salt to blue formazan 
 
Thiazolyl blue tetrazolium bromide or 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl 
tetrazolium bromide is a yellowish water soluble compound that was first developed to 
test the efficacy of anticancer agents.
52
 MTT-tetrazolium was later adapted to test the 
efficacy of potential antibacterial compounds.
47,48
 
 
A bacterial suspension is prepared in the same manner as for the disc diffusion assay, 
starting from a single colony of the organism to be tested. The suspension is incubated 
overnight and diluted to achieve an optical density of 0.5 McFarland standard and 
further diluted 100-folds. The bacterial suspension is subsequently added to a 96 well 
microtiter plate containing a known concentration of the test sample. 
 
Plates are incubated overnight and yellow MTT-tetrazolium is added to the mixture. 
After 60 min of incubation the minimum inhibitory concentration (MIC) is assessed 
visually, as shown in Figure 2.7. MIC refers to the lowest concentration of the test 
sample capable of producing a yellow colour. Although the reductive mechanism in 
which yellow MTT-tetrazolium is converted to blue MTT-formazan is not well 
understood in living bacteria, the MTT assay is widely accepted,
53
 especially as a 
confirmation technique for the disc diffusion assay. 
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Figure 2.7: Exerpt of a 96 well plate showing colour change from yellow MTT-tetrazolium 
(susceptible bacteria) to blue MTT-formazan (resistant bacteria). Photograph adapted 
from assay performed by the author. 
 
Some advantages of the MTT method include: a) the capability to test multiple samples 
at different dilutions simultaneously to determine MICs, b) no expensive equipment to 
measure MICs is required, and c) MICs can be determined visually by a colour 
change.
47
 
 
Although the MTT assay possesses several advantages when compared to the disc 
diffusion assay, a major disadvantage is that the MTT assay is unable to visually 
determine the concentration of test sample capable of inhibiting 50% of the growth of 
microorganisms (IC50).  
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In addition, considering that the MTT assay depends on the presence of living cells in 
order to induce reductive cleavage of yellow MTT-tetrazolium into blue MTT-
formazan,
54
 it might be plausible that false negatives could be mistakenly reported 
especially when test samples are unable to inhibit 100% of cell growth. It could also be 
challenging to the analyst to see a yellow or blue colour especially when dealing with 
strongly coloured test samples. 
 
2.6.4 Turbidity assay 
The turbidity assay explained herein is based on a method for the estimation of the 
amount of bacteria present in a liquid medium, as described in the literature.
49,50
 In 
brief, this method requires the use of a spectrophotometer to measure the turbidity of a 
mixture between bacterial suspension and test sample and subsequently translating the 
measurements into cell density values. 
 
A bacterial suspension is prepared in the same manner as for the MTT-tetrazolium 
assay, starting from a single colony of the organism to be tested. OD is measured at 600 
nm before and after incubation. A turbid bacterial suspension or high reading in the 
spectrophotometer suggests that the organism of interest is resistant to the test sample, 
while a less turbid suspension or low reading in the spectrophotometer is an indication 
of bacterial growth inhibition and hence susceptibility to the test sample.
50
 
 
Figure 2.8 shows a schematic representation of how the turbidity of a bacterial 
suspension is measured. In a typical spectrophotometer, a tungsten lamp emits light, 
which is subsequently dispersed by a diffraction prism. Of the dispersed light a 
monochromatic light band of 600 nm wavelength passes into the test sample. Light that 
passes through the solution gets detected and measured electronically providing an OD 
reading. 
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In order to achieve an accurate turbidimetric reading, the spectrophotometer must be 
adjusted to zero percent absorbance. This is done by measuring the OD of the bacterial 
suspension prior incubation.
18
 
 
 
Figure 2.8: OD of bacterial suspension. Diagram adapted from Taiz L. Et al.
55
 
 
Some advantages of the turbidity method over the MTT assay and disc diffusion assay 
are a) that it is possible to determine IC50 based on turbidity measurements of the test 
samples, b) It is possible to test multiple dilutions simultaneously and c) the turbidity 
method does not rely on visually inspecting a colour change from yellow to blue to 
determine bacterial susceptibility, as in the MTT assay.  
 
Although the turbidity method possesses several advantages, it also possesses some 
disadvantages. For example the use of an expensive instrument (spectrophotometer) to 
measure the OD of test samples and bacterial suspensions could re-direct scientists to 
seek for alternative methods. In addition, aggregation and sedimentation of viable or 
dead cells can interfere with the accuracy of OD measurements. This inaccuracy is due 
to the inability of the diffracted light in the spectrophotometer to get across the sample 
test to the detector when the bacterial concentration is too high.
56
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2.6.5 Turbidity-MTT assay 
Turbidity-MTT assay provides a better tool for the screening of mushroom extracts and 
it was chosen for the testings of mushrooms collected from Eastern Highlands Province, 
Simbu Province and Jiwaka Province from Papua New Guinea. While the turbidity 
method facilitates calculations of IC50 and MIC, the MTT assay serves to visually 
confirm susceptibility of bacterial strains tested. The technique was prepared as outlined 
in the literature with minor modifications,
47,57
 and its optimisation proceeded as follows: 
 
a) Preparation of inoculum 
Bacterial suspensions were prepared by inoculating a single colony into 10 mL of non-
selective Mueller Hinton Broth (MHB) and incubated for 18 - 20h. Inoculum size was 
adjusted to OD600 = 0.08 - 0.1 in order to be comparable with the OD of 0.5 McFarland 
standard. A McFarland standard is prepared by mixing aqueous solutions of barium 
chloride and sulphuric acid and its OD correlates to the concentration of inoculum of 
1.5 x 10
8
 cfu.mL
-1
 (range 1.0 x 10
8
 to 2.0 x 10
8
 cfu.mL
-1
).
58
 Figure 2.9 shows individual 
colony forming units (CFU) (left) and comparison between the turbidity of the 
inoculum after incubation (right). 
 
  
Figure 2.9:Single colony forming units (left) to liquid media (right). Author’s photograph. 
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Following adjustment of inoculum to 0.5 McFarland standard, the concentration of 
bacterial suspension was further diluted 100-fold to prevent issues observed at earlier 
stages during the optimisation of the turbidity-MTT method.  
 
Some of these issues included: a) OD outside upper reading limits of spectrophotometer 
when inoculum size used was equal 0.5 McFarland standard and b) strong colouration 
characteristic of a number of crude mushroom extracts that were regarded as potential 
problems especially in the visual evaluation of colour change from yellow to blue in the 
MTT-assay. 
 
Therefore, decreasing the concentration of the inoculum by 100-fold brought the OD of 
inoculum within the measuring limits of the spectrophotometer plate reader used. In 
addition, as well as providing a decrease in the colouration of  mushroom extracts, it 
allowed the control antibiotic to closely reflect the susceptibility data reported by the 
Clinical and Laboratory Standards Institute (CLSI) guidelines for E. coli and S. 
aureus.
59
  
 
Table 2.4 shows a comparison between experimental susceptibility data of E. coli 
(ATCC 25922) and S. epidermidis against kanamycin and that reported by the CLSI. 
 
Table 2.4: Susceptibility of E. coli and S. epidermidis against kanamycin as determined by the 
turbidity-MTT assay 
Organisms *MIC **CLSI reference 
E. coli β (-) (ATCC 25922) 5.26 (2.63 – 10.53) (n = 8) 1 – 4 (E.coli ATCC 25922) 
S. epidermidis (clinical isolate) 3.95 (1.32 – 10.53) (n = 8) 1 – 4 (S. aureus ATCC 29213) 
All units in µg.mL
-1
. IC50 expressed as median (range). (n) refers to the number of data points. 
*Experimental MIC for kanamycin. **CLSI reference MIC for kanamycin.
59
 Note: S. epidermidis was 
used experimentally and CLSI reports S. aureus. 
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b) Bacterial strains used in initial screening 
The organisms selected for the initial screening were: a) ATCC 25922 E. coli (β-
lactamase negative), and b) S. epidermidis (clinical isolate). 
 
E. coli is a common inhabitant of the large intestine,
60
 and while beneficial to humans 
for its ability to prevent the growth of potentially harmful bacteria, certain strains of E. 
coli are the cause of severe diarrhoea leading to the death of young children.
61
 
 
Based on the current child mortality report published by Liu and co-workers,
62
 
diarrhoea continues to be the second most common cause of death in children younger 
than five years of age worldwide, accounting for almost one million deaths per year.
62
 
In addition, Rangel and colleagues, reported that approximately 74,000 cases of 
infections such as haemolytic anaemia, thrombocytopenia and renal injury are caused by 
E. coli in the United States per year.
63
 
 
S. epidermidis is also part of the normal human flora and despite being considered 
innocuous,
64
 it has become the most important cause of nosocomial infections.
65,66
 
Uçkay and co-workers reported that the minimum bactericidal levels of S. epidermidis 
against most antibiotics has increased by 1000-fold.
65
 This increase in resistance of S. 
epidermidis is alarming, as it represents a major threat to hospitalised patients.
64
 
 
E. coli and S. epidermidis are amongst the most commonly isolated pathogens from 
various clinical conditions. In addition, they are classified as risk level 1 according to 
the AS/NZS 2243.3:2010 standards suitable for dealing in a physical containment level 
1 (PC1) laboratory. E. coli and S. epidermidis are ideal candidates to use for the initial 
screening of mushroom extracts for antibacterial activity. 
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c) Estimation of percentage of growth inhibition, MIC and IC50 
Having measured the OD600 of bacterial suspension and test samples before and after 
the incubation period of 18 - 20h at 37°C, the growth of the treated cultures was 
assessed. IC50 were determined based on comparisons with the average OD readings of 
the untreated control and that of the test sample and calculated as per Equation 1. 
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where: A: higher concentration of test compound of the two points that brackets 50% 
inhibition, B: lower concentration of test compound of the two points that brackets 50% 
inhibition, C: inhibitory activity (%) at the concentration B, D: inhibitory activity (%) at 
the concentration A. 
 
Inhibitory activity (%) was calculated as per Equation 2. 
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Inhibition
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x 1100%  
Equation 2 
 
Where: ODsample: average OD of sample test or positive control after incubation, 
ODblank: average OD of sample test or positive control prior incubation, ODgrowth: 
average OD of bacterial suspension without sample test or positive control. 
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d) Ratio of test sample to inocula 
Mushroom extracts were dissolved in DMSO to produce stock concentrations of 50 
mg.mL
-1
 and subsequently diluted to produce working concentrations of 5 mg.mL
-1
. 
Inoculum size was 1.5 x 10
8
 cfu.mL
-1
 correlating to 0.5 McFarland standard and further 
diluted to produce a working inoculum 1.5 x 10
6
 cfu.mL
-1
. 
 
The volume ratio of test material to bacterial culture once in 96 well plates was 
approximately 1:5. This allowed a sample test range of 8 – 1052 µg.mL-1 reflecting the 
ratios used in the MTT method by Steenkamp et al.
50
 In addition, this ratio also allowed 
a bacterial culture final concentration of 4.0 x 10
5
 cfu.mL
-1
, providing an appropriate 
concentration range for the instrument used.  
 
It is worth noting that the concentration of DMSO when preparing test samples was also 
reduced to 2.1% in 96 well plates reflecting safe concentrations to avoid possible 
antibacterial effect of such reagent.
67
 
 
e) Conclusions on optimisation 
Turbidity-MTT assay for the screening of mushroom extracts appeared advantageous, 
when compared to disc diffusion assay and turbidity or MTT alone. For instance, the 
ability of hydrophobic compounds to diffuse out of a paper disc into aqueous agar is 
known to be a challenge in the Kirby-Bauer assay. However, in the turbidity-MTT this 
problem is solved.  
 
Test samples are appropriately dissolved to guarantee contact with inoculum. When 
MTT is used alone, a common issue is the interference between coloured test samples 
and dye uptake by living microorganisms, and hence not being able to see colour 
change from yellow to blue, as stipulated in the literature.
53
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Relying on OD measurements has solved this issue.
54
 MTT method has also some 
advantages against turbidity assay. A possible issue in the turbidity assay is the 
capability of living and dead cells to segregate or sediment causing erroneous OD 
measurements. Using MTT as a confirmation tool for the presence of living cells to 
induce a colour change from yellow to blue could also be considered an advantage.
56
 
 
Reducing the inoculum size by further diluting its initial concentration from 0.5 
McFarland standard, as well as measuring ODblank prior incubation, proved to be very 
useful because readings fell within the limits of detection of the instrument used. 
Finally, a combination of both MTT (qualitative indicator) and turbidity (quantitative 
indicator) provides a stronger method for the accuracy of antibacterial testings. 
 
2.6.6 Laboratory testing of mushrooms used by Kiovi, Waefo and 
Kopanka 
A total of 52 mushroom extracts were prepared, from the Kiovi (n = 26), Waefo (n = 
16) and Kopanka (n = 10), following the protocol described under methodology in 
section 2.6.1 and tested for their antibacterial potential. Of the 52 extracts tested, about 
29% (n = 15) were active against one or more of the organisms tested. Of the active 
species, all showed activity against S. epidermidis with two extracts exhibiting broad 
spectrum activity. 
 
It is worth noting that most of the active extracts were from mushrooms collected in the 
forest that surrounds the Kiovi tribe (23%, n = 12), followed by the Waefo (4%, n = 2) 
and Kopanka (2%, n = 1). Table 2.5 shows a summary of extracts with ‘good’ (IC50 < 
50 µg.mL
-1), ‘moderate’ (IC50 < 600 µg.mL
-1) and ‘low’ (IC50 > 600 µg.mL
-1
) 
antibacterial activity. 
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Table 2.5 Mushroom extracts showing antibacterial activity 
Sample Code Human Pathogenic Bacteria 
S. epidermidis (c/i) E. coli β (-) ATCC 25922 
ZoI 
(mm) 
MIC 
(µg/mL) 
IC50 
(µg/mL) 
(%)Inh 
(µg/mL) 
ZoI 
(mm) 
MIC 
(µg/mL) 
IC50 
(µg/mL) 
(%)Inh 
(µg/mL) 
Kiovi-MSp1 - - 382 (80) 526 - - - - 
Kiovi-MSp2 - - 290 (72) 379 - - - - 
Kiovi-MSp3 - - 640 (54) 688 - - - - 
Kiovi-MSp4 - 7158 2725 - - - - - 
Kiovi-MSp5 - - - (32) 632 - - - - 
Kiovi-MSp10 15 1000 500 - - - - - 
Kiovi-MSp15 10 519 305 - - - - - 
Kiovi-MSp21 - 23158 7626 - - - - - 
Kiovi-MSp25 - 12210 6892 - - - - - 
Kiovi-MSp26 - 18526 2743 - - - - - 
Kiovi-MSp29 - 263 49 - - - 975 (55) 
1053 
Kiovi-MSp43 15 379 168 - - - - - 
Tapiaku-MSp27 21 295 147 - 17 295 194 - 
Waefo-MSp1 - - - (30) 
2358 
- - - - 
Waefo-MSp9 - - - (16) 
2358 
- - - - 
Kanamycin - 2.63 0.78 - - 2.63 1.00 - 
ZoI: zone of inhibition as determined by the disc diffusion assay. MIC: minimum inhibitory 
concentration as determined by turbidity-MTT assay. IC50: concentration of test sample able to inhibit 
50% of the growth of microorganisms as determined by turbidity-MTT assay. (%) Inh: percentage of 
inhibition other than MIC and IC50. 
 
For the Kiovi, Unale kaula (collection no. Kiovi-MSp29) was the only extract that 
appeared active against S. epidermidis (IC50 49 µg.mL
-1
) and E. coli β (-) (ATCC 
25922) (IC50 975 µg.mL
-1
). In addition, Fulaga dive (Amanita sp. Pers., collection no. 
Kiovi-MSp15, IC50 305 µg.mL
-1
) and Igura hivi (Albatrellus sp. Gray, collection no. 
Kiovi-MSp43, IC50 168 µg.mL
-1
), both mushrooms species were used by the Kiovi 
because it makes them feel well, appeared moderately active against S. epidermidis and 
investigations on their chemistry are discussed in Chapter 3 and Chapter 6 respectively. 
 
For the Waefo, of the 16 mushroom extracts tested, the edible Holipa lua hefola 
(collection no. Waefo-MSp1) and inedible Holipa lua namba (collection no. Waefo-
MSp9) exhibited low antibacterial activity against S. epidermidis (16 – 30 % inhibition 
at concentration > 2000 µg.mL
-1
) according to the turbidity-MTT assay. 
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Finally, for the Kopanka, of the 10 extracts tested, Bongnengs (collection no. Tapiaku-
MSp27) showed broad spectrum activity against the Gram (+) S. epidermidis (IC50 147 
µg.mL
-1
) and Gram (-) E. coli β (-) (ATCC 25922) (IC50 194 µg.mL
-1
) according to the 
disc diffusion assay and turbidity-MTT assay. Interestingly, the Kopanka reported the 
use of Bongnengs as a prophylactic agent and hence it is commonly given to babies to 
prevent diseases and to grow healthy. The antibacterial activity of Bongnengs, as a 
crude extracts reported herein, clearly contributes to evidence-based traditional use of 
this mushroom as medicine. The rest of the extracts tested were considered inactive 
against the bacterial strains tested.  
 
2.7 Conclusions 
A total of 52 mushroom extracts, from three tribes in PNG (Kiovi, Waefo and Kopanka) 
were investigated for their antibacterial potential against S. epidermidis (clinical isolate) 
and E. coli β (-) ATCC 25922. A total of 15 mushroom extracts (29%, n = 52) showed 
some activity against at least one of the bacterial strains used using the turbidity-MTT 
assay. Although turbidity-MTT assay has proven to be superior when compared against 
disc diffusion assay or MTT method alone, in vitro antibacterial screenings of 
mushroom extracts may not be sufficient to correlate effectiveness of such extracts in in 
vivo settings to validate traditional use.
68
 However, in vitro results provide a starting 
point for further biological and chemical investigations towards the discovery of new 
drugs. 
 
2.8 Limitation of this study and future directions 
Australian Quarantine regulations in the import of organic material presented an issue in 
the implementation of morphological assessments on mushroom material and genomic 
DNA extractions for taxonomy studies. There is evidence suggesting that DNA studies 
have provided more accurate outcome in the investigation of phylogeny of mushrooms 
species when compared to standard morphological studies.
69
 Therefore, for future 
directions, DNA extractions and phylogenetic analyses should be incorporated for every 
mushroom species collected from the forest in PNG.  
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2.9 Experimental 
2.9.1 Microorganisms 
ATCC strains of E. coli β (-) were kindly donated by our collaborators from Macquarie 
University, Department of Chemistry and Biomolecular Sciences, NSW 2109, and 
provided in solid media. Clinical isolates of S. epidermidis were kindly donated by 
Department of Microbiology, Canberra Hospital, Garran, ACT 2605 and also provided 
in solid media. Strains were sub-cultured in liquid media and stored at -30°C in 
glycerol. 
 
Glycerol stocks of all bacterial cultures were prepared by mixing equal volumes of 80% 
glycerol and bacterial culture into a labelled glass vial. All media listed below were 
sourced from Bacto Laboratories Pty Ltd, NSW 2170, Australia and prepared as per the 
manufacturer’s instructions unless otherwise noted. BBL™ Mueller Hinton broth and 
DIFCO™ Mueller Hinton agar were used for the growth of the E. coli β (-) and S. 
epidermidis strains. The pH of the medium was adjusted to 7.3 ± 0.1 before autoclaving. 
Microorganisms were stored in slopes on DIFCO™ Mueller Hinton agar. 
 
2.9.2 Controls 
Kanamycin sulphate from Streptomyces kanamyceticus was used as the antibiotic 
control for S. epidermidis and E. coli β (-) and supplied by Sigma Aldrich, Castle Hill, 
NSW 1765, Australia. Dimethylsulfoxide (DMSO) was used as a negative control and 
as a solvent for sample preparation. 
 
DMSO was supplied by Thermo Fisher Scientific Australia Pty Ltd., Scoresby, Vic 
3179, Australia. 3-(4, 5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) 
was used as the dye to determine the viability of the cells and it was sourced from Alfa-
Aesar, Heysham, Lancashire, United Kingdom. 
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2.9.3 Test sample preparation 
Ethanolic mushroom extracts were concentrated to dryness under reduced pressure and 
the resulting dried material re-dissolved in 0.1 mL of DMSO and taken up to 1 mL with 
MHB to achieve concentrations between 5 to 50 mg.mL
-1
 of test sample. 
 
2.9.4 Equipment 
Assays were performed in Nunc 96-well clear flat bottom culture plates (Thermo Fisher 
Scientific, Roskilde Site, Denmark). All plates were read at 600 nm using the BioTek 
Epoch microplate spectrophotometer and Gen5™ 2.0 Data Analysis Software (BioTek 
Instruments, Inc, Winooski, USA). Agar plates were prepared using disposable sterile 
petri dishes. 
 
The absorbance of the working cultures was read using a UV-Mini 1240 UV-Vis 
Spectrophotometer (Shimadzu) and incubation was conducted in a laboratory incubator 
BTC-9090 at 37°C (Thermoline, Wetherill Park, NSW2164, Australia). Sterilisation of 
media was performed in a Tomy high pressure steam steriliser ES-315 (Quantum 
Scientific Pty, Ltd). 
 
All rotary evaporation was performed using a Büchi rotary evaporator R-114 with 
Büchi waterbath B-480. To guarantee sterility, all dealings with microorganisms were 
carried out under a Gelaire laminar air flow cabinet (Kelly Company, Pty Ltd, Seven 
Hills, NSW 2147, Australia). 
 
2.9.5 Growth of microorganisms 
Mueller Hinton Agar (MHA) was used to make slopes for storage of bacteria. Slopes 
were stored at 4˚C, for up to 3 months, and used to prepare working cultures of the 
organisms by subculturing on agar plates to isolate single colonies. 
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A single colony was suspended in 10 mL of MHB and incubated at 37˚C at 
approximately 120 rpm in a shaker incubator for approximately 18 to 20h. The 
inoculum size used in the assays was estimated using a reference 0.5 McFarland 
standard, OD600 = 0.08 – 0.1 for use in turbidity-MTT cell proliferation assays. 
 
2.9.6 Turbidity-MTT biological screening assay 
Broth microdilution assay was performed as outlined in the literature,
57,50
 with minor 
modifications.
70
 Forty microliters of MHB was dispensed into wells 1B1H of the 96 
microtiter well plate. Subsequently, 80 µL of the unfiltered test sample or the 
appropriate antibiotic (i.e. kanamycin 50 µg.mL
-1
 in MHB) was dispensed into well 1A. 
Forty microliters of the test sample or positive control were removed and serially 
diluted down the plate. Growth, sterile and negative controls were also included. 
 
150 μL of bacterial suspension diluted to equal the density of 0.5 McFarland standard 
(OD600 = 0.08 – 0.1) and further diluted 1:100 in MHB were added to wells 1A1H. 
The plate was read at OD600 to control for pre-existing turbidity of the samples prior to 
incubation. The plate was incubated at 37°C for 18 - 20h while being agitated on an 
orbital shaker at 120 rpm. After incubation, the plate was read at OD600 to assess growth 
of the treated cultures. MIC (when possible) and IC50 were determined based on a 
comparison with the average turbidity readings of the untreated control. For 
calculations, see Equation 1 and Equation 2 in section 2.6.5-c. 
 
Finally, 10 µL of MTT dye was added to each well in the microtiter plate and incubated 
for 60 min while being agitated at 120 rpm. After incubation, MIC was inspected 
visually. Yellow colour indicated bacterial inhibition, while blue colour indicated 
bacterial growth. 
 
63 
Chapter three: The Fulaga dive mushroom 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
Chapter Three 
The Fulaga dive 
mushroom 
 
Fulaga dive (collection no. Kiovi-MSp15). Photograph taken and edited by the author. 
 
This section describes ethnomycological and taxonomical background on Fulaga dive, a 
Papua New Guinean macrofungi of the genus Amanita. Antimicrobial guided isolation 
of its biologically active constituents and their structural identification is also reported. 
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Chapter 3 : The Fulaga dive mushroom (Amanitaceae) 
3.1 Introduction 
Fulaga dive (Figure 3.1) is one of the mushrooms traditionally used, for its edibility, by 
the Kiovi tribe of the Lufa District, Eastern Highlands Province in Papua New Guinea 
(PNG). Kiovi particularly reported that after eating this mushroom they experienced a 
sense of “well-being”. This ethmomycological linkage to the Kiovi gave origin to this 
work. 
 
 
Figure 3.1: Fulaga dive (Amanita sp. Pers). Author’s photograph. 
 
A crude extract of Fulaga dive (collection no. Kiovi-MSp15) was found active against 
the Gram (+) bacterium S. epidermidis (IC50: 305 µg.mL
-1
) according to the turbidity-
MTT assay.  
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Bioassay guided purification led to the isolation of two novel furan fatty acids (F-acids), 
(Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) were identified as the 
components responsible for the observed biological activity. Their chemical structures 
are depicted in Figure 3.2. 
 
 
Thus, this chapter entails an investigation of Fulaga dive, bioassay guided isolation and 
chemical structure elucidation of the compounds responsible for its antibacterial 
activity.  
 
3.2 Furan fatty acids (F-acids) 
A saturated 2,5-disubstituted F-acid, 8-(5-hexylfuran-2-yl)-octanoic acid (3.3) (Figure 
3.3), was isolated by Morris et al.
71
 in 1966 from the oil of Exocarpus cupressiformis 
Labill. seeds.
71
  
 
This F-acid natural product represented the first report of its chemical class. Since then, 
scientists have struggled to determine their precise role in nature. Bioactivity studies on 
these metabolites suggest that they possess anti-inflammatory and radical scavenging 
abilities, implying that they may also have the potential of being used as antioxidants to 
help protect humans against ailments such as arteriosclerosis and cardiovascular 
disease.
72
 
  
 
Figure 3.2: (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) isolated from 
Fulaga dive 
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Figure 3.3: Disubstituted furan fatty acid (8-(5-hexylfuran-2-yl)-octanoic acid) from the 
seed oil of Exocarpus cupressiformis Labill. 
 
In 1974, Glass and colleagues
73
 reported the discovery of eight F-acids isolated from the 
liver lipids of the northern pike fish (Esox Lucius L.) obtained from the lakes of St. 
Paul, Minnesota, USA.
73
 The discovery of these homologues, shown on Table 3.1, 
marked the backbone of what is known about the general structure of these types of 
compounds. 
 
Table 3.1: General structure of the most abundant F-acids 
 
Number -m -n -R 
4a 2 8 CH3 
4b 4 8 H 
4c 4 8 CH3 
4d 2 10 CH3 
4e 4 10 H 
4f 4 10 CH3 
4g 4 12 H 
4h 4 12 CH3 
 
Furan fatty acids (F-acids) are a class of compounds that have been isolated from a 
variety of sources, for instance fresh and salt water fish, algae, vegetables, including 
products commonly found in supermarkets such as butter.
73-76
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Although the extent of biological activity of F-acids is not yet known, this type of 
compounds have gained attention for their role as radical scavengers, their potential as 
antioxidants, and their value to society for their potential as dietary supplements or 
functional food.
77
 However, scientists confirmed that although the distribution of F-
acids was widespread, F-acids were mostly found in small quantities, representing an 
issue when attempting biosynthetic studies to learn about their occurrence. 
 
Chemically, the most common F-acids reported have been characterised by the presence 
of either a tri- or tetrasubstituted furan ring, differing from one another by the presence 
or absence of a methyl group on the ring at position 4 and on the length of the chain at 
positions 2 and 5.
78
 In addition, an ‘unusual’ F-acids have been reported in the 
literature, containing a long unsaturated chain of up to 20 carbons in one of the alpha 
positions of the furan ring isolated from sea sponges.
79
 
 
Okada and co-workers
80
 tested the antioxidant activity of a number of naturally 
occurring F-acids on the oxidation of linoleic acid, on an effort to determine their 
biological role. Although these authors found that tetra-substituted F-acids were 
fundamental in the prevention of the oxidation of linoleic acid, they also found that tri-
substituted F-acids were able to delay the oxidation of linoleic acid but their 
concentrations needed to be adjusted. 
 
Okada and colleagues
80
 concluded that there was a correlation between the antioxidant 
strength of F-acids and the substitution of the furan ring, suggesting that the more 
substituted the furan ring the better antioxidant activity.
80
 Very recently, on another 
effort to determine the biological role of F-acids, Wakimoto and co-workers
81
 tested the 
anti-inflammatory effect of tetra-substituted F-acids isolated from the New Zealand 
green-lipped mussel (Perna canaliculus Gmelin). Results of this study revealed the 
potent anti-inflammatory activity of F-acids in vivo (10 mg.kg
-1
 of F-acid, 74% 
reduction of paw swelling in rats).
81
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In late 2012, while screening mushroom extracts used by the Kiovi tribe from PNG, 
Fulaga dive (collection no. Kiovi-MSp15) appeared active against S. epidermidis (IC50 
305 µg.mL
-1
). It is worth mentioning that the strain of S. epidermidis used for initial 
screening showed significant resistance against kanamycin, which was used as the 
positive control for the antibacterial assay. The ratio between IC50 of the crude extract 
and kanamycin was 0.5:1, which indicated that the crude extract tested possessed half 
the potency of kanamycin against the test organism used. This remarkable finding, 
prompted us to identify and characterise the compound or compounds responsible for 
the biological activity shown by the mushroom. 
 
3.3 Characterisation of Fulaga dive and purification of bioactive 
compounds 
Fulaga dive (collection no. Kiovi-MSp15) was characterised on the basis of 
phylogenetic analysis. Genomic DNA was extracted from the stipe of the fungus and 
subsequently submitted to amplification of the internal transcribed spacer (ITS) by 
polymerase chain reaction (PCR).
82
  
 
The PCR product was subjected to Sanger sequencing analysis followed by a BLAST 
search,
83
 which revealed that the three closest relatives of this fungus (Amanita 
virginiana (Murill) Sumst., Amanita ristichii Tulloss and Amanita longistriata S. Imai) 
were members of the section of edible fungi related to Amanita caesarea (Scop.) Pers. It 
should be noted that Fulaga dive (Amanita sp. Pers) lack morphological resemblance to 
closest relatives.  
 
The differences in appearance could be indicative that Fulaga dive (Amanita sp. Pers) is 
a new species. For detail information about DNA extraction and amplification and 
sequencing procedures see experimental sections 3.8.8 and section 3.8.9. Voucher 
samples of this mushroom are kept at Centre for Natural Resources Research and 
Development (CNRRD) at the University of Goroka (UoG) under Kiovi-MSp15.  
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After initial extraction, as described in 0, section 2.6.1, ethanol (EtOH) was removed 
under reduced pressure and the dried extract was reconstituted with methanol (MeOH). 
The resulting methanolic extract was partitioned with a modified Kupchan, as shown in 
Figure 3.4. Five new extracts were obtained: hexane (Hex), dichloromethane (DCM), 
ethyl acetate (EtOAc), n-butanol (n-BuOH) and aqueous.
84
 
 
 
Figure 3.4: Modified Kupchan solvent partition
84
 
 
Kupchan extracts were re-assayed using the turbidity-MTT method described in 0, 
section 2.9.6. Results from the antimicrobial assay suggested activity across all fractions 
(Hex, DCM, EtOAc and n-BuOH) except the aqueous fraction. DCM was the highest 
yielding fraction, with about 1.5 g of material extracted after partition and it was chosen 
to continue with the isolation of the active metabolites.  
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The DCM fraction was fractionated on silica gel 60 (230 – 400 mesh) column using 
petroleum spirit and EtOAc (7:3) as the mobile phase. A total of 45 fractions containing 
approximately 5 mL of eluent were collected and pooled into four major fractions.  
 
The collection pool was based on indications from TLC, 1D 
1
H-NMR, GC-MS 
experiments and comparisons with the crude extract of Fulaga Dive. Fraction three 
contained the major active compounds.  
 
The DCM fraction of Fulaga dive containing the major active compounds was further 
purified using normal phase HPLC with Pet Sp – EtOAc (7:1 isocratic) to furnish (Z)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) (5 mg) and (E)-9-(5-pentylfuran-2-yl)-non-
8-enoic acid (3.2) (15 mg). 
 
Below is a snapshot of the GC-MS chromatogram showing two peaks with the same 
fragmentation pattern with [M]˙+ = 292 and later identified as two diastereoisomers of a 
novel F-acid. In addition, another peak with [M]˙+ = 166 was also later identified as a 
furaldehyde derivative (3.4) found in Fulaga dive. 
 
 
Figure 3.5: TIC from a GC-MS displaying major peaks found in Fulaga dive (collection no. 
Kiovi-MSp15) (Amanita sp. Pers.) 
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3.4 Elucidation of (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
Bioassay-guided fractionation led to the isolation of (E)-9-(5-pentylfuran-2-yl)-non-8-
enoic acid (3.2), which chemical structure is shown in Figure 3.6, as it was the major 
peak observed in HPLC and GC-MS. 
 
 
Figure 3.6: (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) 
 
HREIMS suggested a molecular formula of C18H28O3 through the appearance of a 
molecular ion [M]˙+ of m/z 292.2033 calculated for 292.2038. In addition, this 
molecular formula implied five degrees of unsaturation, calculated by Equation 3: 
 
𝐷𝑜𝑈 =
2𝐶 + 2 + 𝑁 − 𝑋 − 𝐻
2
 
Equation 3 
 
Where; DoU: degree of unsaturation; C: number of carbon atoms in the molecule; N: 
number of nitrogen atoms in the molecule; X: number of halogens and H: number of 
hydrogen atoms in the molecule.  
 
The structure of (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) was elucidated using 
extensive NMR experiments observed in CDCl3, including 
1
H, 
13
C, 
1
H – 13C HSQC, 1H 
– 13C HMBC and 1H – 1H COSY. 
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The 
1
H NMR spectrum shown in Figure 3.7 displayed 10 distinctive resonances. For 
example, a typical slightly deformed A3M2 spin system at 0.90 ppm (J). Such 
deformation is as a result of virtual coupling between a terminal methyl group with a 
long hydrocarbon chain (H – I) commonly observed in fatty acids. 
 
Two A2M2 systems (E, F) and one A2M2XZ system (G), all integrating for two protons 
each, are also visible in the 
1
H NMR spectrum. Finally a complex system of four 
resonances is also visible in the downfield region (5.88 – 6.18 ppm). 
 
 
Figure 3.7: 
1
H (400 MHz) NMR spectrum in CDCl3 of (E)-9-(5-pentylfuran-2-yl)-non-8-
enoic acid (3.2) 
 
On a closer look at the four resonances in the 
1
H NMR spectrum displayed in Figure 
3.8, there can be appreciated two distinctive AB spin systems (A and C) and a clear 
ABX2 spin system (B). A small ABX2 spin system (D) can be also appreciated. 
However, due to the digital resolution of the instrument used, this spin system was 
reported as an AB spin system. All four resonances integrated for one proton each. 
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Mononuclear coupling correlations, 
1
H – 1H COSY, allowed the identification of a E-
alkene consistent with the coupling constants of protons on position 9’’ (δ 6.13, d, J = 
15.9 Hz, 1H) and position 8’’ (δ 6.05, dt, J = 15.9, 6.4 Hz, 1H). For chemical structure 
of 3.2 see Figure 3.6. 
 
 
Figure 3.8: Expansion of region δ 6.17 – 5.89 ppm of 1H (400 MHz) NMR spectrum in CDCl3 
of (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) 
 
The carbon NMR spectrum (not shown herein) displayed 18 discrete resonances and 
with 
1
H – 13C HSQC analyses, allowed the confirmation of a number of proton 
assignments. Finally, 
1
H – 13C HMBC correlations allowed the elucidation of (E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.2). A summary of 
1
H and 
13
C NMR correlations 
can be found in Table 3.2.  
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Table 3.2: 
1
H and 
13
C NMR, HMBC data for (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) 
Position δH (ppm) (multiplicity, |J| (Hz) δC (ppm) HMBC (
1
H → 13C) 
2  151.5  
3 6.00 (d, 3.1) 106.8 C-4, C-2, C-9’’ 
4 5.92 (d, 3.1) 106.1 C-5, C-3 
5  155.7  
1’ 2.59 (t, 7.5) 28.1 C-5, C-4, C-2’ 
2’ 1.76 – 1.24 (m) 27.8 C-1’, C-3’ 
3’ 1.76 – 1.24 (m) 31.4 C-4’, C-2’, C-1’ 
4’ 1.76 – 1.24 (m) 22.4 C-5’, C-3’, C-2’ 
5’ 0.90 (t, 7.0) 14.0 C-4’, C-3’ 
1’’  179.4  
2’’ 2.35 (t, 7.5) 33.9 C-1’’, C-3’’ 
3’’ 1.76 – 1.24 (m) 24.6  
4’’ 1.76 – 1.24 (m) 28.9  
5’’ 1.76 – 1.24 (m) 28.8  
6’’ 1.76 – 1.24 (m) 29.1  
7’’ 2.15 (ddt, 6.4, 6.4, 7.2 ) 32.7 C-9’’, C-8’’, C-6’’ 
8’’ 6.05 (dt, 15.9, 6.4) 128.2 C-9’’, C-7’’ 
9’’ 6.13 (d, 15.9) 118.8 C-2, C-8’’ 
 
3.5 Elucidation of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
Bioassay-guided fractionation also led to the isolation of (Z)-9-(5-pentylfuran-2-yl)-
non-8-enoic acid (3.1), which chemical structure is shown in Figure 3.9. 
 
 
Figure 3.9: (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) 
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HREIMS suggested a molecular formula of C18H28O3 through the appearance of a 
molecular ion [M]˙+ m/z 292.2033 calculated for 292.2038, identical to that of (E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.2). Molecular formula also implied five degrees 
of unsaturation, as calculated by Equation 3. 
 
The structure of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) was also elucidated 
using extensive NMR experiments observed in C6D6, including 
1
H, 
13
C, 
1
H – 13C 
HSQC, 
1
H – 13C HMBC and 1H – 1H COSY. It should be noted that initial 1H NMR 
experiments were performed in CDCl3. However, due to instability of 3.1 in CDCl3, it 
was decided to used C6D6 instead. The instability of (Z)-9-(5-pentylfuran-2-yl)-non-8-
enoic acid (3.1) is discussed in Chapter 4, section 4.5.8. 
 
Moreover, the 
1
H NMR spectrum also displayed 10 distinctive resonances and it was 
relatively similar to that for (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2). In 
addition to the molecular formula and molecular mass calculated for both compounds, 
1
H NMR spectrum was also evidence that (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1) and (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) were related compounds. 
 
On closer inspection of the region between 5.30 – 6.35 ppm, exhibited some remarkable 
differences, for example the ABX2 spin system (D), shown in Figure 3.10, was 
drastically shifted upfield (5.40 ppm) when compared to its equivalent ABX2 spin 
system (B) shown in Figure 3.8 for (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2). 
 
It should be noted that homonuclear 
1
H – 1H COSY correlations provided evidence of 
the presence of a Z-alkene based on coupling constant calculations of protons on 
position 9’’(δ 6.28, d, J = 11.8 Hz, 1H) and position 8’’ (δ 5.40, dt, J = 11.8, 7.3 Hz, 
1H). For chemical structure of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) see 
Figure 3.9. 
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Figure 3.10: Expansion of region δ 6.35 – 5.30 ppm of 1H (800 MHz) NMR spectrum of 
(Z)-9-(5-pentylfuran-2-yl) non-8-enoic acid (3.1) 
 
The upfield shift of the Z-alkene may not be surprising and it could be explained from 
the location of the E-alkene within the molecule. Because the proton in position 8’’ in 
the E-diastereoisomer (Figure 3.6) is within the paramagnetic region as dictated by the 
furan core, an increase in its chemical shift is expected in a similar manner to what 
would be expected for aromatic protons. In the Z-diastereoisomer (Figure 3.9), however, 
the proton in position 8’’ is further away from the paramagnetic region, as dictated by 
the furan ring. Therefore, it would not be expected that this proton would experience an 
increase in its chemical shift. 
 
The 
13
C NMR spectrum displayed 18 discrete resonances and with 
1
H – 13C HSQC 
analysis, allowed the confirmation of a number of proton assignments. 
1
H – 13C HMBC 
correlations allowed the elucidation of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1). A summary of 
1
H and 
13
C NMR correlations can be found in Table 3.3 
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Table 3.3: 
1
H and 
13
C NMR data for (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) 
Position δH (ppm) (multiplicity, |J| (Hz) δC (ppm) 
2  152.3 
3 6.15 (d, 3.2) 110.2 
4 5.92 (d, 3.2) 106.8 
5  156.0 
1’ 2.55 -2.42 (m) 28.1 
2’ 1.60 – 1.10 (m) 28.4 
3’ 1.60 – 1.10 (m) 31.6 
4’ 1.60 – 1.10 (m) 22.7 
5’ 0.83 (t, 6.9) 14.1 
1’’  178.5 
2’’ 2.04 (t, 7.0) 33.7 
3’’ 1.60 – 1.10 (m) 24.7 
4’’ 1.60 – 1.10 (m) 29.1 
5’’ 1.60 – 1.10 (m) 29.6 
6’’ 1.60 – 1.10 (m) 29.6 
7’’ 2.55 – 2.42 (m) 29.6 
8’’ 5.4 (dt, 11.8, 7.3) 129.6 
9’’ 6.28 (d, 11.8) 118.2 
 
3.6 Elucidation of 5-pentylfuran-2-furaldehyde 
Bioassay-guided fractionation also led to the isolation of 5-pentyl-2-furaldehyde (3.4), 
which chemical structure is shown in Figure 3.11. 
 
 
Figure 3.11: 5-pentylfuran-2-furaldehyde (3.4) 
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HRESIMS suggested the molecular formula C10H15O2 through the appearance of a 
protonated molecule of m/z 167.1073 calculated for 167.1072. This formula implied 
four degrees of unsaturation and calculated as per Equation 3. 
 
The structure of 5-pentyl-2-furaldehyde (3.4) was elucidated using extensive NMR 
experiments observed in CDCl3, including 
1
H, 
13
C, 
1
H – 13C HSQC, 1H – 13C HMBC 
and 
1
H – 1H COSY.  
 
The 
1
H NMR spectrum displayed in Figure 3.12 exhibited seven distinctive resonances, 
including a slightly deformed A3M2 system at 0.90 ppm (I), due to virtual coupling with 
a “methylene envelope” (G – H), followed by an A2M2 spin system (F). In addition, two 
AB spin systems (B, E) belonging to the furan ring and finally a singlet at δ 9.51 ppm 
(A), characteristic of an aldehyde are depicted in the 
1
H NMR spectrum.  
 
 
Figure 3.12: 
1
H (400 MHz) NMR spectrum in CDCl3 of 5-pentylfuran-2-furaldehyde (3.4) 
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The 
13
C NMR spectrum displayed 10 discrete resonances (not shown herein). 
1
H – 13C 
HSQC analysis, allowed the assignment of a number of protons and 
1
H – 13C HMBC 
correlations allowed the elucidation of 5-pentylfuran-2-furaldehyde (3.4). A summary 
of 
1
H and 
13
C NMR correlations can be found in Table 3.4. 
 
Table 3.4: 
1
H and 
13
C NMR data for 5-pentylfuran-2-furaldehyde (3.4) 
Position δH (ppm) (multiplicity, |J| (Hz) δC (ppm) 
2  151.9 
3 7.16 (d, 3.5) 123.5 
4 6.23 (d, 3.5) 108.7 
5  164.3 
1’ 2.71 (t, 7.7) 28.5 
2’ 1.86 – 1.55 (m) 27.4 
3’ 1.49 – 1.21 (m) 31.5 
4’ 1.49 – 1.21 (m) 22.5 
5’ 0.90 (t, 7.1) 14.1 
1’’ 9.51 177.1 
 
5-Pentylfuran-2-furaldehyde (3.4) has been reported in the literature as a natural product 
isolated from broth cultures of a Clitoxybe sp.
85
 However, based on observations during 
the purification of 3.1 and 3.2, there is evidence to believe that 5-pentylfuran-2-
furaldehyde (3.4) is an artefact of the novel (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1). 
 
A sample containing a mixture of 3.1, 3.2 and 3.4 was kept at room temperature for 12h. 
5-Pentylfuran-2-furaldehyde (3.4) saw an increase in its concentration while the (Z)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) rapidly degraded and hence a decrease in its 
concentration was observed. F-acids are known for being unstable compounds and it is 
plausible that 3.1 was transformed to 3.4, making 5-pentylfuran-2-furaldehyde (3.4) a 
degradation product of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1). Degradation 
of furan fatty acids (F-acids) is discussed in Chapter 4, section 4.5.8. 
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3.7 Conclusion 
Investigation of the fruiting bodies of Fulaga dive (collection no. Kiovi-MSp15, 
Amanita sp. Pers.) led to the discovery of two novel F-acids, (Z)-9-(5-pentylfuran-2-yl)-
non-8-enoic acid (3.1) and (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2). 
Demonstrated antibacterial activity of crude extracts of Fulaga dive and isolated 
compounds has provided insight about the reason for Fulaga dive’s traditional use. 
 
Fulaga dive produced large amounts of the (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.2) and enough material of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) to 
undertake further biological testings. However, the rapid degradation of the latter 
prompted us to a synthetic approach to produce larger quantities of the two metabolites 
and test their antibacterial and antioxidant activities. Chapter 4 entails the chemical 
synthesis of F-acids isolated from Fulaga dive. 
 
3.8 Experimental 
3.8.1 NMR spectroscopy 
Unless otherwise stated, all spectra were recorded on a Bruker Biospin GmbH NMR 
instrument at 300 K with probe 5 mm PABBO BB/19F-1H/D Z-GRD Z116098/0258. 
1
H and 
13
C NMR experiments were undertaken at 400 MHz and 100 MHz respectively. 
For the elucidation of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1), 
1
H and 
13
C 
spectra were recorded at 800 MHz and 200 MHz on an Ascend Bruker-800 instrument, 
at 298 K with probe 5 mm CPTCI 1H-13C/ 15N/ D Z-GRD Z44909/ 0022. 
 
Chemical shifts (δ) are reported in parts per million (ppm). 1H NMR spectra are 
referenced to the signal from CDCl3 at 7.26 ppm or C6D6 at 7.16 ppm. 
13
C NMR spectra 
are referenced to the central peak in the signal from CDCl3 at 77.0 ppm or C6D6 at 128.0 
ppm. Structural assignments were based on spectra resulting from one or more of the 
following NMR experiments: 
1
H, 
13
C, 
1
H-
1
H COSY, 
1
H-
13
C HSQC and 
1
H-
13
C HMBC. 
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3.8.2 Mass spectrometry 
Low resolution EI mass spectra (LREIMS) were recorded on a Finningan Polaris Q ion 
trap mass spectrometer using positive electron ionisation (EI+) mode at 70 eV. High 
resolution EI mass spectra (HREIMS) positive electron ionisation were recorded on a 
Waters VG autospec premier spectrometer at 70 eV. 
 
Low resolution ESI mass spectra (LRESIMS) were recorded on a ZMD micromass 
spectrometer with Waters Alliance 2690 HPLC. High resolution ESI mass spectra 
(HRESIMS) were recorded on a Waters LCT premier XE time-of-flight (ToF) mass 
spectrometer. 
 
Gas chromatography – mass spectrometery (GC-MS) experiments were recorded using 
an Agilent 7890A GC and 5975C MS detector. The instrument was equipped with a 
HP-5 column [(cross-linked 5 % phenyl methyl silicone), 30 m x 0.25 mm x 0.25 µm 
film thickness] 350°C and split 2:1 using Helium as carrier gas (1 mL/min) by using 
positive ion detection. 
 
Oven temperature program started at 80 °C for 2 min, increasing 10°C/min up to 250°C, 
holding that temperature for 10 min. Mass/charge ratios (m/z) are reported and the 
relative abundance of fragments is shown as percentage of the base peak intensity. 
 
3.8.3 IR spectroscopy 
IR spectra were recorded on a Bruker Alpha-P spectrophotometer. Samples were free of 
solvent and diagnostic peaks are reported in wavenumbers (cm
-1
). 
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3.8.4 UV measurements 
UV spectra were recorded on a UV-Mini 1240 UV-Vis Spectrophotometer (Shimadzu); 
using 1.00 cm quartz cells in DCM. Absorption maxima are recorded in nm (log ε). 
3.8.5 Chromatography 
Thin layer chromatography (TLC) was performed with Merck aluminium backed plates, 
pre-coated with silica gel 60 F254 (0.2 mm). TLC plates were observed under UV light 
(254 nm) and/or by developing in ceric phosphomolybdic acid (100 mL water, 5 g 
phosphomolybdic acid, 0.6 g Ce(SO4)2, 6 mL concentrated H2SO4) dip, followed by 
heating.  
 
Flash chromatography was performed under pressure using normal phase silica gel 
(230-400 mesh Scharlau 60) as a stationary phase and reagent grade solvents as eluent. 
Semi-preparative HPLC was performed using an Agilent 1100 system with diode array 
detector, using a Phenomenex Luna 5µ Silica (2) 100 A, 250 x 10.00 mm 5 micron 
column and pre-column Phenomenex part no. AJO-7220.  
 
Purification of (Z- & E)-diastereoisomers (3.1 and 3.2); elution was carried out under 
gradient starting at 1:9 EtOAc and Pet Sp. for 40 min then changing to 100% EtOAc up 
to 65 min run. Flow rate was setup at 2 mL/min and detection at λ 254 nm and 290 nm. 
 
For biological testings, 96 microtiter plates were read using a BioTek Epoch microplate 
spectrophotometer at 600 nm. Gen5™ 2.0 Data Analysis Software (BioTek Instruments, 
Inc, Winooski, USA) was used for data analysis. Agar plates were prepared using 
disposable sterile petri dishes. The absorbance of the working cultures was read using a 
UV-Mini 1240 UV-Vis Spectrophotometer (Shimadzu). 
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3.8.6 Solvents, culture media and controls 
In general, all organic solvents were reagent grade solvents for extractions and 
chromatography and used without further purification unless otherwise stated. Pet Sp. 
(60 – 80 °C) and EtOAc were distilled prior to use. Purification of other solvents was 
carried out using typical procedures or as stipulated under Perrin & Armarego, 
Purification of Laboratory Chemicals, 3
rd
 Edition.
86
 
All media, BBL™ Mueller Hinton broth and DIFCO™ Mueller Hinton agar were 
sourced from Bacto Laboratories Pty Ltd, Australia and prepared as per the 
manufacturer’s instruction unless otherwise noted. The pH of the medium was adjusted 
to 7.3 ± 0.1 before autoclaving. 
 
Kanamycin sulphate from Streptomyces kanamyceticus was used as the antibiotic 
control for the sensitive strains of S. epidermidis and E. coli β (-) and supplied by Sigma 
Aldrich, St Louis, USA. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide 
(MTT) was used as the dye to determine the viability of the cells and it was sourced 
from Alfa-Aesar, Heysham, England. 
 
3.8.7 Turbidity-MTT assay 
Turbidity-MTT microdilution assay for Kupchan extracts and isolated compounds from 
Fulaga dive (Amanita sp. Pers.) were performed as outlined in 0 section 2.9.6 
 
3.8.8 DNA extraction 
Approximately 50 mg of grand stipe were collected and digested at 70°C for 10 min 
with 400 μl digestion TES lysis buffer [10 mM Tris (pH 8), 1 mM EDTA (pH 8) and 
1% sodium dodecyl sulphate (SDS)]. Following neutralisation with 400 μl 2.8 M KOAc 
mixture was spin at 4˚C at 2500 rpm for 10 min. Supernatant was transferred to a new 
microfuge tube and DNA was purified by adding approximately 800 μl of isopropanol 
followed by spinning for 15 min at 2500 rpm.  
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Solvent was removed and genomic DNA (gDNA) was rinsed five times with 800 μl of 
95% EtOH followed by 800 μl of 70% EtOH. gDNA was allowed to dry and 
reconstituted with TE buffer [10 mM Tris and 1 mM EDTA (both at pH 8)] for long 
term storage.
82
 
 
3.8.9 Amplification and sequencing. 
Amplification was performed in a C1000 Touch Thermal Cycler (Bio-Rad Laboratories, 
California, USA), in a volume of 10 µl containing 0.5 μM of each of ITS primers,83 0.08 
µl of Takara Ex Taq and, 1 µl of Ex Taq buffer (Takara Bio, Otsu-shi, Japan), and 1 µl 
of gDNA. The thermal cycler program used was 2 mins at 95°C and 35 cycles of 30 sec 
at 95°C, 30 sec at 56°C, and 40 sec at 72°C.  
 
The amplification products were purified with the QIAquick PCR purification kit 
(QIAGEN, Basel, Switzerland). The sequencing reaction of the amplification product 
was performed in a C1000 Touch Thermal Cycler (Bio-Rad Laboratories, California, 
USA) using the ITS4, reverse primer and BigDye® kit (Applied Biosystems, Rotkreuz, 
Switzerland). The thermal cycler program used was 5 mins at 94°C and 30 cycles of 10 
sec at 96°C, 5 sec at 50°C, and 4 min at 60°C. Sequence product was analysed with a 96 
capillary 3730 DNA Analyser (Applied Biosystems, California, USA).
83
 
 
3.8.10 Metabolite data 
(Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) and (E)-9-(5-pentylfuran-2-yl)-non-8-
enoic acid (3.2): pale yellow solid; UV (DCM) λmax (log ε) 373 (1.69), 276 (3.23) nm; 
IR (neat) νmax 3400 – 2400 (br) 2924 (s), 1703 (s), 778 (m) cm
-1
; 
1
H NMR (CDCl3, 400 
MHZ); and 
13
C NMR (CDCl3, 100 MHZ) see table 3.2 and 3.3. EIMS m/z 292 [M]˙
+
 
(74), 235 (22), 177 (100), 151 (21), 121 (26), 107 (84) 95 (24), 55 (26); HREIMS m/z 
292.2033 (calculated for C18H28O3, 292.2038). 
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5-pentylfuran-2-furaldehyde (3.4): pale yellow oil; 
1
H NMR (CDCl3, 400 MHZ) and 
13
C NMR (CDCl3, 100 MHZ) see table 3.4. EIMS m/z 166 [M]˙
+
 (50), 109 (100), 81 
(57), 53 (31); HRESIMS m/z 167.1073[M+H]
+
 (calculated for C10H15O2, 167.1072). 
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Chapter Four 
Synthesis of novel furan 
fatty acids: 
(Z- & E)-9-(5-pentylfuran-
2-yl)-non-8-enoic acid 
 
 
This section is primarily concerned with the synthesis of two novel naturally occurring 
furan fatty acids (F-acids), (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) and (E)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), isolated from Fulaga dive (Amanita sp. 
Pers.) native to the Eastern Highlands Province, Papua New Guinea (PNG). In addition, 
this section also provides background on previous synthetic routes to F-acids and the 
biosynthetic origin of this class of compounds. 
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Chapter 4 : Synthesis of furan fatty acids (F-acids) 
4.1 Introduction 
Furan fatty acids (F-acids) are a class of compounds that have been isolated from a 
variety of sources, including fresh and salt water fish, algae and vegetables.
73-75
 Glass 
and co-workers
78
 characterised eight F-acids homologues by the presence of either a tri- 
or tetrasubstituted furan ring. F-acids differed from one another by the presence or 
absence of a methyl group on the ring at carbon 4 and on the length of the chain at 
carbon 2 and 5.
78
 It is worth noting that two ‘unusual’ F-acids have been reported in the 
literature; a) a disubstituted F-acid isolated from the seed oil of Exocarpus 
cupressiformis Labill.
71
 and b) a F-acid containing a long unsaturated chain of up to 20 
carbons in one of the alpha positions of the furan ring isolated from sea sponges.
79
 
 
Although the extent of biological activity of F-acids is not yet known, this type of 
compounds have gained attention for their role as radical scavengers and their potential 
as antioxidants.
77
 Batna and Spiteller performed a series of experiments using a 
synthetic C-18 disubstituted F-acid, 9-(5-pentylfuran-2-yl)-nonanoic acid (4.1), to study 
its oxidative stability via conversion to (Z)-10,13-dioxo-octadec-11-enoic acid (4.2).
87
 
Figure 4.1 shows a schematic representation of the oxidation of the C-18 synthetic 
disubstituted F-acid. 
 
 
Figure 4.1:Oxidation of 9-(5-pentylfuran-2-yl)-nonanoic acid (4.1) to dioxoenoic acid (4.2) 
 
When 4.1 was stirred under pure oxygen in the dark or under light irradiation, no 
spontaneous oxidation was observed. In addition, when the enzyme soy bean 
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lipoxygenase-1 (L-O˙) was added to the reaction and the experiment repeated under the 
same conditions, 4.1 remained unchanged. The same was true when 4.1 was in contact 
with linoleic acid; no dioxoenoic acid (4.2) was formed. However, when linoleic acid 
and L-O˙ were present in the mixture, the oxidation of 4.1 occurred and (Z)-10,13-
dioxo-octadec-11-enoic acid (4.2) was formed in small amounts as the degradation 
product.
87
 
 
Batna and Spiteller
87
 provided a mechanistic explanation for the conversion of 4.1 to 
dioxoenoic acid (4.2). These authors suggested that the first step involved the oxidation 
of linoleic acid (4.3) by L-O˙ in the presence of oxygen to form (9Z, 11E)-9-
hydroperoxyoctadecadienoic acid (4.4), as shown in Figure 4.2. Subsequently, 4.4 was 
cleaved to form alkoxyl radicals (R-O˙) or peroxyl radicals (R-OO˙) following reaction 
with divalent metal ions (e.g. Fe
2+
) available from the enzyme soy bean lipoxygenase-1 
(L-O˙), similar to a Fenton reaction.87 These authors also suggest that a peroxyl radical 
(R-OO˙) is an intermediate product of the oxidation of linoleic acid (4.3) by L-O˙. 
 
 
Figure 4.2:Oxidation of linoleic acid (4.3) by soybean-lipoxygenase-1(L-O˙) to alkoxyl 
radicals (R-O˙) or peroxyl radicals (R-OO˙) 
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Batna and Spiteller
87
 presumed that one of the radicals formed after initial oxidation of 
linoleic acid (4.3) could then attack positions 2 or 5 of the furan ring of their synthetic 
9-(5-pentylfuran-2-yl)-nonanoic acid (4.1) forming a furanoid radical intermediate, 
which rapidly undergoes ring opening to give a stable mesomeric radical. The stability 
of this intermediate radical allows it to trap a second alkoxyl radical (R-O˙) forming a 
ketal, which undergoes hydrolysis to give the corresponding (Z)-10,13-dioxo-octadec-
11-enoic acid (4.2). The diagram shown in Figure 4.3, illustrates that a single F-acid can 
scavenge two alkoxyl radicals. 
 
 
Figure 4.3: Oxidation of 9-(5-pentylfuran-2-yl)-nonanoic acid (4.1) by alkoxyl radicals. 
 
Batna and Spiteller
87
 also suggested that only small amounts of disubstituted F-acid 
(4.1) was oxidised to its corresponding dioxoenoic acid (4.2).
87
 Such observation was 
consistent with the work of Okada and co-workers
80
 on the reactivity of F-acids. Okada 
and co-workers
80
 suggested that the reactivity of F-acids was dependant on the number 
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of substituents on the furan ring. For instance tetrasubstituted F-acids were more 
reactive than trisubstituted and the latter more reactive than disubstituted F-acids.
80
 
 
4.2 Biosynthesis of F-acids 
F-acids are biosynthesised from acetic acid units in a similar manner to their straight-
chain fatty acids counterpart.
88
 Scheinkoenig and Spiteller
88
 demonstrated through their 
feeding experiments of 
13
C labelled acetate on suspension cultures of a Saccharum sp., 
that the basic carbon chain skeleton of F-acids was formed following the fatty acid 
pathway. Thus, in order to understand the biosynthetic origin of F-acids it is important 
to understand the general process of how fatty acids are formed. 
 
4.2.1 Formation of acetyl coenzyme A 
Coenzyme A (CoA), a heat stable cofactor, was found to be required in many enzyme-
catalysed acetylations: CoA consists of an adenine nucleotide at one end of the 
molecule. This nucleotide is joined to a pantothenate unit by pyrophosphate. CoA also 
consists of a β-mercaptoethylamine unit with a terminal sulfhydryl group, the latter 
being the reactive site in this molecule.
89
 Figure 4.4 shows the structure of CoA. 
 
 
Figure 4.4: Coenzyme A (CoA) 
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CoA can be converted to acetyl-CoA by oxidative decarboxylation of pyruvate with 
nicotinamide adenine dinucleotide (NAD
+
). This reaction is catalysed by the enzyme 
pyruvate dehydrogenase (Figure 4.5).
89
 
 
 
Figure 4.5: Oxidative decarboxylation of pyruvate to acetyl CoA 
 
4.2.2 Formation of malonyl coenzyme A 
The fatty acid synthesis starts with the irreversible carboxylation of acetyl-CoA to 
malonyl-CoA, which is catalysed by the enzyme acetyl-CoA carboxylase.
89
 Figure 4.6 
shows the formation of malonyl-CoA.  
 
 
Figure 4.6: Generation of malonyl CoA 
 
The enzyme acetyl-CoA carboxylase contains a biotin prosthetic group, composed of 
two fused five-membered heterocyclic rings. One of the five-membered rings is a cyclic 
sulphide with a long saturated hydrocarbon chain ending with a carboxyl group. The 
second five-membered ring is a cyclic urea moiety. The carboxyl group of biotin is 
covalently attached to the ε-amino group of a lysine residue. The biotin prosthetic group 
reacts with bicarbonate to produce a carboxybiotin intermediate. In the next step, 
deprotonation occurs causing formation of carbon dioxide, which subsequently acts as 
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an electrophile in the reaction with the acetyl-CoA anion to create malonyl-CoA (Figure 
4.7).
89
 
 
 
Figure 4.7: Mechanistic representation for the generation of malonyl-CoA 
 
4.2.3 The synthesis of fatty acids 
The synthesis of fatty acids continues with the attachment of acetyl-CoA and malonyl-
CoA to an acyl carrier protein (ACP). These reactions are catalysed by acetyl- and 
malonyl transacylase enzymes. 
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The next step in the elongation phase of fatty acid synthesis is the reaction between 
acetyl-ACP and malonyl-ACP in a Claisen-like condensation where acyl-malonyl-ACP 
is the condensing enzyme. The product of this reaction is the four carbon unit 
acetoacetyl-ACP and CO2 is released (Figure 4.8).
89
 
 
The next three steps in the synthesis of fatty acids involve a series of enzymatically 
controlled reactions firstly reducing the keto group at carbon-3 of acetoacetyl-ACP to 3-
hydroxybutyryl-ACP using NADPH as the reducing agent. 3-Hydroxybutyryl-ACP 
subsequently undergoes a dehydration reaction via an E1cB mechanism producing 
crotonyl-ACP and finally reduction of the double bond of crotonyl-ACP leads to 
butyryl-ACP. In the second round of the elongation phase of fatty acid synthesis, 
butyryl-ACP condenses with malonyl-ACP to form a six-carbon unit and the process of 
elongation is ready to be repeated.
89
 
 
 
Figure 4.8: Fatty acid pathway 
 
4.2.4 The synthesis of F-acids 
After the discovery of eight F-acids from the northern pike fish by Glass and co-
workers,
73
 scientists speculated whether fish synthesised this type of compounds on 
their own or if they acquired them from their diet. Scientists agreed that depending on 
the season and the type of fish the concentration of F-acids changed dramatically.
73
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Sand and co-workers
90
 performed in vivo experiments on interconversions of F-acids in 
fish by administering 
14
C-labelled acetate.
90
 These authors concluded that fish are 
unable to biosynthesise F-acids on their own, though fish were able to metabolise this 
class of compounds in a similar manner to polyunsaturated fatty acids. 
 
In addition, Sand and co-workers
90
 also concluded that the acetate is incorporated into 
the carboxylic side chain by chain elongation. However, acetate is not incorporated into 
the alkyl chain and furan ring, suggesting that fish obtained F-acids from their diet.
90
 
 
Glass and co-workers,
78
 while characterising F-acids from fish lipids, speculated that 
this class of compounds might be biosynthesised from linoleic acid (4.3).
78
 
Subsequently, Gorst-Allman and co-workers, 
91
 while investigating the occurrence of F-
acids in plants, confirmed that compounds of this class containing a pentyl side chain in 
one of the alpha positions of the furan ring do come from linoleic acid (4.3).
91
  
 
Peroxidation of linoleic acid (4.3) is still speculated to be initiated by the enzyme 
lipoxygenase (L-O·) and oxygen from air. This lipoxygenase type reaction with linoleic 
acid (4.3) produces a peroxyl radical (R-OO˙). Initial peroxidation is followed by ring 
closure and bond rearrangement producing a disubstituted F-acid.  
 
Finally, the methyl groups in the β-position of the furan ring are incorporated via a 
methylation reaction with methionine forming 9-(3,4-dimethyl-5-pentylfuran-2-yl)-
nonanoic acid (4.5).
91
 Figure 4.9 shows a schematic representation of peroxidation of 
linoleic acid (4.3) to 4.5. 
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Figure 4.9: Generally accepted biogenesis of F-acids 
 
4.3 Examples on previous chemical synthetic pathways 
F-acids are a class of compounds that have been characterised as either tri- or 
tetrasubstituted furan derivatives.
78
 However, a disubstituted F-acid, 8-(5-hexylfuran-
2yl)-octanoic acid (3.3), isolated from the seed oil of Exocarpus cupressiformis Labill. 
has been reported.
71
 The synthesis of 3.3 was first reported by Elix and Sargent
92
 and 
the reaction scheme is shown in Figure 4.10.  
 
Reaction sequence started from 2-furoic acid, which was converted to 2-furoyl chloride 
(4.6) with thionyl chloride. Subsequent reaction of 2-furoyl chloride (4.6) with dipentyl 
cadmium afforded 2-hexanoylfuran (4.7).  
 
A modified Wolff-Kishner reaction was performed on 2-hexanoylfuran (4.7) reducing 
the ketone to give 2-hexylfuran (4.8). The synthesis continued with acylation of 2-
hexylfuran (4.8) with suberic anhydride and boron trifluoride diethyl etherate to give 8-
(5-hexyl-2-furyl)-8-oxo-oxtanoic acid (4.9). 
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Finally reduction of the ketoacid in 4.9 with a modified Wolff-Kishner reaction afforded 
8-(5-hexylfuran-2yl)-octanoic acid (3.3). 
 
 
Figure 4.10: Synthesis of 8-(5-hexylfuran-2-yl)-octanoic acid (3.3) isolated from E. 
cupressiformis Labill. 
 
Glass and co-workers
73
 reported that 11-(3,4-dimethyl-5-pentylfuran-2-yl)-undecanoic 
acid (4.10) was the most abundant F-acid extracted from fish lipids and Rahn and co-
workers
93
 reported its total synthesis. The reaction sequence is shown in Figure 4.11. 
 
The first step involved a condensation reaction between furan-3,4-diylbis-(methylene)-
diacetate (4.11) and pentanoic acid anhydride in the presence of boron trifluoride 
diethyl etherate to produce (2-pentanoylfuran-3,4-diyl)-bis-(methylene)-diacetate (4.12). 
Subsequent reduction of all carbonyls under Wolff-Kishner conditions gave the 5-
pentylfuran-dimethanol derivative (4.13). 
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Figure 4.11: Synthesis of 11-(3,4-dimethyl-5-pentylfuran-2-yl)-undecanoic acid (4.10) 
 
The hydroxyl groups of 4.13 were exchanged by chlorine with phosgene and the 
resulting dichloro compound (4.14) underwent reduction reaction with LiAlH4 to give 
3,4-dimethyl-2-pentylfuran (4.15). Insertion of the fourth substituent on the furan ring 
to produce 2-(10-chlorodecyl)-3,4-dimethyl-5-pentylfuran (4.16) was achieved by 
metalation with n-BuLi and subsequent reaction of the lithiated derivative with 1-
chloro-10-iododecane.  
 
Finally, 4.16 underwent lithium-halogen exchange and carbonation to produce the 
desire tetrasubstituted F-acid 11-(3,4-dimethyl-5-pentylfuran-2-yl)-undecanoic acid 
(4.10). 
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Rahn and co-workers
94
 also reported the synthesis of a radioactive F-acid to study their 
biological conversions, following an alternative route to that shown on Figure 4.11. 3,4-
Dimethyl-5-pentylfuran (4.15) was formylated under Vilsmeier’s conditions producing 
3,4-dimethyl-5-pentyl-2-furaldehyde (4.17).  
 
Wittig olefination between 4.17 and the ylid prepared from (6-carbomethoxyhexyl)-
triphenylphosphonium iodide gave 4.18. Lindlar’s hydrogenation gave a tetra 
substituted F-acid methylester (4.19) and subsequent Arndt-Eistert homologation 
reaction with 
14
CH2N2 introduced the additional labeled carbon producing the F-acid 
derivative (4.20). Figure 4.12 shows the synthetic scheme. 
 
 
Figure 4.12: Synthesis of labelled F-acid derivative 
 
On an attempt to synthesise the second most abundant F-acid 11-(3-methyl-5-
pentylfuran-2-yl)-undecanoic acid (4.21) reported by Glass and co-workers,
73
 Bach and 
Krueger
95
 took advantage of the reactivity of bromine as a substituent at the furan ring 
to synthesise 4.21.  
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Dibromo-furaldehyde (4.22) was used as starting material and it was cross-coupled with 
10-undecynoic acid benzyl ester, under Sonogashira conditions, which selectivity at 
position 2 of the furan ring furnished 4.23. A Wittig olefination was subsequently 
carried out, achieving in this manner 4.24.  
 
Finally, Negishi coupling allowed the exchanged of bromine at the β-position on the 
furan moiety in 4.24 by a methyl group and subsequent hydrogenation afforded the 
trisubstituted F-acid, 11-(3-methyl-5-pentylfuran-2-yl)-undecanoic acid (4.21). Figure 
4.13 shows the reaction scheme. 
 
 
Figure 4.13: Synthesis of 11-(3-methyl-5-pentylfuran-2-yl)-undecanoic acid (4.21) 
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4.4 Synthesis of (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
Previous synthetic approaches served as precedent for a synthetic route towards the 
preparation of F-acids (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) 
isolated from Fulaga dive (Amanita sp. Pers.). Considering the availability of potential 
starting materials in our laboratory a retrosynthetic analysis was performed in order to 
determine starting points for the forward synthesis of such F-acids. Figure 4.14 shows a 
schematic representation of interconversions and disconnections leading to candidates 
for the forward synthesis of 3.1 and 3.2. 
 
 
Figure 4.14: Retrosynthetic analysis for the synthesis of F-acids (3.1 and 3.2) (X = halogen) 
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Thus, it seemed reasonable to achieve target acids (Z- & E)-9-(5-pentylfuran-2-yl)-non-
8-enoic acid (3.1 and 3.2) through functional group interconversion and selective 
reduction of a furan alkynol derivative similar to that used by Bach and Kruger
95
 
(Figure 4.13) but taking care to stop at the alkene without over-reduction to the alkane. 
In addition, through disconnection of the alkynol chain from the furan core, we would 
afford a terminal acetylenic alcohol and a halogenated alkyl furan derivative. 
 
Finally, the halogenated alkylfuran could be achieved by disconnection of the halogen 
substituent and the pentyl side chain from the furan core, giving the convenient and 
commercially available starting materials: furan and a five-carbon haloalkane. 
Similarly, the long chain terminal acetylenic alcohol could be prepared from the 
alkylation of propargyl alcohol and subsequent migration of the triple bond to the end of 
the chain. 
 
4.5 Results and discussion 
4.5.1 Alkylation of furan 
The first step in the forward synthesis towards the two naturally occurring F-acids, (Z- 
& E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) was the ortho-lithiation and 
subsequent alkylation of furan (4.25) with n-butyllithium (n-BuLi) and 1-bromopentane 
to form 5-pentylfuran (4.26) as shown of Figure 4.15. 
 
 
Figure 4.15: Alkylation of furan (4.25), 95% yield. 
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The use of alkyllithium reagents to induce deprotonation at one of the α-positions of the 
furan ring prior to addition of an electrophile has been previously explored.
96
 As shown 
in Figure 4.16, mechanistic evidence of this type of reactions suggest that lithium 
coordinates with the oxygen of furan (4.25) while the alkyl portion of n-BuLi removes a 
proton producing butane. The furan-lithium intermediate undergoes an SN2 reaction 
with 1-bromopentane to yield 5-pentylfuran (4.26) and lithium bromide, which is easily 
removed during aqueous work-up. 
 
 
Figure 4.16: Mechanistic representation of the alkylation of furan (4.25) 
 
Although mechanistic evidence was suggestive of a straight forward transformation, 
first attempts were challenging and optimisation became important. First, with general 
directions from Koldobskii and co-workers, 
97
 n-BuLi was added dropwise to a solution 
of furan (4.25) in dried THF at 0°C. The resulting mixture was stirred for 30 min before 
1-bromopentane was added at -78°C. The resulting 1:1:1 ratio mixture was allowed to 
stir for an extra 30 min before work-up.  
 
This attempt proved to be inefficient, as mostly starting material was recovered. The 
poor yield obtained (approx. 13%) prompted us to modify the reaction conditions in an 
attempt to improve the yield of the reaction. 
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Citron and co-workers
98
 provided ideas to modify the reaction. The temperature of 
addition of the alkylithium was modified from 0°C to -78°C. It was assumed that by 
decreasing the temperature, the deprotonation process could be sufficiently slow to 
guarantee complete deprotonation of furan (4.25) avoiding side reactions between the 
alkyllithium and the electrophile alone.  
 
After addition of the electrophile, the 1:1:1 mixture was allowed to stir for three hours, 
allowing to reach room temperature, to make sure the reaction could go to completion. 
Unfortunately this second attempt also proved to be inefficient, as mostly unreacted 
starting material was present at the end of the reaction. However, in a parallel 
experiment where a slightly higher concentration of the alkyllithium was used, the 
results were more promising, as the yield of the reaction increased. Uncertainties about 
the true concentration of the alkyllithium used in the first two attempts prompted us to 
re-standardise n-BuLi against N-benzylbenzamide under the exact conditions as 
described by Burchat and colleagues.
99
 
 
Finally, the work of Rhan and co-workers
93
 on the synthesis of F-acids, the work of 
Thomas and co-workers
100
 on the synthesis of thiophenes, and the experience gained 
from failed experiments provided successful directions for the synthesis of 5-
pentylfuran (4.26). 
 
By adding two equivalents of furan (4.25) to a solution of n-BuLi in dried THF at -
20°C, deprotonation of furan (4.25) was achieved in a controlled manner and prevented 
side reactions between the alkyllithium and the electrophile once added. The resulting 
mixture was brought to 0°C and stirred for 2.5h at which time 1-bromopentane was 
added and the mixture was stirred overnight at room temperature, producing 5-
pentylfuran (4.26) in high yields (95%). 
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Evidence of a successful reaction was obtained from NMR analyses. For example, the 
appearance of two doublets of doublets at 7.30 ppm (A) and 6.29 ppm (B) in the 
aromatic region of the 
1
H NMR spectrum, as well as a doublet of doublet of triplets at 
5.98 ppm (C) suggesting substitution in one of the alpha positions of the furan ring. 
Figure 4.17 shows downfield region of the 
1
H NMR spectrum of 5-pentylfuran (4.26). 
 
 
Figure 4.17: Downfield region of 
1
H (400 MHz) NMR spectrum in CDCl3 of 5-pentylfuran 
(4.26) 
 
4.5.2 Halogenation of 5-pentylfuran 
The second step in the synthesis of (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1 and 3.2) was the halogenation of 5-pentylfuran (4.26). Bach and Kruegar
95
 took 
advantage of the reactivity of bromine in the synthesis of F-acids.  
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Therefore, the use of N-bromosuccinamide (NBS) to incorporate bromine seemed 
reasonable. Figure 4.18 shows the reaction scheme of the bromination of 4.26. 
 
Figure 4.18: Bromination of 5-pentylfuran (4.26) 
 
Although the use of NBS in halogenation reactions has been well documented,
101-102
 
most attempts at this reaction proved challenging, as mostly complex mixture of 
resonances were observed in the 
1
H NMR spectrum.  
 
Looking at the mechanisms of this type of transformations, light and heat play the role 
of radical initiators in the homolysis of NBS to release one bromine atom and produce 
hydrobromic acid (HBr), as a by-product, upon reaction with alkylfuran. HBr 
subsequently undergoes homolytic cleavage and interacts with another NBS producing 
bromine, which becomes the brominating agent in the transformation to 2-bromo-5-
pentylfuran (4.27).
96
  
 
Based on the mechanism shown in Figure 4.19, there is no reason to think that NBS 
could also remove one hydrogen (-H1) from the side chain at position C-1, indicating 
that bromination can also occur at the allylic carbon. However, that still does not 
explain the complex mixture of resonances observed in the 
1
H NMR spectrum. 
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Figure 4.19: Proposed mechanism of the bromination of alkylfuran 
 
Considering the photosensitivity of bromination reactions, with general instructions 
from Raheem and co-workers,
102
 the reaction mixture was protected from light. In 
addition, NBS was added at 0°C and the mixture was allowed to slowly reach 25˚C. By 
reducing the temperature of addition and protecting the reaction mixture from light, the 
halogenation could be slowed down to avoid side reactions, as on previous attempts.  
 
Evidence of bromination in the alpha position of the furan ring was confirmed by the 
disappearance of a doublet of doublet of triplets in the 
1
H NMR spectrum and its 
conversion to a slightly deshielded AB system belonging to 2-bromo-5-pentylfuran 
(4.27). Although the reaction seemed to have worked, according to the 
1
H NMR 
spectrum, it rapidly decomposed to a complex mixture of products. This issue prompted 
me to seek other strategies to make a more stable halogenated derivative. 
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Gidron and co-workers
103
 in their experiments with α-oligofurans, as semiconductors, 
provided general directions in the use of elemental iodine as the halogenating agent. 
Figure 4.20 shows the general reaction scheme. 
 
 
Figure 4.20: Iodination of 5-pentylfuran (4.26), 72% yield. 
 
5-Pentylfuran (4.26) was added to a solution of n-BuLi in dried THF at -20°C and 
subsequently stirred for 2h at 0°C. A solution of iodine in dried THF was added and the 
resulting mixture was stirred overnight.  
 
As shown in Figure 4.21, the downfield region of the 
1
H NMR spectrum in black 
exhibits the disappearance of an ABC spin system (7.30 ppm, labelled as A) and its 
conversion into a slightly more deshielded AB spin system, supported by the 
1
H NMR 
spectrum in red (6.40 ppm, labelled as A). 
 
The downfield movement of the AB spin system is expected due to the incorporation of 
an electron donating group such as iodine in the α-position of the furan ring. Thus, 
switching to iodine as the halogenating agent rendered 2-iodo-5-pentylfuran (4.28) with 
few by-products. 
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Figure 4.21: Downfield region of 
1
H NMR (400 MHz) spectrum in CDCl3 of 5-pentylfuran 
(4.26 - black) and 2-iodo-5-pentylfuran (4.28 - red) 
 
4.5.3 Protection, alkylation and deprotection of propargyl alcohol  
The third step towards the synthesis 3.1 and 3.2 was to create a 9-carbon acetylenic 
alcohol to serve as a substrate in the subsequent cross-coupling reaction with the halo-
heteroaryl compound 4.28. Thus, propargyl alcohol (4.29) and 1-bromohexane were the 
obvious reactants to carry out the synthesis of such acetylenic alcohol. 
 
There is precedent indicating that propargyl alcohol (4.29) could be deprotonated twice 
when a strong base such as n-BuLi is used.
96
 The deprotonation process indicates that 
an alkoxyde would be firstly formed, due to a pKa 16 of the hydroxyl proton. 
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In addition, a dianion would be subsequently created, as the proton attached to the sp 
hybridised carbon (pKa 25) would be also removed. 
 
According to literature, 
96
 if an electrophile reacts with an anion, the electrophile would 
preferentially react at the alkynyl anion and not the alkoxide. However, there is no 
evidence suggesting that an electrophile would not react at the alkoxide too. 
 
Thus, propargyl alcohol (4.29) underwent a tetrahydropyranilation reaction with 3,4-
dihydro-2H-pyran (DHP), using pyridinium p-toluenesulfonate (PPTS) as a catalyst to 
protect the hydroxyl group from deprotonation and in that manner guarantee alkylation 
in the desired position. Figure 4.22 shows the reaction scheme for the protection of 
propargyl alcohol. 
 
 
Figure 4.22: Protection of propargyl alcohol (4.29), 90% yield. 
 
In this reaction, the π-bond, chimerically assisted by the oxygen of DHP, would react 
with the acidic proton of PPTS and subsequently 4.29 acting as a nucleophile would 
approach the oxonium ion formed. The conjugate base of PPTS would regain a proton 
forming 2-(prop-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.30) as shown in Figure 4.23. 
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Figure 4.23: Mechanistic representation of the protection of propargyl alcohol (4.29) 
 
Upon protection of propargyl alcohol (4.29), the sp hybridised carbon was deprotonated 
by n-BuLi at -78°C in dried THF. The lithiated intermediate subsequently underwent an 
SN2 reaction with 1-bromohexane forming 2-(non-2-yn-1-yloxy)-tetrahydro-2H-pyran 
(4.31). Hexamethylphosphoramide (HMPA) was added to the reaction mixture, to 
solvate lithium cations to generate more naked anions, in order to accelerate the 
otherwise slow SN2 reaction between the lithiated intermediate and alkylhalide. 2-
(Non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31) was used in the next step without 
further purification and/or characterisation. 
 
 
Figure 4.24: Alkylation of protected propargyl alcohol 
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The final step before transitioning to cross-coupling reactions was the deprotection of 2-
(non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31). The THP group being unstable under 
acid conditions, provided clues of how to remove it from 4.31.
96
 In the presence of acid, 
a lone pair of electrons from the acyclic oxygen atom of 4.31 accepts a proton from the 
acid causing electron movement from the THP group to reform the alcohol. In addition, 
an oxonium ion is created and it is subsequently decomposed to 2-methoxytetrahydro-
2H-pyran, as shown on Figure 4.25. 
 
 
Figure 4.25: Acid hydrolysis of acetal in MeOH 
 
Experimentally, 2-(non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31) was deprotected with 
p-toluenesulfonic acid in MeOH producing non-2-yn-1-ol (4.32). As shown in Figure 
4.26, deprotection of the alkylated alcohol was evident by the disappearance of all 
resonances in the 
1
H NMR spectrum characteristic of a tetrahydropyran. In addition, 
typical resonances of a long chain internal acetylenic alcohol were also evident. For 
example a terminal methyl group (D) followed by a methylene “envelop” (C), as well 
as, an A2M2X2 spin system at 2.21 ppm (B) and an A2X2 spin system (A) deshielded 
due to inductive effect by the hydroxyl group of the alcohol. 
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Figure 4.26: 
1
H (400 MHz) NMR spectrum in CDCl3 of non-2-yn-1-ol (4.32), 90% yield. 
 
4.5.4 Alkyne “zipper” isomerisation 
The internal alkyne of non-2-yn-1-ol (4.32) must be converted into a terminal alkyne in 
order to perform cross-coupling reactions with 2-iodo-5-pentylfuran (4.28). Initial 
directions were given by Brown and Yamashita
104
 from their work on the isomerisation 
of long chain alkynes. 
 
The original reaction used 2-hexyne as the test compound and potassium 3-
aminopropylamide (KAPA), classified as a “superbase” of high reactivity created in situ 
and key reagent in the isomerisation reaction. KAPA was prepared from the reaction 
between potassium hydride (KH) and aminopropylamine (APA). It should be noted that 
at this point, it was considered to replace KH for sodium hydride (NaH), as a more 
manageable reagent. 
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As shown in Figure 4.27, mechanistically, KAPA allows a series of protonations and 
deprotonations via an allene intermediate until the internal triple bond migrates to the 
terminal position of the chain. The final proton is transferred to the carbanion during 
acid work-up to form the terminal alkyne. 
 
 
Figure 4.27: “Zipper” isomerisation reaction mechanism 
 
Sodium hydride (NaH) was used instead of KH to produce a solution of NAPA and key 
reagent for this reaction. Precedent for the use of NaH was provided by Goh and co-
workers.
105
 It is worth noting that early attempts at the “zipper” reaction using the 
protected acetylenic alcohol (4.31) as a test sample were unsuccessful. Success was not 
achieved even when NAPA was replaced for the original KAPA. 
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It seemed plausible that for the “zipper” reaction to take place, the most acidic proton in 
4.31 must have been abstracted by NAPA or KAPA. However, the presence of a THP 
protecting group having electron withdrawing effect from the neighbouring acetal 
would make the proton 1’-H, shown in Figure 4.28, more acidic and the reaction would 
not take place. 
 
 
Figure 4.28: “Zipper” reaction on 2-(non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31) 
 
As described in section 4.5.3, 2-(non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31) was 
deprotected under acidic conditions forming non-2-yn-1-ol (4.32) and re-submitted to 
isomerisation reaction under the conditions used by Goh and colleagues. With 4.32, as 
the new substrate, it would be expected that an excess of NAPA would deprotonate the 
most acidic proton (pKa 15) forming an alkoxide. The formation of an alkoxide as an 
electron source around 1’-H will decrease the acidity of this proton, favouring 4’-H 
proton to be abstracted by NAPA and form the allene intermediate until non-8-yn-1-ol 
(4.33) is formed. Figure 4.29 shows the reaction scheme. 
 
 
Figure 4.29:”Zipper” reaction on non-2-yn-1-ol (4.32), 70% yield. 
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The completion of the alkyne isomerisation reaction was confirmed by the presence of 
the acetylenic methine resonance as a triplet (1.93 ppm, J = 2.7 Hz) in the 
1
H proton 
NMR spectrum. In addition, the disappearance of a singlet quaternary carbon, at 86.6 
ppm in the 
13
C NMR spectrum and appearance of a protonated carbon resonance at 68.1 
ppm supported acetylene migration to the terminal position and hence the formation of 
non-8-yn-1-ol (4.33). 
 
4.5.5 Cross-coupling reaction 
The fifth step towards the synthesis of (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1 and 3.2) was a Sonogashira cross-coupling reaction between 2-iodo-5-pentylfuran 
(4.28) and non-8-yn-1-ol (4.33) to produce 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34). 
Figure 4.30 shows the reaction scheme. 
 
 
Figure 4.30: Sonogashira cross-coupling reaction, 44% yield. 
 
Sonogashira reactions between heteroaryliodide compounds and terminal alkynols, 
using different catalysts and bases, have been previously reported in the literature.
106-108
 
In addition, Bach and Krueger
95
 also used Sonogashira cross-coupling reactions in their 
synthesis of the second most abundant F-acid reported by Glass and co-workers,
78
 11-
(3-methyl-5-pentylfuran-2-yl)-undecanoic acid (4.21).  
 
As presented in Figure 4.31, a Sonogashira cross-coupling reaction begins with the 
palladium catalytic cycle, which forms a complex due to oxidative addition of an 
alkylhalide to the palladium catalyst (Pd
0
).   
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This complex increases the oxidation state of Pd
0
 to Pd
II
.
 
The
 
palladium catalytic cycle 
continues with transmetalation with an organocopper reagent, which is simultaneously 
formed through a reaction between a terminal alkynol and a copper catalyst in the 
presence of a base such as pyrrolidine. 
 
The alkynol is deprotonated by the base and the resulting alkynyl anion replaces iodide 
in the Pd
II
 complex, regenerating the copper iodide catalyst. Finally, reductive 
elimination gives the new cross-coupled product and the palladium catalyst is 
regenerated. 
 
 
Figure 4.31: Palladium and copper catalytic cycles. Adapted from Organic Chemistry 
Portal.
109
 
 
Experimentally, Alami and co-workers
110
 provided directions for the synthesis of 9-(5-
pentylfuran-2-yl)-non-8-yn-1-ol (4.34). Thus, 2-iodo-5-pentylfuran (4.28) was cross-
coupled with non-8-yn-1-ol (4.33) using tetrakis-(triphenylphosphine)-palladium and 
copper iodide (CuI) as catalyst and co-catalyst respectively. 
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Pyrrolidine was used as the solvent and base and the reaction mixture was allowed to 
stir overnight at room temperature, producing 4.34 after purification. The disappearance 
of the acetylenic proton at 1.93 ppm in the 
1
H NMR spectrum and the appearance of a 
new quaternary carbon in the 
13
C NMR spectrum at71.4 ppm as a result of the new 
sigma carbon-carbon bond formed between 4.28 and the alkynol 4.33 served as 
confirmation that 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34) was successfully 
synthesised. 
 
4.5.6 Oxidation of 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol 
The retrosynthetic analysis described in section 4.4 provided general guidelines for the 
synthesis of (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2). Thus, in the 
final stages of the synthesis of F-acids isolated from Fulaga dive, it seemed reasonable 
to begin by selectively reducing the alkyne to the corresponding Z- and E-alkenes, 
followed by functional group interconversion to obtain the target acids. 
 
After the initial attempts at reducing 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34), the 
resulting Z-furan alcohol derivative appeared to be unstable showing a very particular 
degradation pathway, which is discussed in more detail in section 4.5.8. Because of the 
instability of the Z-furan alcohol, it was decided that functional group interconversion 
was going to be explored followed by selective reduction of the alkyne. 
 
There is precedence available on how to convert primary alcohols to their corresponding 
carboxylic acids.
96
 A common method is the use of potassium permanganate (KMnO4) 
in basic solutions. However, being a strong oxidiser, KMnO4 is capable of oxidising 
double and triple bonds before oxidising the intended alcohol. Therefore, this method 
was found unsuitable, as oxidative cleavage of the triple bond and the π-bonds of furan 
in 4.34 were likely to occur. 
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Another common method is the use of Jones reagent for the interconversions of primary 
alcohols to their corresponding carboxylic acids.
111
 Jones reagent uses a solution of 
chromium (VI) in aqueous sulfuric acid (H2SO4), which forms a red solution of chromic 
acid. The resulting red solution turns green by the building up of chromium (IV), which 
is an indication that the reaction went to completion. Considering the well-known acid 
sensitivity of furan derivatives, the use of Jones reagent was also found unsuitable for 
our purpose. 
 
Finally, Corey and Schmidt
112
 reported the use of pyridinium dichromate (PDC) in 
dimethylformamide (DMF) to convert primary alcohols to carboxylic acids at neutral 
conditions. The neutral conditions were found to be appealing for our purpose. As 
shown in the proposed mechanism on Figure 4.34, the primary alcohol would react with 
a chromium (VI) complex, which subsequently could also react intra or inter-
molecularly to produce an aldehyde intermediate and its corresponding chromium (IV), 
as by-product. The aldehyde could presumably further react with any excess of 
chromium (VI) present in the mixture to produce the corresponding carboxylic acid. 
 
 
Figure 4.32: Proposed mechanistic approach of Corey and Schmidt oxidation.
113,114
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Experimentally, 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34) was added to a solution of 
PDC in DMF at 0˚C and the reaction mixture was stirred overnight allowing to reach 
room temperature. Partial oxidation of 4.34 to its corresponding aldehyde intermediate 
was confirmed by the appearance of an aldehydic proton at around 9.75 ppm in the 
1
H 
NMR spectrum. However, the formation of carboxylic acid was uncertain, as several 
unidentified proton resonances were also visible.  
 
In light of the uncertainty of whether the single step reaction was in fact successful, GC-
MS analysis was performed. GC-MS clearly suggested the formation of the aldehyde 
derivative by the appearance of a molecular ion [M]˙+ at m/z 274 though no evidence of 
a carboxylic acid was detected. It was then decided to explore other oxidation methods 
to obtain the carboxylic acid in two steps. 
 
a) Oxidation of primary alcohol to aldehyde 
With general directions obtained from Zúñiga and co-workers,
115
 a mixture of catalytic 
amounts of TEMPO radical and a slight excess of bis-acetoxy-iodobenzene (BAIB) in 
DCM were used to promote the transformation of 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol 
(4.34) to the corresponding aldehyde 4.35, as shown in Figure 4.33. 
 
The oxidation of the primary alcohol to aldehyde was performed successfully and it was 
used in the next step without further purification. 
 
 
Figure 4.33: Epp and Widlanski oxidation of primary alcohols.
116
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Although many efforts have been done to determine the mechanism of the oxidation of 
an alcohol to its corresponding aldehyde using oxoammonium salts as primary oxidant, 
the mechanism is not very well understood. However, experimental studies have been 
reported on the mechanism of this reaction suggesting that TEMPO alone is not the 
primary oxidant.
117
  
 
Figure 4.34 shows a schematic representation of acid catalysed “bismutation”, where 
TEMPO undergoes two different transformations. For example, TEMPO can be reduced 
to form hydroxylamine or oxidised to form its corresponding oxoammonium salt. The 
resulting oxoammonium salt becomes the primary oxidant. 
 
 
Figure 4.34: Acid catalysed “bismutation” of TEMPO radical 
 
Furthermore, Epp and Widlanski
116
 suggested that the first molecule of acid responsible 
for the catalysis of TEMPO to its oxoammonium salt could be generated by ligand 
exchange between BAIB and the primary alcohol. 
 
An interaction of this sort would release acetic acid capable of initiating the 
“bismutation” of TEMPO radical. The resulting oxoammonium salt would react with 
the primary alcohol to form the desired aldehyde and hydroxylamine as a by-product. 
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Hydroxylamine could be further oxidised by BAIB back to TEMPO, also generating 
another molecule of acetic acid, initiating the catalytic cycle. Figure 4.35 shows a 
schematic representation of the oxidation of a primary alcohol as per Epp and 
Widlanski.
116
 
 
 
Figure 4.35: Oxidation of primary alcohols to aldehydes by Epp and Widlanski
116
 
 
b) Oxidation of aldehyde to carboxylic acid 
Lindgren and Nilsson
118
 reported the preparation of carboxylic acids from aldehydes 
using chlorite as the oxidant. Almost a decade later, Pinnick and co-workers
119
 reported 
very similar work to Lindgren and Nilsson’s in the oxidation of aldehydes with some 
variations in their methodology. 
 
Thus, hereafter the conversion of aldehydes to carboxylic acids under sodium chlorite 
(NaClO2) in aqueous tertiary butanol (t-BuOH) would be referred to as Pinnick-
Lindgren oxidation.
118-119
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9-(5-Pentylfuran-2-yl)-non-8-ynal (4.35) was oxidised under Pinnick-Lindgren
118-119
 
conditions to form 9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36) and the reaction 
scheme is shown in Figure 4.36 
 
 
Figure 4.36: Pinnick-Lingren oxidation of aldehyde to carboxylic acid, 80% yield. 
 
Mechanistically, the reaction would begin with protonation of the aldehyde with sodium 
dihydrogen phosphate (NaH2PO4). Sodium dihydrogen phosphate anion subsequently 
interacts with sodium chlorite (NaClO2) to form the chlorite anion and re-form 
NaH2PO4.  
 
The protonated aldehyde subsequently undergoes nucleophilic attack by the chlorite 
anion forming the corresponding carboxylic acid and hypochlorus acid (HOCl), as by-
product. A radical scavenger such as 2-methyl-2-butene is added to the reaction mixture 
to prevent HOCl from forming unwanted side reactions. 
 
Figure 4.37 exhibits a mechanistic representation of the oxidation of aldehydes to 
carboxylic acids under Pinick-Lindgren conditions also showing the quenching of 
hypochlorus acid with 2-methyl-2-butene. 
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Figure 4.37: Mechanism of Pinnick-Lindgren
118-119
 oxidation of aldehydes to carboxylic 
acids. 
 
Experimentally, general directions were given by Schmidt and co-workers.
120
 A freshly 
prepared mixture of NaClO2, sodium dihydrogen phosphate (NaH2PO4) and 2-methyl-2-
butene in an aqueous t-BuOH was added to 4.35. The resulting mixture was allowed to 
stir until 9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36) was completely formed and no 
4.35 was observed by TLC.  
 
The synthesis of 9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36) was confirmed by the 
appearance of a molecular ion [M]˙+ at m/z 290 in the GC-MS, in agreement with the 
molecular formula C18H26O3. The disappearance of the aldehydic proton in the 
1
H NMR 
spectrum, as well as the presence of a carbonyl resonance in the 
13
C NMR spectrum was 
diagnostic that the reaction was successful. 
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4.5.7 Selective reduction of 9-(5-pentylfuran-2-yl)-non-8-ynoic acid 
The last step in the synthesis to (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 
and 3.2) was selective reduction of the alkyne in 9-(5-pentylfuran-2-yl)-non-8-ynoic 
acid (4.36) to for both Z- and E-diastereoisomers. 
 
a) Partial hydrogenation of acetylenic F-acid to Z-alkene 
There is literature precedent suggesting the use of Lindlar’s catalyst in the reduction of 
alkynes to (Z)-alkenes with low Z/E isomerisation and overreduction.
121
 The traditional 
Lindlar’s catalyst is composed of 5 wt.% palladium (Pd) supported on porous calcium 
carbonate (CaCO3) or barium sulphate (BaSO4).
122
 In addition, Lindlar’s catalyst is 
usually treated with various forms of lead (Pb), as poison, and quinoline as an additional 
source of catalyst poison.
123
 
 
Garcia-Mota and co-workers
123
 reported that alkene adsorption to the metal catalyst 
surface is decreased when significant amounts of Pb are added.
123
 In addition, when 
quinoline is added to the mixture, it binds to the metal catalyst surface blocking active 
sites that otherwise would be occupied by hydrogen, hence avoiding overreduced 
products.
123
  
 
McEwen and co-workers
124
 suggested that rather than a simple blocking effect, poisons 
in Lindlar’s catalyst rearrange the palladium structure.124 Therefore, as shown in Figure 
4.38, the alkyne would bind to the metal catalyst surface and interact with hydrogen 
atoms also adsorbed on the metal surface followed by syn-addition of hydrogen atoms 
to the alkyne. 
 
The number of active sites available and the amount of hydride formed is dependent on 
the amount of Pb and extra poison (e.g. quinoline) bound to the metal surface. The ratio 
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between the amounts of poison bound to the Pd active surface is important to avoid 
overreduction to the alkane. In this diagram, poison is represented by a skull. 
 
 
Figure 4.38: Schematic representation of Lindlar’s hydrogenation mechanism 
 
As a first attempt in the reduction of 9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36), 
with directions from Paterson and Tudge, a solution of 4.36 in EtOAc was added to a 
mixture of Lindlar catalyst (palladium 5% wt. on CaCO3 poisoned with Pb), under an 
atmosphere of hydrogen (H2).
125
 The mixture was stirred for 10 min and quinoline was 
added, as extra poison.  
 
The mixture was stirred for three hours at which point the reaction mixture was 
analysed by GC-MS and 
1
H NMR. No reduction of 4.36 was observed. It was reasoned 
that if the amount of quinoline present in the mixture was blocking all active sites of the 
metal catalyst surface, reducing the amount of quinoline seemed logical. In addition, if 
Lindlar’s catalyst was already poisoned with Pb, it was plausible that quinoline was not 
needed at all. 
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In the absence of quinoline, 4.36 was completely reduced to its corresponding alkane 
derivative. Several attempts were performed hereafter, gradually increasing the amounts 
of quinoline and also performing the reaction in different solvents. The reaction was 
monitored via GC-MS every 30 min for three hours. Partial reduction of 4.36 to (Z)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) was observed according to GC-MS analysis 
with mostly unreacted starting material. 
 
McEwen and co-workers
124
 reported that commercial palladium (Pd) foil could catalyse 
the partial hydrogenation of acetylenes to Z-alkenes with high selectivity.
124
 These 
authors suggested that Pd metal is in fact “Lindlar’s catalyst” and any poison added 
serves to modify the surface structure of the catalyst.
124
 Considering these assumptions, 
attention was drawn to Pd on activated charcoal, free of poison. In addition, quinoline 
was replaced by ethylenediamine, following directions from Campos and co-workers
121
 
and the selective hydrogenation of alkynes to Z-alkenes with minimal Z/E isomerisation 
and overreduction.
121
 
 
Thus, the standard Lindlar catalyst was replaced by a mixture of Pd on activated 
charcoal (Pd/C) and the amounts of ethylenediamine were tested to afford the best yield 
of the desired product. Figure 4.39 shows the reaction scheme of the partial reduction of 
9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36). 
 
 
Figure 4.39: Partial hydrogenation reaction to Z-alkene, 80% yield. 
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Exchanging the standard Lindlar’s catalyst for Pd/C and quinoline for ethylendiamine, 
as the poison, proved successful in the synthesis of (Z)-9-(5-pentylfuran-2-yl)-non-8-
enoic acid (3.1). On characterisation, a molecular ion [M]˙+ at m/z 292 in the GC-MS 
was consistent with the mass originally assigned for the natural product. In addition, the 
appearance of an AB and ABM2 spin systems downfield in the 
1
H NMR spectrum 
having a coupling constant of approximately 11 Hz was evidence that the (Z)-alkene 
was formed. 
 
b) Partial hydrogenation of acetylenic F-acid to E-alkene 
In contrast, partial hydrogenations of acetylenic compounds to give the E-alkene have 
been achieved by Birch-type reductions.
126
 However, the strong conditions of these 
reactions using alkali metals dissolved in amines could damage functional groups, 
which make the selective reduction of alkynes to E-alkenes very difficult. Chen and co-
workers
126
 described a selective Ni-catalysed semihydrogenation of alkynes to E-
alkenes using hypophosphorous acid (H3PO2) as the hydrogen donor, with apparently 
high tolerance to different functional groups (Figure 4.40).
126
 
 
 
Figure 4.40: Selective E-reduction of alkynes with hypophosphorous acid 
 
Chen and co-workers
126
 presumed that the Z-alkene was initially formed and rapidly 
isomerised to the more stable E-alkene in the presence of H3PO2. In addition, these 
authors noted that H3PO2 was important for the isomerisation to occur as in its absence, 
isomerisation was not evident.
126
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Luo and co-workers
127
 also reported a Pd catalysed semihydrogenation of alkynes to E-
alkenes employing triethylsilane (HSiEt3) as the reducing agent (Figure 4.41). These 
authors also presumed that the Z-alkene was generated and subsequently isomerised to 
the more stable E-alkene in the presence of CuSO4.
127
 
 
 
Figure 4.41: Selective E-reduction of alkynes with triethylsilane 
 
As for the selective reduction of 9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36) to (E)-
9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), no selective hydrogenation has been 
explored thus far. (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) rapidly isomerised 
to (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), while in CDCl3 in the NMR tube. 
When 3.1 was characterised in deuterated benzene (C6D6), no isomerisation to 3.2 was 
observed in the 
1
H NMR spectrum. Therefore, as shown in Figure 4.42, for the 
synthesis of (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), (Z)-9-(5-pentylfuran-2-
yl)-non-8-enoic acid (3.1) was kept in CDCl3 until complete isomerisation was observed 
by 
1
H NMR spectroscopy. 
 
 
Figure 4.42: Isomerisation of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) to (E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.2) in CDCl3, > 99% yield. 
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4.5.8 Degradation of F-acids 
The degradation of F-acids is still a matter of speculation. F-acids are believed to be 
good antioxidants for their ability to scavenge free radicals and singlet oxygen.
80,128
 
Okada and co-workers,
80
 in their experiments on the uses of F-acids to prevent the 
oxidation of linoleic acid, concluded that tetrasubstituted F-acids possessed the highest 
antioxidant capabilities, followed by trisubstituted F-acids, as they showed a significant 
decrease in their antioxidant effect. 
 
Moreover, Okada and co-workers
80
 concluded that disubstituted F-acids were 
practically inactive, as no significant antioxidant capabilities were observed. 
Experiments conducted by Batna and Spiteller
87
 were somewhat in agreement with 
those reported by Okada and co-workers,
80
 as oxidation of a disubstituted F-acid was 
only possible when soybean lipoxygenase-1, linoleic acid and vigorous gassing of pure 
oxygen were present. 
 
It should be noted that all F-acids previously used to test antioxidant potentials 
possessed unbranched saturated hydrocarbon chains at C2 and C5 positions of the furan 
ring. It should also be noted that the disubstituted F-acids, (Z)-9-(5-pentylfuran-2-yl)-
non-8-enoic acid (3.1) and (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), 
synthesised herein, possess in position C2 of the furan ring, an internal alkene on the 
side chain ending with a carboxylic acid. 
 
Finally, the likelihood that 3.1 isomerises to the more stable F-acid derivative 3.2 
followed by oxidative cleavage of the double bond to produce 5-pentyl-2-furaldehyde 
(3.4) without the need to produce the dioxoenoic acid cannot be ruled out. 
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During purification of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) from a mixture 
of compounds, as shown on Figure 4.43, the intensity of 3.1 in the TIC of the GC-MS, 
which appeared at a retention time (Rt) of 28.2 min, decreased. In comparison, the 
intensity of 5-pentyl-2-furaldehyde (3.4) increased, when the sample mixture was left 
on the bench top, at room temperature for a period of at least 24h. 
 
 
Figure 4.43: TIC from GC-MS of a mixture of compounds from DCM fraction of Fulaga dive 
(Amanita sp. Pers.) 
 
On observations of the 
1
H NMR spectrum for 3.1 in CDCl3, the downfield region shown 
in blue in Figure 4.44, shows resonances characteristic of (Z)-9-(5-pentylfuran-2-yl)-
non-8-enoic acid (3.1), as expected. However, after a period of 24h, the appearance of 
new resonances in the downfield region of the 
1
H NMR spectrum, shown in red, were 
also evident. These resonances suggested almost complete isomerisation to (E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.2) and only trace amounts of the Z-alkene were 
visible, as well as a small aldehydic proton resonance at about 9.5 ppm 
 
If the sample mixture was left at room temperature for several days, the intensity of the 
aldehydic proton increased. Isolation of the furaldehyde derivative (3.4) was proof that 
it was in fact an aldehyde, as per the singlet 9.51 ppm, 
1
H NMR spectrum in black. In 
addition, the appearance of a molecular ion at m/z 166 is consistent with 5-pentyl-2-
furaldehyde (3.4). 
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It is worth noting that 5-pentyl-2-furaldehyde (3.4) has been previously reported,
85
 as a 
natural product, isolated from a Clitocybe sp. (MKACC 53267). However, our 
observations of the degradation of F-acid (3.1) suggest that 3.4 might be an artefact 
formed due to the instability of F-acid (3.1). 
 
 
Figure 4.44: 
1
H NMR (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) degradation 
observations 
 
The structure of 5-pentyl-2-furaldehyde (3.4) was further confirmed by formylation 
reaction of 5-pentylfuran (4.26) under Vilsmeier conditions.
129
 Figure 4.45 shows the 
reaction scheme. 
 
 
Figure 4.45: Formylation of 5-pentylfuran (4.26), 40% yield. 
 
Vilsmeier reaction, uses dimethylformamide (DMF) and phosphoryl trichloride (POCl3) 
to form an iminium salt, which 4.26 subsequently approaches losing its aromaticity. 
Aromaticity of 4.26 is restored upon deprotonation with DMF. 
F-acid 3.1 
F-acids 3.1 and 3.2 and furaldehyde derivative 
3.4 visible 
Furaldehyde derivative 3.4 
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Chloride ion is released allowing the formation of another iminium intermediate, which 
upon aqueous work-up leads to the synthesis of 5-pentylfuran-2-furaldehyde (3.4), as 
shown in Figure 4.46. 
 
 
Figure 4.46: Formation of iminium salt (Vilsmeier reagent).
130
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A member of our research group, while working with (Z)-3-(5-pentylthiophene-2-yl)-
prop-2-en-1-ol analogue to (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) and (E)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), also noticed two unique decomposition 
pathways as shown in Figure 4.47.
131
 
 
 
Figure 4.47: Observed decomposition pathways for thiophene analogue 
 
Apparently degradation pathway (i) was observed when the sample was stored open to 
air at room temperature and it was thought to occur via photolytic homolysis of the π-
bond followed by free rotation and regeneration of the π-bond producing the more 
stable E-alkene, as shown in Figure 4.48. 
 
 
Figure 4.48: Proposed photoisomerisation of Z- thiophene alcohol 
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With regards to (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1), no isomerisation was 
observed in the 
1
H NMR spectrum when 3.1 was dissolved in C6D6, even when left 
under sunlight for an hour or under shortwave UV light for 15 min. It is worth noting 
that only when 3.1 was dissolved in CDCl3, resonances characteristic of an E-alkene 
were observed in the 
1
H NMR spectrum. Although photoisomerisation reactions of 
alkenes are not uncommon, the process usually requires a photosensitiser or a catalyst to 
aid in the homolysis and free rotation of the π-bond.132 It is plausible that the presence 
of acidic CDCl3 could act as a catalyst for the isomerisation to occur. 
 
When a neat sample of the thiophene alcohol was stored at 4°C under air, it was 
hypothesised that decomposition pathway (ii) took place and 5-pentylthiophene-2-
carbaldehyde was formed. The disappearance of the olefinic and allylic methylene 
resonances and the appearance of an aldehydic singlet at 9.82 ppm in the 
1
H NMR 
spectrum confirmed the hypothesis. This oxidative process was thought to occur due to 
the presence of triplet oxygen in the air, as samples stored under argon in benzene 
solution did not experience decomposition pathway (ii). Oxidative reactions of this type 
have been previously reported. However, they typically require a catalyst to induce the 
homolytic cleavage of the alkene.
133
 Figure 4.49 shows a proposed mechanism for the 
oxidative cleavage of the π-bond in 3.1. 
 
 
Figure 4.49: Propose mechanism of oxidative cleavage of F-acid (3.1).
133
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Likewise, degradation pathway (ii) was also observed during isolation of (Z)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.1) when it was left at room temperature for over 
24h. F-acids are known for their radical scavenging capabilities and their potential as 
antioxidants.
72
 Therefore, aerobic oxidation of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic 
acid (3.1) to 5-pentyl-2-furaldehyde (3.4) is evidence of its antioxidant potential.  
 
4.6 Conclusions 
The naturally occurring F-acids: (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) and 
(E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2), isolated from Fulaga dive (Amanita 
sp. Pers.), collected in the Eastern Highlands Province of Papua New Guinea and used 
traditionally by the Kiovi tribe for its edibility, were successfully synthesised.  
 
A diastereoselective synthesis of 3.1 and 3.2 from 9-(5-pentylfuran-2yl)-non-8-ynoic 
acid (4.36) proved challenging. Selective reduction of 4.36 to 3.1 was successfully 
achieved using Pd/C and ethylendiamine as a poison. However, its rapid isomerisation 
to E-diastereoisomer and oxidative cleavage of the π-bond producing 5-pentyl-2-
furaldehyde (3.4), made (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) very difficult 
to handle. Although the synthesis of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) 
and (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) were achieved by the proposed 
synthetic pathway, such synthetic work could be improved by making 3.1 in fewer 
steps. Perhaps with guidance from degradation pathway (ii) 3.1 might be achieved by 
Wittig olefination of 5-pentyl-2-furaldehyde (3.4). 
 
4.7 Experimental 
For general information on instrumental methods used for the characterisation of (Z)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid 1 and (E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
2 and pre-cursors, see experimental section in Chapter 3, section 3.8.1 to 3.8.6. 
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4.7.1 Experimental data 
5-Pentylfuran (4.26). – Directions were given previously.93,100 
Furan (4.25) (7.3 mL, 100 mmol) was added dropwise to a 
solution of n-BuLi (29.4 mL, 50 mmol of 1.7 M in hexane 
solution) in dried THF (200 mL), at -15 to -20°C (CCl4/CO2) under an atmosphere of 
argon. After the addition, the mixture was stirred at 0°C (crushed ice) for two hours. 1-
Bromopentane (6.2 mL, 50 mmol) was subsequently added and the mixture was stirred 
overnight while allowing to warm up to room temperature. Small pieces of crushed ice 
were added to quench the reaction and the organic layer separated. The aqueous layer 
was extracted with diethyl ether (3 x 30 mL) and the combined organic layers were 
washed with NaHCO3, followed by NaCl and water, dried over Na2SO4 and 
concentrated under reduced pressure (60 mBar ± 5), yielding 2-pentylfuran (4.26) 
(95%) as a pale yellow liquid. UV (DCM) λmax (log ε) 231 (3.6) nm; IR (neat) νmax 2929 
(m), 1956 (w), 1008 (m), 724 (s) cm
-1
; Rf (0.43, petroleum spirit 100%); 
1
H NMR (400 
MHz, CDCl3): δ 7.30 (1 H, d, J = 1.4 Hz, 2-H), 6.28 (1 H, dd, J = 3.2, 1.4 Hz, 3-H), 
5.98 (1H, m, 4-H), 2.62 (2 H, t, J = 7.6 Hz, 1’-H), 1.64 (2 H, m, 2’-H), 1.33 (4 H, m, 3’, 
4’-H), 0.91 (3 H, t, J = 6.0 Hz, 5’-H). 13C NMR (100 MHz, CDCl3): δ 156.6 (2-C), 
140.5 (CH, 3-C), 109.9 (CH, 4-C), 104.4 (CH, 3-C), 31.3 (CH2, 1’-C), 27.9 (CH2, 3’-C), 
27.7 (CH2, 2’-C) 22.4 (CH2, 4’-C), 13.9 (CH3, 5’-C). EIMS m/z 138 [M]˙
+
 (29), 95 (8), 
81 (100), 53 (20), 39 (8); HREIMS m/z 138.1045 (calculated for C9H14O, 138.1045). 
 
2-Iodo-5-pentylfuran (4.28). - With guidance from Gidron 
and co-workers
103
 elemental Iodine with n-BuLi in dried 
THF were used for this reaction as follows: 5-Pentylfuran 
(4.26) (1.0 g, 7.4 mmol) was added dropwise to a solution of n-BuLi (13.8 mL, 15.2 
mmol of 1.1 M in hexane solution) in dried THF (150 mL), at -15 to -20 °C (CCl4/CO2) 
under an atmosphere of argon. After the addition, the mixture was stirred at 0°C 
(crushed ice) for two hours. A solution of iodine (3.6 g, 14.1 mmol) in THF (7 mL) 
previously kept at 0°C (crushed ice) was then added dropwise and the mixture was 
stirred overnight, protected from light while allowing to warm up to room temperature. 
Ice/water was added to quench the reaction and the mixture extracted with petroleum 
spirit (3 x 30 mL). The combined organic layers were washed with Na2S2O3 and then 
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passed through a plug of silica (100% petroleum spirit) and dried over Na2SO4 and 
concentrated under reduced pressure (60 mBar ± 5), yielding 2-iodo-5-pentylfuran 
(4.28) (72%) as a dark green liquid. UV (DCM) ) λmax (log ε) 233.5 (3.95) nm; IR (neat) 
νmax 2926 (m), 1009 (m), 778 (s) cm
-1
; Rf (0.5, petroleum spirit 100%); 
1
H NMR (400 
MHz, CDCl3): δ 6.41 (1 H, d, J = 3.2 Hz, 3-H), 5.92 (1 H, d, J = 3.2 Hz, 4-H), 2.63 (2 
H, t, J = 7.6 Hz, 1’-H), 1.62 (2 H, t, m, 2’-H), 1.32 (4 H, m, 3’, 4’-H), 0.90 (3 H, t, J = 
7.0 Hz, 5’-H). 13C NMR (100 MHz, CDCl3): δ 162.3 (5-C), 120.6 (CH, 3-C), 107.9 
(CH, 4-C), 84.1 (2-C), 31.2 (CH2, 1’-C), 28.2 (CH2, 3’-C), 27.6 (CH2, 2’-C) 22.3 (CH2, 
4’-C), 13.9 (CH3, 5’-C). EIMS m/z 264 [M]˙
+
 (49), 207 (100), 179 (23); HREIMS m/z 
264.0004 (calculated for C9H13O 127-I, 264.0011). 
 
2-(Prop-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.30). 
- Propargyl alcohol (4.29) (11.5 mL, 200 mmol) and 
3, 4-dihydro-2H-pyran (18.2 mL, 200 mmol) were 
added to a solution of pyridinium p-
toluenesulfonate (5.0 g, 20 mmol) in CH2Cl2 (250 mL). Mixture was stirred overnight, 
at room temperature, under an atmosphere of argon. A concentrated aqueous solution of 
NaHCO3 was added to quench the reaction and the organic layer separated. The aqueous 
layer was extracted with CH2Cl2 (3 x 30 mL) and the combined organic layers were 
washed first with a saturated solution of NaCl then with water, dried over Na2SO4 and 
concentrated under reduced pressure, yielding 2-(prop-2-yn-1-yloxy)tetrahydro-2H-
pyran (4.30) (90%) as a pale brown liquid. UV (DCM) ) λmax (log ε) 228 (1.23) nm; IR 
(neat) νmax 3229 (br), 2942 (m), 2970 (m), 1118 (s), 1024, 901, 664 (br), cm
-1
; Rf (0.37, 
petroleum spirit: ethyl acetate, (9:1)); 
1
H NMR (400 MHz, CDCl3): δ 4.82 (1 H, t, J = 
3.6 Hz, 2-H), 4.26 (2 H, dd, J = 13.3, 2.4 Hz, 1’-H), 3.87 – 3.81 (1 H, m, 6a-H), 3.57 – 
3.51 (1 H, m, 6b-H), 2.40 (1 H, tt, J = 2.4, 0.6 Hz, 3’-H), 1.88 – 1.51 (6 H, m, 3, 4, 5-H). 
13
C NMR (100 MHz, CDCl3): δ 96.8 (2-C), 79.7 (2’-C), 73.9 (CH, 3’-C), 61.9 (CH2, 6-
C), 53.9 (CH2, 1’-C), 30.2 (CH2, 3-C), 25.3 (CH2, 5-C), 18.9 (CH2, 4-C). EIMS m/z 139 
[M-H]
+
 (15), 85 [C5H9O]
+
 (100), 56 (52), 39 (73), 29 (34); HREIMS m/z 85.0653 
(calculated for C5H9O, 85.0653). 
 
 
139 
Chapter four: Synthesis of furan fatty acids (F-acids) 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
2-(Non-2yn-1-yloxy)-tetrahydro-2H-pyran 
(4.31). - n-BuLi (8.7 mL, 14.8 mmol of 1.7 
M in hexane solution) was added dropwise 
to a solution of 2-(prop-2-yn-1-yloxy)-
tetrahydro-2H-pyran (4.30) (2.1 g, 14.8 mmol) in dried THF (30 mL), at -70°C 
(acetone/CO2) under argon. After the addition, hexamethylphosphoramide (10 mL) was 
also added and the mixture was stirred at -70°C for two hours. Acetone/CO2 cooling 
bath was changed for crushed ice and 1-bromohexane (2.3 mL, 16.3 mmol) was added 
and the mixture was stirred overnight while allowing to warm up to room temperature. 
A solution of 2 M HCl was carefully added to quench the reaction and the aqueous layer 
was extracted with diethyl ether (3 x 30 mL). The combined organic layers were washed 
with NaCl and water, dried over Na2SO4 and concentrated under reduced pressure. The 
crude 2-(non-2yn-1-yloxy)-tetrahydro-2H-pyran (4.31) was used in the next step 
without further purification and/or characterisation. 
 
Non-2-yn-1-ol (4.32). - p-Toluenesulfonic acid (94.0 
mg, 0.5 mmol) was added to a stirring solution of crude 
2-(non-2-yn-1-yloxy)-tetrahydro-2H-pyran (4.31) (5 g) 
in methanol (100 mL). Mixture was stirred overnight, at 
which time methanol was removed under reduced pressure and product was re-
dissolved in diethylether. The ethereal layer was washed with NaHCO3, 1 M NaOH, 
NaCl then with water, dried over Na2SO4 and concentrated under reduced pressure 
yielding non-2-yn-1-ol (4.32) (90%) as a yellow liquid. UV (DCM) ) λmax (log ε) 233 
(1.96) nm; IR (neat) νmax 3287 (br), 2932 (s), 1549 (m), 1474 (m), 1023 (m), cm
-1
; Rf 
(0.51, petroleum spirit: ethyl acetate, (1:1)); 
1
H NMR (400 MHz, CDCl3): δ 4.25 (2 H, t, 
J = 2.2 Hz, 1-H), 2.20 (2 H, tt, J = 7.1, 2.2 Hz, 4-H), 1.60 (1 H, s, OH), 1.50 (2 H, m, 5-
H), 1.41 – 1.25 (6 H, m, 6, 7, 8-H), 0.88 (3 H, t, J = 6.8 Hz, 9-H). 13C NMR (100 MHz, 
CDCl3): δ 86.6 (3-C), 78.2 (2-C), 51.4 (CH2, 1-C), 31.3 (CH2, 7-C), 28.5 (CH2, 5-C), 
28.5 (CH2, 6-C), 22.5 (CH2, 8-C), 18.7 (CH2, 4-C); 14.0 (CH3, 9-C). EIMS m/z 109 [M-
H2C=OH]
+
 (39), 67 (100), 55 (92), 41 (83); HREIMS m/z 109.1019 (calculated for 
C8H13, 109.1017). 
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Non-8-yn-1-ol (4.33). – Directions were obtained from 
Goh and co-workers.
105
 NaH (562.8 mg, 23.5 mmol) 
was dissolved in 14 mL of anhydrous 1,3-
diaminopropane (APA) under argon at room temperature, giving a light grey 
effervescent solution of NAPA. Mixture was heated at 70°C for 40 min, at which time 
the colour changed to clear brown. Non-2-yn-1-ol (4.32) (766.0 mg, 7.8 mmol) was 
added at room temperature. After addition, the mixture became thicker producing an 
intense brown colour and fine effervescence. Iced water and saturated NH4Cl were 
carefully added to quench the reaction, followed by extraction with diethylether (3 x 30 
mL). The combined organic layers were further washed with 2 M HCl, NaHCO3, NaCl, 
water, dried over Na2SO4 and concentrated under reduced pressure, yielding non-8-yn-
1-ol (4.33) (70%) as a clear orange liquid. UV (DCM) ) λmax (log ε) 231 (2.31) nm; IR 
(neat) νmax 3307 (br), 2929 (s), 2857 (s), 2120 (w) 1055 (m), 626 (s), cm
-1
; Rf (0.42, 
petroleum spirit: ethyl acetate, (1:1)); 
1
H NMR (400 MHz, CDCl3): δ 3.63 (2 H, t, J = 
6.6 Hz, 1-H), 2.18 (2 H, td, J = 7.0, 2.5 Hz, 7-H), 1.93 (1 H, t, J = 2.9 Hz, 9-H), 1.60 – 
1.32 (10 H, m, 2, 3, 4, 5, 6-H), 1.25 (1 H, s, OH). 
13
C NMR (100 MHz, CDCl3): δ 84.6 
(8-C), 68.1 (CH, 9-C), 62.9 (CH2, 1-C), 32.7 (CH2, 2-C), 28.8 (CH2, 4-C), 28.6 (CH2, 6-
C), 28.3 (CH2, 5-C), 25.6 (CH2, 3-C); 18.3 (CH2, 7-C). EIMS m/z 140 [M]˙
+
 (17), 109 
[M-H2C=OH]
+
 (16), 67 (100), 55 (55), 41 (55); HREIMS m/z 140.1201 (calculated for 
C9H16,O, 140.1201). 
 
9-(5-Pentylfuran-2-yl)-non-8-yn-1-
ol (4.34). – Directions were given 
by Alami and co-workers.
110
 A 
mixture of 2-iodo-5-pentylfuran (4.28) (102.9 mg, 0.4 mmol), tetrakis 
(triphenylphosphine)-palladium (22.0 mg, 5%) and CuI (7.40 mg, 10%) were degassed. 
Subsequently, pyrrolidine (6 mL) was added. After addition, the mixture was stirred for 
two minutes at room temperature. A solution of non-8-yn-1-ol (4.33) (109.0 mg, 0.8 
mmol) in pyrrolidine was added dropwise, and the mixture was stirred for two hours. 
Petroleum ether was added to the resulting mixture and the precipitate was removed by 
 
 
141 
Chapter four: Synthesis of furan fatty acids (F-acids) 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
filtration. The organic layer was washed with NH4Cl, followed by NaCl and water, 
dried over Na2SO4 and concentrated under reduced pressure, yielding a crude 9-(5-
pentylfuran-2-yl)-non-8-yn-1-ol (4.34). Crude sample was further purified via flash 
chromatography (EtOAc:Pet Sp, 1:3) to produce the title compound as a clear yellow 
liquid (44%) (UV (DCM) ) λmax (log ε) 245 (2.61) nm; IR (neat) νmax 3356 (br), 2929 
(m), 2858 (m), 2214 (w), 1592 (w), 1011 (m), 782 (m), cm
-1
; Rf (0.21, petroleum spirit: 
ethyl acetate, (3:1)); 
1
H NMR (400 MHz, CDCl3): δ 6.36 (1 H, d, J = 2.8 Hz, 3-H), 5.92 
(1 H, d, J = 2.8 Hz, 4-H), 3.64 (2 H, t, J = 6.5 Hz, 1’’-H), 2.58 (2 H, t, J = 7.6 Hz, 1’-
H), 2.42 (2 H, t, J = 7.0 Hz, 7’’-H) 1.64 – 1.31 (16 H, m, 2’, 3’. 4’, 2’’, 3’’, 4’’, 5’’, 6’’-
H), 0.89 (3 H, t, J = 5.9 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 157.2 (5-C), 135.6 
(2-C), 114.6 (CH, 3-C), 105.8 (CH, 4-C), 94.2 (8’’-C), 71.4 (9’’-C), 63.0 (CH2, 1’’-C), 
32.7 (CH2, 3’’-C), 31.3 (CH2, 3’-C), 28.9 (CH2-5’’-C), 28.8 (CH2, 4’’-C). 28.4 (CH2, 
1’-C), 28.2 (CH2, 6’’-C), 27.6 (CH2, 2’-C), 25.6 (CH2, 2’’-C), 22.4 (CH2, 4’-C), 19.5 
(CH2, 7’’-C), 14.0 (CH3, 5’-C). EIMS m/z 276 [M]˙
+
 (55), 217 [M – C3H7O] (22), 177 
(100), 105 (34), HREIMS m/z 276.2088 (calculated for C18H28O2, 276.2089). 
 
9-(5-Pentylfuran-2-yl)-non-8-ynal 
(4.35). - Directions were obtained 
from Zúñiga and co-workers.
115
 A 
mixture of 9-(5-pentylfuran-2-yl)-
non-8-yn-1-ol (4.34) (113.0 mg, 0.4 mmol), TEMPO (12.8 mg, 0.1 mmol) and BAIB 
(228.6 mg, 0.7 mmol) in DCM (20 mL) were vigorously stirred overnight in a 50 mL 
round bottom flask until all starting material was consumed. An aqueous solution of 
10% Na2S2O3 was added to the mixture to quench the reaction and stirred for few 
minutes. Mixture was transferred to a separatory funnel and the aqueous layer was 
washed once with DCM. The organic layers were combined and washed with NaHCO3, 
NaCl, dried over Na2SO4 and concentrated under reduced pressure, affording the titled 
compound, as a yellow oil (Rf 0.35 (EtOAc:Pet Sp 1:3)). Product was used without 
further purification and/or characterisation in the next step. 
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9-(5-Pentylfuran-2-yl)-non-8-ynoic 
acid (4.36). – General directions 
were obtained from Schmidt and co-
workers.
120
 In a test tube with 
stopper were vigorously stirred until well mixed 0.2 parts of t-BuOH (22.6 mL), 0.1 
parts of 2-methyl-2-butene (9.8 mL, purity 80%), 3.5 parts of NaClO2 (395.5 mg), 2.9 
parts of NaH2PO4 (324.8 mg) and 0.1 parts of water (16.9 mL). Mixture was added to a 
100 mL round bottom flask containing 9-(5-Pentylfuran-2-yl)-non-8-ynal (4.35) (113 
mg, 1.0 part) and stirred vigorously until no starting material was visible by TLC (3-4h). 
Water was added to the mixture and extracted with EtOAc (30 mL x 2). Combined 
organic layers were washed with NaHCO3, NaCl, dried over Na2SO4 and evaporated 
under reduced pressure. Purification by flash chromatography (ethyl acetate/petroleum 
spirit 3:1) was performed to obtain the title compound (4.36) as a viscous oil (80%). IR 
(neat) νmax 3400 – 2400 (br), 2931 (m), 2859 (m), 1707 (s), 1181 (br) 628 (m), cm
-1
; Rf 
(0.43, petroleum spirit: ethyl acetate, (1:3)); 
1
H NMR (400 MHz, CDCl3): δ 6.37 (1 H, 
d, J = 3.2 Hz, 3-H), 5.93 (1 H, d, J = 3.2 Hz, 4-H), 2.58 (2 H, t, J = 7.6 Hz, 1’-H), 2.43 
(2 H, t, J = 7.0 Hz, 2’’-H), 2.37 (2 H, t, J = 7.4 Hz, 7’’-H) 1.70 – 1.25 (16 H, m, 2’, 3’. 
4’, 3’’, 4’’, 5’’, 6’’-H), 0.89 (3 H, t, J = 6.9 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 
178.5 (1’’-C), δ 157.2 (5-C), 135.6 (2-C), 114.6 (CH, 3-C), 105.8 (CH, 4-C), 94.0 (8’’-
C), 71.5 (9’’-C), 33.7 (CH2, 1’-C), 31.3 (CH2, 2’’-C), 28.5 (CH2, 3’-C), 28.5 (CH2, 7’’-
C). 28.2 (CH2, 6’’-C), 28.2 (CH2, 5’’-C), 27.6 (CH2, 2’-C), 24.5 (CH2-4’’-C), 22.4 
(CH2, 3’’-C), 19.5 (CH2, 4’-C), 14.0 (CH3, 5’-C). EIMS m/z 290 [M]˙
+
 (100), 233 (44), 
177 (78), 105 (31), HRESIMS m/z 313.1780 (calculated for C18H26O323Na, 313.1780). 
 
(Z)-9-(5-Pentylfuran-2-yl)-non-8-enoic 
acid (3.1). - Campos and co-workers
121
 
provided general directions. A mixture 
of 9-(5-pentylfuran-2-yl)-non-8-ynoic 
acid (4.36) (20.3 mg, 1.0 Eq), and Pd/C (10% w.t.) (1.146 mg of Pd, 0.12 Eq) in EtOAc 
were degassed and backfilled with hydrogen. This process was repeated three times. 
Subsequently, ethylenediamine (65.3 µL, 9.8 Eq) was added dropwise. Reaction was 
degassed and backfilled with hydrogen. Process repeated three times. Mixture was then 
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vigorously stirred for three hours at room temperature under an atmosphere of 
hydrogen. Mixture was vacuum filtered over celite and EtOAc layer washed with 
NH4Cl, NaHCO3 and NaCl, dried over Na2SO4 and concentrated under reduced 
pressure, yielding (Z)-9-(5-Pentylfuran-2-yl)-non-8-enoic acid (3.1) (80%) as a mobile 
liquid. UV (DCM) ) λmax (log ε) 276 (3.23) nm; IR (neat) νmax 3400 – 2400 (br), 2929 
(s), 2858 (m), 1707 (s), 1589 (w), 1538 (w), 1181 (br), 780 (m), cm
-1
; Rf (0.2, 
petroleum spirit: ethyl acetate, (3:1)); 
1
H NMR (400 MHz, C6D6): δ 6.28 (1 H, d, J = 
11.8 Hz, 9’’-H), δ 6.15 (1 H, d, J = 3.2 Hz, 3-H), 5.92 (1 H, d, J = 3.2 Hz, 4-H), 5.43 – 
5.37 (1 H, dt, J = 11.8, 7.3 Hz, 8’’-H), 2.52 – 2.45 (4 H, m, 1’, 7’’-H), 2.05 (2 H, t, J = 
7.1 Hz, 2’’-H), 1.60 – 1.11 (16 H, m, 2’, 3’. 4’, 3’’, 4’’, 5’’, 6’’-H), 0.83 (3 H, t, J = 6.8 
Hz, 5’–H). 13C NMR (100 MHz, C6D6): δ 178.5 (1’’-C), δ 156.03 (5-C), 152.3 (2-C), 
129.6 (CH, 8’’-C), 118.2 (CH, 9’’-C), 110.2 (CH, 3-C), 106.8 (CH, 4-C), 33.7 (CH2, 
2’’-C), 31.6 (CH2, 3’-C), 29.6 (CH2, 7’’-C), 29.6 (CH2, 6’’-C), 29.6 (CH2, 5’’-C), 29.1 
(CH2, 4’’-C), 28.4 (CH2, 2’-C), 28.1 (CH2, 1’-C). 24.7 (CH2-3’’-C), 22.7 (CH2, 4’-C), 
14.1 (CH3, 5’-C). EIMS m/z 292 [M]˙
+
 (74), 235 (22), 177 (100), 151 (21), 121 (26), 
107 (84) 95 (24), 55 (26); HREIMS m/z 292.2033 (calculated for C18H28O3, 292.2038). 
 
(E)-9-(5-Pentylfuran-2-yl)-non-8-
enoic acid (3.2). - (Z)-9-(5-
Pentylfuran-2-yl)-non-8-enoic acid 
(3.1) in CDCl3 was left overnight in 
an NMR tube in the presence of light to induce complete isomerisation to (E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.2). 
1
H and 
13
C NMR spectra were in agreement 
with that for the naturally occurring compounds isolated from Fulaga dive (Amanita sp. 
Pers.). For complete 
1
H and 
13
C NMR data refer to Chapter 3, section 3.4 and section 
3.5. 
 
5-Pentylfuraldehyde (3.4). – General directions were given 
previously.
129
 DMF (0.3 mL, 3.2 mmol) was added to 
POCl3 kept at 0 °C (crushed ice). Reaction vessel was 
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capped and heated at 85°C for 1.5h. Mixture was cooled down to 0°C once more and a 
solution of 5-pentylfuran (4.26) (345.0 mg, 2.5 mmol) in DMF was added dropwise. 
Mixture was allowed to come to room temperature and stirred for 24h or until no 
starting material was visible. A saturated aqueous solution of NaHCO3 was added until 
pH 8 at which time the mixture became effervescent. Resulting mixture was then 
extracted with DCM (3 x 40 mL) and organic layer was washed with 1:1 
NaCl:NaHCO3. Resulting mixture was passed through a plug of silica, dried over 
Na2SO4 and concentrated under reduced pressure, yielding the title compound as pure 
yellow oil 40%. 
1
H NMR (400 MHz, CDCl3) δ 9.51 (1 H, s, 1’’-H), 7.16 (1 H, d, J=3.5 
Hz, 3-H), 6.23 (1 H, d, J=3.5 Hz, 4-H), 2.71 (2 H, t, J=7.7 Hz, 1’-H), 1.70 (2 H, m, 2’-
H), 1.49 – 1.21 (4 H, m, 3’, 4’-H), 0.90 (3 H, t, J=7.1 Hz, 5’-H). 13C NMR (100 MHz, 
CDCl3) δ 177.1 (1’’-C), 164.3 (2-C), 152.0 (5-C), 123.5 (3-C), 108.7 (4-C), 31.5 (3’-C), 
28.5 (1’-C), 27.4 (2’-C), 22.5 (4’-C), 14.1 (5’-C). EIMS m/z 166 [M]˙+ (49), 109 (100), 
81 (60), 53 (40); HRESIMS m/z 167.1073 (calculated for C10H15O2, 167.1072). 
 
145 
Chapter five: Furan fatty acids: synthesis and SARs 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
Chapter Five 
Furan fatty acids: synthesis 
and structure activity 
relationship studies (SARs) 
 
 
 
This section shows the synthesis of furan based homologues and thiophene based 
analogues of (Z- & E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) isolated 
from an Amanita sp. Pers., native to the Eastern Highlands Province of Papua New 
Guinea (PNG). In addition, this section provides background on the DPPH antioxidant 
assay, which is used for structure activity relationship studies (SARs).  
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Chapter 5 Furan fatty acids: synthesis and SARs 
5.1 Introduction 
Aliphatic monocarboxylic acid derivatives, commonly known as fatty acids (FAs), play 
an important role in protecting the integrity of cell membranes from toxins and can act 
as a source of energy for the human body in times of need.
23
 Hydrophobic compounds 
of this nature, in particular polyunsaturated fatty acids (PUFAs), are thought to be vital 
for the normal development of the central nervous system (CNS), as research studies 
have linked neurodegenerative diseases such as schizophrenia, depression and dementia 
to decreased levels of PUFAs.
27
 
 
Generally, FAs are important, as food supplements, for their antioxidant properties and 
their ability to scavenge potentially toxic oxygen species.
77
 Research studies have 
shown that another class of FAs containing a furan moiety, named furan fatty acids (F-
acids) also scavenge toxic reactive oxygen contributing to the nutritional benefits of 
aliphatic monocarboxylic acid derivatives.
76
 In addition, F-acids have been reported to 
possess anti-inflammatory activity,
81
 and also to have the potential to rescue brain cells 
from decaying due to oxidative biochemical reactions.
134
 
 
Lemke and co-workers
77
 carried out a series of experiments to determine the scavenging 
role of a trisubstituted F-acid. These authors found that singlet oxygen (
1
O2) was able to 
oxidise the trisubstituted F-acid to fatty acyl radicals and hence F-acids could serve as 
radical scavengers of 
1
O2 and most likely other reactive oxygen species.  
 
It should be noted that earlier studies of the antioxidant capabilities of F-acids have 
suggested that their radical scavenging activity depends on the number of substituents 
around the furan core, with disubstituted F-acids being practically inactive.
80
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However, more recent studies have suggested that the low antioxidant activity of 
disubstituted F-acids could increase proportionally with concentration.
135
 Ellamar and 
co-workers
135
 confirmed that disubstituted F-acids possess low antioxidant activity 
(approx. 20%, 100 µg.mL
-1
) and such activity increases with concentration. 
 
Recently, two naturally occurring unsaturated C-18 disubstituted F-acids were isolated 
by us from an edible Amanita sp. Pers., from the highlands of Papua New Guinea 
(PNG). In contrast to the results reported by Ellamar and co-workers, where a saturated 
C-18 disubstituted F-acid showed a radical scavenging activity of about 20% at 100 
µg.mL
-1
, the unsaturated F-acids isolated by us exhibited higher radical scavenging 
activity according to the DPPH assay (approx. 50%, 88 µg.mL
-1
). The chemical 
structures of both F-acids isolated from the Amanita sp. Pers. are shown in Figure 5.1. 
 
 
Figure 5.1: (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) and (E)-9-(5-pentylfuran-2yl)-
non-8-enoic acid (3.2) 
 
Although different biological activities have been reported for FAs, PUFAs and F-acids, 
there exists derivatives such as 5-pentyl-2-furaldehyde (3.4) and 2-pentylfuran (4.26), 
which have been reported in the literature to possess melanogenesis inhibitory 
activity.
85
 Furthermore, acetylenic thiophene based analogues of F-acids have also been 
reported as natural products from Blumea obliqua, and they have shown nematocidal, 
insecticidal, antiviral and antibiotic properties.
45
 Therefore, we elected to build a small 
library of furan based homologues and thiophene based analogues of (Z- & E)-9-(5-
pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) for structure activity relationship 
studies (SARs). 
  
148 
Chapter five: Furan fatty acids: synthesis and SARs 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
5.2 Methodology 
5.2.1 DPPH assay 
The DPPH assay for the determination of radical scavenging activity of homologues 
and analogues of naturally occurring F-acid explained herein is based on a method 
described by Moyo and co-workers.
136
 In brief, this method uses purple 2,2-diphenyl-1-
picrylhydrazyl stable free radical (DPPH˙) as an indicator for radical scavenging 
activity. An alcoholic solution of purple DPPH˙ is mixed with a solution of test sample 
or ascorbic acid (5.1), which was used as a positive control, and incubated for 30 min in 
the dark. Generally, the purple methanolic stable free radical DPPH˙ undergoes a radical 
reaction with the test sample and when DPPH˙ is neutralised leads to the development 
of a yellow colour typical of picrylhydrazine derivative (DPPH-H).
31
 As shown in 
Figure 5.2, a purple colour and strong absorption between 515 – 520 nm suggest that the 
sample has no radical scavenging activity. Furthermore, a yellow colour and low 
absorption between 515 -520 nm is an indication of radical trapping by DPPH˙ to form 
DPPH-H and an indication of radical scavenging activity of the sample tested.  
 
 
Figure 5.2: DPPH: radical trap for ascorbic acid (5.1), OD = optical density 
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Once the optical density (OD) of DPPH˙ and test sample was measured at λ517 nm 
(OD517), the percentage of radical scavenging activity (RSA) was determined by 
decolouration of DPPH˙ solution and calculated by Equation 4: 
 
 











blankDPPH
blanksample
ODOD
ODOD
xRSA 1100%
 
Equation 4 
 
In order to calculate the effective concentration of sample necessary to decrease the OD 
of DPPH˙ by a specified amount, for example 50% (EC50), Equation 5 was used: where: 
A: higher concentration of test sample of the two points that brackets 50% inhibition, B: 
lower concentration of test compound of the two points that bracket 50% inhibition, C: 
RSA (%) at the concentration B, D: RSA (%) at the concentration A. 
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DPPH˙ free radical is known for its ability to react with abstractable hydrogen species 
from compounds containing phenol, amino or thiophenol groups. In addition, it is 
commonly used as indicator to test antioxidant activity.
77
 The general mechanism for 
this transformation is shown in Figure 5.3. 
 
 
Figure 5.3: Direct H-atom-abstraction process 
 
Ionita
137
 reported that DPPH˙ can react with other radicals (R˙) to produce derivatives 
such as R-DPPH-H. However, this author also reported that DPPH˙ is not a good 
scavenger of toxic oxygen active species such as hydrogen peroxide, hydroxyl radicals 
or superoxide anion radicals that are commonly generated by biological processes such 
as respiration or oxidation of FAs.
137
 
 
F-acids have been reported as potential radical scavengers of toxic oxygen species.
77
 
Okada and co-workers
80
 carried out a set of experiments in an effort to explain the 
antioxidative mechanism observed in F-acids. These authors ruled out the possibility of 
F-acids being hydroperoxide decomposers, because F-acids only decomposed linoleic 
hydroperoxides slightly and therefore, it was assumed that the generation of new free 
radicals could induce further unwanted radical reactions. Okada and co-workers
80
 
subsequently attempted the DPPH˙ assay to test the radical scavenging activity of F-
acids. Although F-acids were lacking an abstractable hydrogen atom, F-acids were able 
to reduce the absorption of DPPH˙. 
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Because of the ability of F-acids in reducing DPPH˙ even when the samples tested were 
lacking an abstractable hydrogen, Okada and co-workers
80
 concluded that it was 
plausible that the mechanism for the antioxidant activity of F-acids involved a proton 
concerted electron-transfer process, as an alternative mechanism for antioxidants to 
scavenge DPPH˙.80 The general mechanism is shown in Figure 5.4. 
 
 
Figure 5.4: Proton concerted electron-transfer process 
 
Wang and Zhang
138
 undertook a theoretical approach to explain the radical scavenging 
activity of a neuroprotective agent, edaravone (5.2), against DPPH˙ for SARs. 
Edaravone (5.2) has no phenol, amino, thiophenol or any other apparent abstractable 
hydrogen atom able to react with DPPH˙.  
 
Based on their calculations, Wang and Zhang
138
 concluded that a concerted electron-
transfer process is not thermodynamically feasible, as the ionisation potential of DPPH:ˉ 
is significantly lower than that for 5.2. However, based on calculations for bond 
dissociation enthalpies of DPPH-H and 5.2, Wang and Zhang found that bond 
dissociation enthalpy for DPPH-H was significantly higher than that for edavarone 
(5.2), making the reaction possible via an abstractable hydrogen atom. 
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Further calculations indicated that the hydrogen atom at position-4 of edavarone (5.2) 
was abstractable as it was better resonance stabilised than hydrogen at postion-7. Figure 
5.5 shows the reaction scheme between 5.2 and DPPH˙and resonance forms. 
 
 
Figure 5.5: Hydrogen abstraction and resonance forms for edavarone (5.2) 
 
The question still remains, whether F-acids such as (Z- & E)-9-(5-pentylfuran-2-yl)-
non-8-enoic acid (3.1 and 3.2) would follow a concerted electron transfer to DPPH˙ or if 
they would possess an abstractable hydrogen atom able to directly reduce DPPH˙ to its 
hydrazyl derivative? The answer for this question is still speculative.  
 
As shown in Figure 5.6, (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) could react 
with DPPH˙via a direct hydrogen atom abstraction either at position-7” or position-1’, 
as both donating sites are well stabilised through resonance effects.  
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Figure 5.6: Resonance forms of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) derived 
radicals with hydrogen abstraction at position 7’’ and 1’ 
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5.2.2 General procedures for chemical synthesis of homologues 
and analogues 
Alkylfuran and alkylthiophene were prepared by addition of freshly distilled furan 
(4.25) or thiophene (5.3) to a solution of n-BuLi in dried THF under an atmosphere of 
nitrogen or argon. Addition was performed dropwise at -20°C (CCl4/CO2) for the furan 
derivative and 0°C (crushed ice) for the thiophene derivative.  
 
The temperature of addition was adjusted for both furan (4.25) and thiophene (5.3) 
products based on optimisation for the best yield obtained. The resulting mixtures were 
stirred at 0°C for 100 – 120 min and the corresponding alkylhalide was subsequently 
added. After addition of the electrophile, the reaction mixtures were stirred overnight. 
 
5-Pentylfuran (4.26) was subsequently added to a solution of n-BuLi in dried THF 
under nitrogen or argon at -20°C (CCl4/CO2) and futher stirred for 120 min at 0°C until 
addition of resublimed iodine. For the thiophene derivative, 5-pentylthiophene (5.4) was 
added at 0°C (crushed ice) followed by an increase in the temperature to 25˚C. The 
temperature of the mixture was subsequently brought to -78°C (acetone/CO2) until 
addition of resublimed iodine. Reaction mixtures were allowed to stir until complete 
formation of 2-iodo-5-pentylfuran (4.28) or 2-iodo-5-pentylthiophene (5.5) respectively. 
 
Internal alkynols were achieved in three steps, starting from the incorporation of a 
tetrahydropyranil group to propargyl alcohol (4.29). Subsequently, the protected 
propargyl alcohol (4.30) was subjected to a number of metalation and alkylation 
reactions followed by deprotection yielding two new internal alkynols, hex-2-yn-1-ol 
(5.6) and dodec-2-yn-1-ol (5.7) respectively. Finally, the internal triple bond of each 
alkynol was moved to the terminal portion of the hydrocarbon chain by reaction with 
sodium aminopropylamide (NAPA), yielding hex-5-yn-1-ol (5.8) and dodec-11-yn-1-ol 
(5.9), as described in Chapter 4, sections 4.5.3 and 4.5.4. 
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A number of cross coupling reactions between the corresponding heteroarylhalides with 
terminal alkynols, using tetrakis(triphenylphosphine)palladium and copper iodide, as 
catalyst and co-catalyst and pyrrolidine as the solvent base were performed to yield 
three new furan alkynol derivatives (5.10 – 5.12) and four thiophene acetylenic alcohols 
(5.13 – 5.16) respectively. Figure 5.7 shows part one of the general reactions for the 
synthesis of homologues and analogues. 
 
 
Figure 5.7: Synthesis of homologues and analogues – part 1. For reaction conditions and 
yield see experimental data in section 5.6.3 
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The last steps in the synthesis of homologues and analogues involved the oxidation of 
furan and thiophene acetylenic alcohols (5.10 – 5.16) to their corresponding carboxylic 
acids followed by selective reduction of the triple bond. 
 
For the oxidation reaction, this was achieved in two steps: firstly, furan and thiophene 
acetylenic alcohols (5.10 – 5.16) were oxidised to their corresponding aldehydes via 
reaction with TEMPO radical and bis-acetoxyiodobenzene (BAIB) and secondly, the 
aldehyde intermediates (5.17 – 5.23) were further oxidised under Pinnick conditions 
yielding the corresponding acetylenic acids (5.24 – 5.30). Finally, a modified Lindlar 
hydrogenation reaction served well in the selective reduction of the triple bond to the Z-
alkenes (5.31 – 5.35). Figure 5.8 shows part two of the general reactions for the 
synthesis of homologues and analogues. 
 
 
Figure 5.8: Synthesis of homologues and analogues – part 2. For reaction conditions and yield 
see experimental data in section 5.6.3 
 
5.3 Antioxidant testing of homologues and analogues  
A total of 26 homologues and analogues were tested for their radical scavenging 
properties using the DPPH˙ method. All samples exhibited some degree of activity as 
they were able to reduce the optical density (OD) of DPPH˙ radical. Typically, an OD517 
for a methanolic solution of 100 µM DPPH˙ radical would range between 0.5000 – 
0.8000. Therefore, low OD of the reaction mixture (DPPH radical and test samples) 
would indicate high radical scavenging activity. The OD517 for most of the test samples 
screened, at their highest concentration (88 µg.mL
-1
), were found to be between 0.2035 
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to about 0.5000, indicating moderate to low radical scavenging activity. Table 5.1 
shows a summary of radical scavenging activity as determined by the DPPH˙ assay. 
Table 5.1: (%) Radical scavenging activity (RSA) of homologues and analogues 
Compounds (%) RSA 
5-pentylfuran (4.26) < 10 
5-pentylthiophene (5.4) < 10 
3-(5-pentylfuran-2-yl)-prop-2-yn-1-ol (5.10) 17 
3-(5-pentylthiophene-2-yl)-prop-2-yn-1-ol (5.13) < 10 
6-(5-pentylfuran-2-yl)-hex-5-yn-1-ol (5.11) 25 
6-(5-pentylthiophene-2-yl)-hex-5-yn-1-ol (5.14) 31 
9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34) 17 
9-(5-pentylthiophene-2-yl)-non-8-yn-1-ol (5.15) < 10 
12-(5-pentylfuran-2-yl)-dodec-11-yn-1-ol (5.12) < 10 
12-(5-pentylthiophene-2-yl)-dodec-11-yn-1-ol (5.16) < 10 
3-(5-pentylfuran-2-yl)-propiolic acid (5.24) 19 
3-(5-pentylthiophene-2-yl)-propiolic acid (5.27) 21 
6-(5-pentylfuran-2-yl)-hex-5-ynoic acid (5.25) 24 
6-(5-pentylthiophene-2-yl)-hex-5-ynoic acid (5.28) 18 
9-(5-pentylfuran-2-yl)-non-8-ynoic acid (4.36) 15 
9-(5-pentylthiophene-2-yl)-non-8-ynoic acid (5.29) 17 
12-(5-pentylfuran-2-yl)-dodec-11-ynoic acid (5.26) 18 
12-(5-pentylthiophene-2-yl)-dodec-11-ynoic acid (5.30) 17 
(Z)-6-(5-pentylfuran-2-yl)-hex-5-enoic acid (5.31) < 10 
(Z)-6-(5-pentylthiophene-2-yl)-hex-5-enoic acid (5.33) < 10 
(Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1) 50 
(E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.2) 48 
(Z)-9-(5-pentylthiophene-2-yl)-non-8-enoic acid (5.34) 20 
(Z)-12-(5-pentylfuran-2-yl)-dodec-11-enoic acid (5.32) 21 
(Z)-12-(5-pentylthiophene-2-yl)-dodec-11-enoic acid (5.35) < 10 
5-pentyl-2-furaldehyde (3.4) 52 
Ascorbic acid
a
 (5.1) 95 
a
Positive control (1.1 µg.mL
-1
). All test samples have a concentration of 88 µg.mL
-1
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It is not surprising that 5-pentylfuran (4.26) would appear inactive in the DPPH˙ test, as 
according to previous research, the RSA of F-acids depends on the number of 
substituents around the furan ring, with tetrasubstituted F-acids being the most active.
80
 
Likewise, it may not be surprising that the analogous alkylthiophene (5.4) would behave 
in a similar manner. Interestingly, when a moderate electron withdrawing group (e.g. an 
aldehyde) is incorporated to the available alpha position of the furan ring the RSA 
increases dramatically. Although this is a matter of speculation, the increase in RSA 
observed in 5-pentyl-2-furaldehyde (3.4) might be due to the possibility of position 1’ in 
the alkyl chain possessing an abstractable hydrogen atom able to react with DPPH˙ 
producing a radical that could be resonance stabilised four times in a similar manner as 
its homologue (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid (3.1). With regards to 5-
pentylthiophene-2-carbaldehyde (not shown herein), it might be plausible that it could 
behave in a similar manner as its furan based analogue. However, 5-pentylthiophene-2-
carbaldehyde must be synthesised first and tested to accept or reject such hypothesis. 
Figure 5.9 shows: RSA of alkylfuran (4.26), alkylthiophene (5.4) and 5-pentyl-2-
furaldehyde (3.4). 
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Figure 5.9: RSA: +Ctrl = ascorbic acid (5.1); PF = pentylfuran (4.26), PT = pentylthiophene 
(5.4) and PF-CHO = 5-pentyl-2-furaldehyde (3.4) 
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When replacing the aldehyde in one of the α-positions of the furan ring with terminal 
acetylenic alcohols of various chain sizes, it is interesting to see that the RSA initially 
increases, with increasing chain lengths. However, after reaching the optimal length, 
which in this case seems to be a total of six carbons in one of the alpha positions of the 
ring, the RSA seems to decrease when the side chain increases in length. A similar 
behaviour was observed with thiophene analogues, where the incorporation of a six 
carbon terminal acetylenic alcohol was the most active. 
 
Figure 5.10 shows a comparison between furan based homologues and thiophene based 
analogous acetylenic alcohol derivatives of the naturally occurring F-acids, where F: 
furan and T: thiophene; C3: total of three carbons in the side chain ending in –OH. 
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Figure 5.10: RSA: +Ctrl = ascorbic acid (5.1) and heteroaryl acetylenic alcohols. PF = 
pentylfuran, PT = pentylthiophene. C3, C6, C9 and C12 = number of carbons in the side 
chain ending in -OH 
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Figure 5.11 shows a comparison between furan based and thiophene based acetylenic 
acids, where F: furan and T: thiophene; C3: number of carbons in the side chain ending 
in a carboxylic acid.  
 
No obvious differences can be observed amongst the acetylenic acids tested as the RSA 
is approximately 20% for all. All acetylenic acids were very stable at room temperature 
in air for several weeks and very little or no change was observed based on 
1
H NMR 
spectroscopy. 
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Figure 5.11: RSA: +Ctrl = ascorbic acid (5.1) and heteroaryl acetylenic acids. PF = 
pentylfuran, PT = pentylthiophene. C3, C6, C9, C12 = number of carbons in the side chain 
ending in –CO2H 
 
When acetylenic acids were selectively reduced to their corresponding Z-alkenes, a 
similar behaviour was observed between furan and thiophene derivatives. The C-18 F-
acid and the C-18 thiophene fatty acid (T-acid) appeared more active when compared to 
their C-15 and C-21 counterparts.   
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It is worth noting that the synthetic C-18 F-acid tested herein is (Z)-9-(5-pentylfuran-2-
yl)-non-8-enoic acid (3.1), which was originally isolated from Fulaga dive (Amanita sp. 
Pers.). While the C-15 and C-21 F-acids are not naturally occurring, and although a 
matter of speculation, it is plausible that nature is selective of the size of the chain 
suggesting C-18 to be the optimal size for the RSA. 
 
It should also be noted that while T-acids are not naturally occurring, and although the 
C-18 T-acid tested herein appeared less active than the C-18 F-acid, the C-18 T-acid 
showed similar RSA to a disubstituted F-acid tested by Ellamar and co-workers, which 
showed 20% RSA on the DPPH˙ assay.135  
 
Figure 5.12 shows a comparison between Z-furan and Z-thiophene based fatty acids. 
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Figure 5.12: RSA: +Ctrl = ascorbic acid (5.1) and Z-Furan and Z-thiophene fatty acids. PF = 
pentylfuran, PT = pentylthiophene. C6, C9 and C12 = number of carbons in the side chain 
ending in –CO2H 
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5.4 Antibacterial testing of homologues and analogues  
For the antibacterial testing of furan based homologues and thiophene based analogues 
of F-acids isolated from Fulaga dive (Amanita sp. Pers.) approximately 1 mg of product 
were used for sample preparation. 
 
Samples were prepared at stock concentrations of 1000 µg.mL
-1
 and further diluted in 
96 well plates to obtain a concentration range of 1.64 – 210.53 µg.mL-1. For (Z- & E)-9-
(5-pentylfuran-2-yl)-non-8-enoic acid (3.1 and 3.2) and 5-pentyl-2-furaldehyde (3.4) the 
concentration range was 0.33 – 42.11 µg.mL-1. 
 
Detailed information of sample preparation and antibacterial assay is described in 0, 
turbidity-MTT assay experimental section 2.9.6. 
 
A total of 26 samples were tested for their antibiotic effect against organisms such as: S. 
typhi, Pseudomonas aeruginosa Migula, C. albicans and S. aureus. With exception of 
the sensitive strain of S. aureus used, all organisms appeared to be resistant to the 
samples tested. 
 
Table 5.2 shows a summary of antibacterial activity of homologues and analogues 
against S. aureus sensitive strain only. 
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Table 5.2: Susceptibility of S. aureus against homologues and analogues 
 
Compounds 
Antibacterial activity 
(S. aureus) 
MIC IC50 (%) Inh 
5-pentylfuran   210.53 (19%) 
5-pentylthiophene   210.53 (6%) 
3-(5-pentylfuran-2-yl)-prop-2-yn-1-ol   210.53 (24%) 
3-(5-pentylthiophene-2-yl)-prop-2-yn-1-ol   210.53 (8%) 
6-(5-pentylfuran-2-yl)-hex-5-yn-1-ol   210.53 (18%) 
6-(5-pentylthiophene-2-yl)-hex-5-yn-1-ol   210.53 (6%) 
9-(5-pentylfuran-2-yl)-non-8-yn-1-ol   210.53 (17%) 
9-(5-pentylthiophene-2-yl)-non-8-yn-1-ol   210.53 (22%) 
12-(5-pentylfuran-2-yl)-dodec-11-yn-1-ol   210.53 (9%) 
12-(5-pentylthiophene-2-yl)-dodec-11-yn-1-ol   210.53 (16%) 
3-(5-pentylfuran-2-yl)-propiolic acid   210.53 (45%) 
3-(5-pentylthiophene-2-yl)-propiolic acid  113.86 210.53 (73%) 
6-(5-pentylfuran-2-yl)-hex-5-ynoic acid  138.9 210.53 (53%) 
6-(5-pentylthiophene-2-yl)-hex-5-ynoic acid 210.53 107.00  
9-(5-pentylfuran-2-yl)-non-8-ynoic acid   210.53 (36%) 
9-(5-pentylthiophene-2-yl)-non-8-ynoic acid 52.63 15.29  
12-(5-pentylfuran-2-yl)-dodec-11-ynoic acid 210.53 24.13  
12-(5-pentylthiophene-2-yl)-dodec-11-ynoic acid   210.53 (40%) 
(Z)-6-(5-pentylfuran-2-yl)-hex-5-enoic acid  129.21 210.53 (81%) 
(Z)-6-(5-pentylthiophene-2-yl)-hex-5-enoic acid 210.53 130.09  
(Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid  20.01 42.11 (67%) 
(E)-9-(5-pentylfuran-2-yl)-non-8-enoic acid  29.63 42.11 (66%) 
(Z)-9-(5-pentylthiophene-2-yl)-non-8-enoic acid  88.21 210.53 (72%) 
(Z)-12-(5-pentylfuran-2-yl)-dodec-11-enoic acid  116.86 210.53 (82%) 
(Z)-12-(5-pentylthiophene-2-yl)-dodec-11-enoic 
acid 
  210.53 (34%) 
5-pentyl-2-furaldehyde   42.11 (28%) 
Kanamycin
a
 1.32 0.500  
a
Positive control (50µg.mL
-1
), all samples (1000 µg.mL
-1
). Numerical values for minimum 
inhibitory concentration (MIC), inhibition concentration at 50% (IC50) and inhibition (Inh) 
164 
Chapter five: Furan fatty acids: synthesis and SARs 
 
Edwin M Castillo Martinez – The Australian National University 2016 
 
concentration are also given in µg.mL
-1 
 
S. aureus growth inhibition was compared against a single concentration of all samples 
tested, which was chosen from the range 1.64 – 210.53 µg.mL-1. Monosubstituted 
furans and thiophenes, as well as their disubstituted alcohol derivatives showed low 
levels of inhibition of bacterial growth (52.63 µg.mL
-1
, < 20 %) suggesting that at the 
concentration tested S. aureus was resistant to the compounds tested. 
 
Figure 5.13 compares monosubstituted furan and thiophene and their alcohol derivatives 
against kanamycin, as positive control. 
 
 
Figure 5.13: Bacterium growth inhibition: +Ctrl = kanamycin, F = furan, T = thiophene, P = 
pentyl. C3, C6, C9, C12 = number of carbons in the side chain ending in -OH 
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When comparing disubstituted furan and thiophene acetylenic acid derivatives, the story 
was different from that of furan and thiophene alcohols. The percentage of inhibition 
increased in all acetylenic acids when compared to their alcohol derivatives, especially 
for 9-(5-pentylthiophen-2-yl)-non-8-ynoic acid (5.29) (PT-C9CO2H). In order to 
understand why this happened, we need to understand how this class of compounds 
might work in vivo. Until then, it is very difficult to speculate without knowing the 
mechanism of action of these class of compounds. 
 
To the best of my knowledge, this is the first time furan and thiophene based fatty acids 
have been evaluated for their antibacterial potential. Figure 5.14 shows a comparison 
between furan and thiophene acetylenic acids. 
 
 
Figure 5.14: Bacterium growth inhibition: +Ctrl = kanamycin, F = furan, T = thiophene. C3, 
C6, C9, C12 = number of carbons in the side chain ending in -CO2H 
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Interestingly, when comparing F-acids and T-acids, with Z-geometry the story changed 
again. Although the percentage of bacterium growth inhibition increased in all samples 
tested when compared to the antibacterial activity of their alcohol derivatives, S. aureus 
showed higher susceptibility to synthetic (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1) (ZFC9) (> 80%, 52.63 µg.mL
-1
). In addition, S. aureus showed higher 
susceptibility to a mixture of two diastereoisomers from the naturally occurring F-acids 
(3.1 and 3.2), (ZE-FC9-Nat) (> 95%, 10.52 µg.mL
-1
). 
 
Although a matter of speculation, the increase in activity exhibited by a mixture of 3.1 
and 3.2 against the bacteria tested, when compared to the activity shown by 3.1 alone, 
might be indicative that synergism could play a role in such increase in activity. Figure 
5.15 shows a comparison between Z-F-acids and Z-T-acids antibacterial activity against 
S. aureus. 
 
 
Figure 5.15: Bacterium growth inhibition: +Ctrl = kanamycin, F = furan, T = thiophene, 
Nat = natural. C6, C9, C12 = number of carbons in the side chain ending in -CO2H 
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5.5 Conclusion 
A total of 26 compounds have been investigated for their antibiotic potential against S. 
aureus (clinical isolate), S. typhi, P. aeruginosa and C. albicans. E. coli was not 
included in the final screening because crude extracts and F-acids isolated from Fulaga 
dive (Amanita sp. Pers.) did not show any growth inhibition and therefore it was 
concluded that E. coli was resistant against the F-acid tested. The test samples screened 
showed low to moderate activity against the Gram (+) S. aureus. Although in vitro 
antibacterial screenings of these compounds may not be sufficient to correlate 
effectiveness in vivo to validate traditional use, these results do provide a starting point 
for further biological and chemical investigation towards the discovery of new drugs. 
 
As for furan based homologues and thiophene analogues to the naturally occurring F-
acids isolated from Fulaga dive (Amanita sp. Pers.) to the best of my knowledge, this is 
the first time they have been screened for their antibacterial potential. Although some of 
the results reported herein show good bacterium growth inhibition, the samples tested 
are no match for the antibiotic strength of kanamycin. Finally I can conclude that S. 
aureus showed more susceptibility against (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid and 
9-(5-pentylthiophene-2-yl)-non-8-ynoic acid. 
 
5.6 Experimental 
For general information on instrumental methods used for the characterisation of F-
acids, T-acids and pre-cursors, see experimental section in Chapter 3, section 3.8.1 to 
3.8.6. 
 
5.6.1 Culture media and controls 
All media, BBL™ Mueller Hinton broth and DIFCO™ Mueller Hinton agar were 
sourced from Bacto Laboratories Pty Ltd, NSW 2170, Australia and prepared as per the 
manufacturer’s instruction unless otherwise noted. The pH of the medium was adjusted 
to 7.3 ± 0.1 before autoclaving. 
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Kanamycin sulphate from Streptomyces kanamyceticus supplied by Sigma Aldrich, 
Castle Hill, NSW 1765, Australia, was used as the antibiotic control for the sensitive 
strains of S. aureus, multidrug resistant S. aureus, S. typhi and P. aeruginosa. 
Amphotericin B was used as the positive control for C. albicans and also supplied by 
Sigma Aldrich. 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) 
was used as the dye to determine the viability of the cells, 2,2-diphenyl-1-
picrylhydrazyl (DPPH) was used for the antioxidant assay with ascorbic acid as the 
positive control. MTT, DPPH and ascorbic acid were sourced from Alfa-aesar, 
Heysham, England. 
 
5.6.2 Bioassays 
For the DPPH˙ assay, sample tests and positive control were prepared at the same 
concentrations. First a stock solution of the appropriate positive control was prepared in 
MeOH to achieve a concentration of 10 mM. Stock solution was further diluted to a 
working solution of 1 mM. 
 
A methanolic stock solution of DPPH was also prepared at a concentration of 1000 µM. 
DPPH stock solution was further diluted to a working concentration of 200 µM. Radical 
scavenging reaction was carried out in 96 well plates and therefore, 100µL of MeOH 
were added to wells 1b to 1h followed by 200µL of test sample or positive control to 
well 1a. Samples and/or positive control were serially diluted (1:2). Finally 100µL of a 
methanolic solution of DPPH was added to the wells and incubated for 30 min in the 
dark. Serial concentration range of positive control and samples after addition of DPPH 
was 0.7 µg.mL
-1
 to 88 µg.mL
-1
. Upon incubation, OD517 was read to assess radical 
scavenging activity of test samples. 
 
Turbidity-MTT microdilution assay was performed as outlined in Chapter 2, section 
2.9.6 
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5.6.3 Experimental data 
5-Pentylthiophene (5.4). – A two-necked round bottom flask 
was charged with 200 mL of dried THF at 0 ºC. Subsequently, 
n-BuLi (37.0 mL, 44.0 mmol of 1.2 M in hexane solution) was 
added dropwise, followed by freshly distilled thiophene (5.3) (4.8 mL, 60.0 mmol). The 
resulting mixture was stirred for 100 min at which point 1-bromopentane (5.8 mL, 46.2 
mmol) was added, and the reaction mixture was allowed to stir overnight. Water was 
added to quench the reaction and the resulting mixture was extracted with diethylether 
(2 x 30 mL). The organic layer was washed with saturated NH4Cl solution (3 x 50 mL), 
saturated NaHCO3 solution (2 x 50 mL) and dried with Na2SO4, filtered and reduced in 
vacuo yielding the title compound, as a mobile yellow oil (95%). Rf (0.71, Pet. Spirit 
100%). UV (CH2Cl2) λmax (log ε) 234.5 (3.57). IR vmax 2925 (m), 1459 (w), 1035 (m), 
687 (s) cm
-1
. 
1
H NMR (400 MHz, CDCl3): δH 7.11 (1 H, dd, J = 5.1, 1.2 Hz, 2-H), 6.92 
(1 H, dd, J = 5.1, 3.5 Hz, 3-H), 6.79 (1 H, d, J = 3.5 Hz, 4-H), 2.83 (2 H, t, J = 7.8, 7.4 
Hz, 1’-H), 1.69 (2 H, m, 2’-H), 1.37 (4 H, m, 3’H & 4’H), 0.91 (3 H, t, J = 7.1 Hz, 5’-
H). 
13
C NMR (CDCl3, 100 MHz) δC 145.9 (C, 2-C), 126.6 (CH, 3-C), 123.9 (CH, 4-C), 
122.7 (CH, 5-C), 31.5 (CH2, 1’-C), 31.3 (CH2, 2’-C), 29.9 (CH2, 3’-C), 22.4 (CH2, 4’-
C), 14.0 (CH3, 5’-C). GC-MS (+ve ion) m/z: [M]
·+
 154 (40), 111 (8), 97 (100), 84 (5), 
45 (9). HREIMS m/z 154.0816 (calculated for C9H14S 154.0816). 
 
2-Iodo-5-pentylthiophene (5.5). – A two-necked round 
bottom flask was charged with a solution of 5-
pentylthiophene (5.4) (3.0 g, 19.8 mmol) in dried THF (90 
mL) 0ºC. Subsequently, n-BuLi (16.5 mL, 19.5 mmol of 1.2 M in hexane solution) was 
added dropwise, resulting in a dark brown solution. The resulting mixture was allowed 
to reach room temperature (RT), and subsequently cooled to -78ºC (acetone/CO2), at 
which time a solution of iodine (5.0 g, 19.6 mmol) in dried THF (12 mL) was added, 
generating a dark red solution. The resulting mixture was allowed to reach RT and it 
was stirred for an extra 120 min. The reaction mixture was poured into DCM (240 mL), 
and the organic layer washed with saturated NaHCO3 solution (2 x 30 mL) and 1:1 
NaCl:Na2S2O3 solution (4 x 30mL). The resulting solution was dried with Na2SO4, 
filtered and reduced in vacuo, affording the title compound, as a dark red oil (4.34g, 
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80%). UV (CH2Cl2) λmax (log ε) 255.0 (3.74). IR vmax 3426 (b), 2926 (m), 1455 (m), 739 
(s) cm
-1
. 
1
H NMR (400 MHz, CDCl3): δH 7.04 (1 H, d, J = 3.5, 3-H), 6.47 (1 H, d, J = 
3.5, 4-H), 2.79 (2 H, t, J = 7.6, 1’-H), 1.64 (2 H, m, 2’-H), 1.33 (4 H, m, 3’,4’-H), 0.90 
(3 H, m, 5’-H). 13C NMR (CDCl3, 100MHz) δC 152.2 (C, 5-C), 136.5 (CH, 3-C), 125.8 
(CH, 4-C), 69.3 (C, 2-C) , 31.2 (CH2, 1’-C), 31.1 (CH2, 2’-C), 30.2 (CH2, 3’-C), 22.4 
(CH2, 4’-C), 14.0 (CH3, 5’-C). GC-MS (+ve ion) m/z: [M]
·+
 280 (27), 223 (100), 207 
(9), 167 (14), 97 (21). HREIMS m/z 279.9778 (calculated for C9H13S 127 I). 
 
2-(Hex-2yn-1-yloxy)-tetrahydro-2H-pyran (5.6a). - 
n-BuLi (8.3 mL, 14.1 mmol of 1.7 M in hexane 
solution) was added dropwise via syringe to a 
solution of 2-(prop-2-yn-1-yloxy)-tetrahydro-2H-
pyran (4.30) (2.0 g, 14.1 mmol) in dried THF (30 mL), at -70°C (acetone/CO2) under an 
atmosphere of argon. Subsequently, hexamethylphosphoramide (10 mL) was also added 
and the mixture was stirred at -70°C for two hours. Acetone/CO2 cooling bath was 
changed for crushed ice and 1-bromopropane (1.4 mL, 15.5 mmol) was added and the 
mixture was stirred overnight while allowing to reach RT. A solution of 2 M HCl was 
carefully added to quench the reaction and the aqueous layer was extracted with diethyl 
ether (3 x 30 mL). The combined organic layers were washed with NaCl and water, 
dried over Na2SO4 and concentrated under reduced pressure. The crude mixture was 
used in the next step without further purification and/or characterisation. 
 
2-(Dodec-2-yn-1-yloxy)-tetrahydro-2H-
pyran (5.7a). - n-BuLi (8.4 mL, 14.3 
mmol of 1.7 M in hexane solution) was 
added dropwise to a solution of 2-(prop-
2-yn-1-yloxy)-tetrahydro-2H-pyran (4.30) (2.0 g, 14.3 mmol) in dried THF (30 mL), at 
-70°C (acetone/CO2) under an atmosphere of argon. Subsequently, 
hexamethylphosphoramide (10 mL) was added and the mixture was stirred at -70 °C for 
two hours. acetone/CO2 cooling bath was changed for crushed ice and 1-bromononane 
(2.5 mL, 15.7 mmol) was added and the mixture was stirred overnight while allowing to 
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reach RT. A solution of 2 M HCl was carefully added to quench the reaction and the 
aqueous layer was extracted with diethyl ether (3 x 30 mL). The combined organic 
layers were washed with NaCl and water, dried over Na2SO4 and concentrated under 
reduced pressure. The crude mixture was used in the next step without further 
purification and/or characterisation. 
 
Hex-2-yn-1-ol (5.6).- p-Toluenesulfonic acid (95.6 mg, 0.6 
mmol) was added to a stirring solution of crude 2-(hex-2-yn-1-
yloxy)-tetrahydro-2H-pyran (5.6a) (3.8 g) in methanol (100 mL). 
Mixture was stirred overnight, at which time methanol was 
removed under reduced pressure and product was re-dissolved in ether. The ethereal 
layer was washed with NaHCO3, 1 M NaOH, NaCl then with water, dried over Na2SO4 
and concentrated under reduced pressure yielding hex-2-yn-1-ol (5.6) (77%) as a yellow 
liquid. UV (DCM) ) λmax (log ε) 239 (1.68) nm; IR (neat) νmax 3356, 2933, 1485, 1309, 
1009, cm
-1
; Rf (0.43, petroleum spirit: ethyl acetate, (1:1));
 1
H NMR (400 MHz, 
CDCl3): δ 4.25 (2 H, t, J = 2.2 Hz, 1-H), 2.19 (2 H, tt, J = 7.2, 2.2 Hz, 4-H), 1.68 (1 H, 
s, OH), 1.53 (2 H, dq, J = 7.2, 7.2, 5-H), 0.97 (3 H, t, J = 7.2, 6-H). 
13
C NMR (100 
MHz, CDCl3): δ 86.4 (3-C), 78.4 (2-C), 51.4 (CH2, 1-C), 21.9 (CH2, 5-C), 20.7 (CH2, 4-
C), 14.4 (CH3, 6-C). EIMS m/z 97 [M-H]
+
 (18), 83 (100), 69 (56), 55 (91), 41 (75); 
HREIMS m/z 97.0650 (calculated for C6H9O, 97.0653). 
 
Dodec-2-yn-1-ol (5.7). - p-Toluenesulfonic acid 
(92.3 mg, 0.5 mmol) was added to a stirring 
solution of 2-(dodec-2-yn-1-yloxy)-tetrahydro-
2H-pyran (5.7a) (4.9 g) in methanol (100 mL). 
Mixture was stirred overnight, at which time methanol was removed under reduced 
pressure and product was re-dissolved in ether. The ethereal layer was washed with 
NaHCO3, 1 M NaOH, NaCl then with water, dried over Na2SO4 and concentrated under 
reduced pressure yielding dodec-2-yn-1-ol (5.7) (85%) as a yellow liquid. UV (DCM) ) 
λmax (log ε) 229 (1.77) nm; IR (neat) νmax 3301, 2922, 2853, 1002, cm
-1
; Rf (0.57, 
petroleum spirit: ethyl acetate, 1:1);
 1
H NMR (400 MHz, CDCl3): δ 4.24 (2 H, m, 1-H), 
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2.20 (2 H, tt, J = 7.1, 2.16 Hz, 4-H), 1.69 (1 H, s-broad, OH), 1.50 (2 H, m, 5-H), 1.26 
(12 H, m, 6, 7, 8, 9, 10, 11-H), 0.87 (3 H, t, J = 6.6, 12-H). 
13
C NMR (100 MHz, 
CDCl3): δ 86.6 (3-C), 78.3 (2-C), 51.4 (CH2, 1-C), 31.9 (CH2, 10-C), 29.5 (CH2, 5-C), 
29.3 (CH2, 6-C), 29.1 (CH2, 7-C), 28.9 (CH2, 8-C), 28.6 (CH2, 9-C), 22.6 (CH2, 11-C), 
18.7 (CH2, 4-C); 14.1 (CH3, 12-C). EIMS m/z 151 [M - H2C=OH]
+
 (4), 111 (26), 67 
(90), 55 (100), 41 (3493); HREIMS m/z 151.1488 (calculated for C11H19, 151.1487). 
 
Hex-5-yn-1-ol (5.8).- Sodium hydride (562.8 mg, 23.5 mmol) 
was dissolved in 14 mL of anhydrous 1,3-diaminopropane 
(APA) under argon at RT, to give a light grey, effervescent 
solution of NAPA. Mixture was then heated at 70°C for 40 min, at which time colour 
changed to clear brown. Hex-2-yn-1-ol (5.6) (766.0 mg, 7.8 mmol) was added at RT. 
After addition, mixture became thicker and a strong brown colour and fine 
effervescence were observed. Iced water and saturated NH4Cl were carefully added to 
quench the reaction, followed by extraction with diethyl ether (3 x 30 mL). The 
combined organic layers were further washed with 2 M HCl, NaHCO3, NaCl, water, 
dried over Na2SO4 and concentrated under reduced pressure, yielding hex-5-yn-1-ol 
(5.8) (42%) as a clear orange liquid. UV (DCM) ) λmax (log ε) 230 (2.59) nm; IR (neat) 
νmax 3293, 2938, 2867, 1059, 628, cm
-1
; Rf (0.36, petroleum spirit: ethyl acetate, 1:1); 
1
H NMR (400 MHz, CDCl3): δ 3.67 (2 H, t, J = 6.1 Hz, 1-H), 2.23 (2 H, td, J = 6.9, 2.6 
Hz, 4-H), 1.95 (1 H, t, J = 2.6 Hz, 6-H), 1.73 – 1.58 (4 H, m, 2, 3-H), 1.53 (1 H, s, OH). 
13
C NMR (100 MHz, CDCl3): δ 84.2 (5-C), 68.5 (CH, 6-C), 62.3 (CH2, 1-C), 31.7 (CH2, 
2-C), 24.7 (CH2, 3-C), 18.2 (CH2, 4-C). EIMS m/z 98 [M]˙
+
 (26), 97 [M – H] (6), 67 
(100), 53 (60), 39 (93); HREIMS m/z 97.0654 (calculated for C6H9O, 97.0653). 
 
Dodec-11-yn-1-ol (5.9). - Sodium hydride 
(562.8 mg, 23.5 mmol) was dissolved in 14 mL 
of anhydrous 1,3-diaminopropane (APA) under 
argon at RT, to give a light grey, effervescent solution of NAPA. Mixture was then 
heated at 70°C for 40 min, at which time colour changed to clear brown. Dodec-2-yn-1-
ol (5.7) (766 mg, 7.8 mmol) was added at RT. After addition, mixture became thicker 
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and a strong brown colour and fine effervescence were observed. Iced water and 
saturated NH4Cl were carefully added to quench the reaction, followed by extraction 
with diethyl ether (3 x 30 mL). The combined organic layers were further washed with 2 
M HCl, NaHCO3, NaCl, water, dried over Na2SO4 and concentrated under reduced 
pressure, yielding dodec-11-yn-1-ol (5.9) (67%) as a clear orange liquid. UV (DCM) ) 
λmax (log ε) 244 (2.29) nm; IR (neat) νmax 3311, 2924, 2854, 1052, 627, cm
-1
; Rf (0.42, 
petroleum spirit: ethyl acetate, (1:1)); 
1
H NMR (400 MHz, CDCl3): δ 3.63 (2 H, t, J = 
6.6 Hz, 1-H), 2.17 (2 H, td, J = 7.0, 2.6 Hz, 10-H), 1.93 (1 H, t, J = 2.6 Hz, 12-H), 1.59 
– 1.45 (6 H, m, 2, 3, 9-H), 1.28 (10 H, m, 4, 5, 6, 7, 8-H). 13C NMR (100 MHz, CDCl3): 
δ 84.8 (11-C), 68.0 (CH, 12-C), 63.0 (CH2, 1-C), 32.8 (CH2, 2-C), 29.5 (CH2, 4-C), 29.4 
(CH2, 5-C), 29.4 (CH2, 6-C), 29.1 (CH2, 7-C); 28.7 (CH2, 9-C), 28.5 (CH2, 8-C), 25.7 
(CH2, 3-C) 18.3 (CH2, 10-C). EIMS m/z 182 [M]˙
+ 
(4), 81 (82), 67 (100), 55 (70), 41 
(63); HREIMS m/z 67.0548 [M – (H2C)6H2C=OH]
+
 (calculated for C5H7, 67.0548). 
 
3-(5-Pentylfuran-2-yl)-prop-2-yn-1-ol (5.10). - In a 
two-necked round bottom flask, 2-iodo-5-
pentylfuran (4.28) (100.0 mg, 0.4 mmol), Pd(PPh3)4 
(23.0 mg, 5%.), CuI (7.6 mg, 10%.), propargyl 
alcohol (4.29) (42.5 mg, 0.8 mmol), pyrrolidine (3 mL) was added. The reaction was 
degassed several times and back filled with argon. Reaction mixture was stirred at RT 
overnight covered in aluminium foil. The reaction was cooled to 0°C at which time 15 
mL of saturated NH4Cl solution was slowly added. The reaction was extracted with 3 
portions of Et2O (15 mL) and the combined organic layers were washed with saturated 
NH4Cl solution (3 × 20 mL) followed by H2O (20 mL), and concentrated under reduced 
pressure. The dark orange crude was subjected to flash column chromatography (silica, 
eluent v/v pet. spirit: Et2O = 1:1), affording the title compound as a light yellow oil 
(60%). UV (MeOH) ) λmax (log ε) 260 (4.03) nm; IR (neat) νmax 3390 (br), 2928 (m), 
2220 (w), 1014 (m), 786 (m), cm
-1
; Rf (0.3, petroleum spirit: ethyl acetate, (3:1)); 
1
H 
NMR (400 MHz, CDCl3): δ 6.50 (1 H, d, J = 3.3 Hz, 3-H), 5.97 (1 H, dt, J = 3.3, 0.8 
Hz, 4-H), 4.50 (2 H, s, 1’’-H), 2.59 (2 H, t, J = 7.6 Hz, 1’-H), 1.67 – 1.60 (2 H, m, 2’-
H), 1.33 – 1.29 (4 H, m, 3’,4’-H), 0.89 (3 H, t, J = 6.9 Hz, 5’-H). 13C NMR (100 MHz, 
CDCl3): δ 158.4 (5-C), 134.4 (2-C), 116.8 (3-C), 106.2 (4-C), 91.4 (3’’-C), 51.6 (1’’-C), 
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31.3 (1’-C), 28.2, 27.5, 22.3, 14.0 (5’-C). EI-MS m/z (%): [M]·+ 192 (90), 135 (100), 
107 (57). HREIMS m/z 192.1148 (calculated for C12H16O2, 192.1150). 
 
3-(5-pentylthiophene-2-yl)-prop-2-yn-1-ol (5.13). 
- 2-Iodo-5-pentylthiophene (5.5) (152.3 mg, 0.5 
mmol), Pd(PPh3)4 (31.4 mg, 5%) and CuI (10.3 
mg, 10%) were degassed several times and back 
filled with argon. Pyrrolidine (10 mL) was subsequently added. After addition, the 
mixture was stirred for two minutes at RT. A solution of propargyl alcohol (60.9 mg, 
1.1 mmol) in pyrrolidine was then added dropwise, and the mixture was stirred 
overnight. Petroleum ether was added to the resulting mixture and the precipitate was 
removed by filtration on silica using a mixture of EtOAc and petroleum spirit (1:1). 
Organic layer was washed with NH4Cl, followed by NaCl and water, dried over Na2SO4 
and concentrated under reduced pressure, yielding 3-(5-pentylthiophene-2-yl)-prop-2-
yn-1-ol (5.13) (47%) as a clear orange liquid. Rf (0.5, EtOAc:Pet. spirit 1:1) IR vmax 
3318 (w, br), 2956 (m), 2927 (s), 2856 (m), 2219 (w), 1537 (m), 1354 (m), 1185 (m), 
1012 (vs), 799 (vs). 
1
H NMR (400 MHz, CDCl3): δH 7.03 (1 H, d, J = 3.6, 3-H), 6.63 (1 
H, d, J = 3.6, 4-H), 4.49 (2 H, s, 1’’-H), 2.76, (2 H, t, J =7.6, 1’-H), 1.66 (3 H, m, 2’-H), 
1.30 (4 H, m, 3’, 4’-H), 0.89 (3 H, t, J = 7.0, 5’-H). 13C NMR (CDCl3, 100 MHz) δC 
148.6 (C, 5-C), 132.5 (CH, 3-C), 124.0 (CH, 4-C), 119.6 (C, 2-C), 90.3 (C, 2’’-C), 79.6 
(C, 3’’-C), 51.8 (CH2, 1’’-C), 31.2 (CH2, 1’-C), 31.2, 30.1, 22.3, 14.0 (CH3, 5’-C) EIMS 
m/z: [M]
·+
 208 (78), 151 (100), 123 (53), 79 (11). HREIMS m/z 208.0921 (calculated 
for C12H16OS 208.0922) 
 
6-(5-Pentylfuran-2-yl)-hex-5-yn-1-ol (5.11). 
- 2-Iodo-5-pentylfuran (4.28) (99.0 mg, 0.4 
mmol), Pd(PPh3)4 (23.0 mg, 5%) and CuI 
(7.6 mg, 10%) were degassed several times and backfilled with argon. Pyrrolidine (10 
mL) was subsequently added. After addition, the mixture was stirred for two minutes at 
RT. A solution of hex-5-yn-1-ol (5.8) (130.2 mg, 1.3 mmol) in pyrrolidine was then 
added dropwise, and the mixture was stirred for two hours. Petroleum ether was added 
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to the resulting mixture and the precipitate was removed by filtration. Organic layer was 
washed with NH4Cl, followed by NaCl and water, dried over Na2SO4 and concentrated 
under reduced pressure, yielding the title compound (61%) as a mobile liquid. UV 
(MeOH) λmax (log ε) 256 (4.05) nm; IR (neat) νmax 3371 (br), 2929 (s), 2861 (m), 2214 
(w), 1649 (m), 784 (sh) cm
-1
; Rf (0.17, petroleum spirit: ethyl acetate, 3:1); 
1
H NMR 
(400 MHz, CDCl3): δ 6.37 (1 H, d, J = 3.2 Hz, 3-H), 5.93 (1 H, d, J = 3.2 Hz, 4-H), 
3.70 (2 H, t, J = 6.0 Hz, 1’’-H), 2.58 (2 H, t, J = 7.6 Hz, 4’’-H), 2.48 (2 H, t, J = 6.7 Hz, 
1’-H) 1.75 – 1.61 (6 H, m, 2’, 2’’, 3’’-H), 1.53 (1H, s, OH), 1.33 – 1.29 (4 H, m, 4’-H) 
0.89 (3 H, t, J = 6.9 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 157.3 (5-C), 135.5 (2-
C), 114.7 (CH, 3-C), 105.8 (CH, 4-C), 93.7 (5’’-C), 71.4 (6’’-C), 62.4 (CH2, 1’’-C), 
31.8 (CH2, 2’’-C), 31.3 (CH2, 2’-C), 28.2 (CH2, 1’’-C)), 27.6 (CH2, 3’’-C ). 24.7 
(CH2, 3’-C), 22.4 (CH2, 4’-C)), 19.3 (CH2, 1’-C), 14.0 (CH3, 5’-C). EIMS m/z [M]˙
+
 
234 (37), 177 (86), 159 (100), 149 (17), 133 (33); HREIMS m/z 234.1617 (calculated 
for C15H22O2, 234.1620). 
 
6-(5-pentylthiophene-2-yl)-hex-5-yn-1-ol 
(5.14). - 2-Iodo-5-pentylthiophene (5.5) 
(149.5 mg, 0.5 mmol), Pd(PPh3)4 (34.6 
mg, 5%) and CuI (9.5 mg, 10%) were degassed several times and backfilled with argon. 
Pyrrolidine (10 mL) was subsequently added. After addition, the mixture was stirred for 
two minutes at RT. A solution of hex-5-yn-1-ol (5.8) (104.6 mg, 1.1 mmol) in 
pyrrolidine was then added dropwise, and the mixture was stirred overnight. Petroleum 
ether was added to the resulting mixture and the precipitate was removed by filtration 
on silica using a mixture of EtOAc and petroleum spirit (1:1). Organic layer was 
washed with NH4Cl, followed by NaCl and water, dried over Na2SO4 and concentrated 
under reduced pressure, yielding the title compound (56%) as a clear orange liquid. Rf 
(0.45, EtOAc:petroleum spirit 1:1) IR vmax 3370 (w, br), 2927 (s), 2219 (w), 780 (sh) 
cm
-1
. 
1
H NMR (400 MHz, CDCl3): δ 6.92 (1 H, d, J = 3.5, 3-H), 6.59 (1 H, d, J = 3.5, 4-
H), 3.70 (2 H, t, J = 6.0, 1’’-H), 2.74, (2 H, t, J =7.6, 1’-H), 2.46 (2 H, t, J = 6.6 Hz, 4’’-
H), 1.77 – 1.59 (6 H, m), 1.38 – 1.28 (3 H, m), 0.89 (3 H, t, J = 7.0, 5’-H). 13C NMR 
(CDCl3, 100 MHz) δ 147.0 (5-C), 131.1 (CH, 3-C), 123.9 (CH, 4-C), 121.3 (2-C), 93.1 
(5’’-C), 74.7 (6’’-C), 62.6 (CH2, 1’’-C), 32.1 (CH2, 2’’-C), 31.4 (CH2, 1’-C), 31.3 (CH2, 
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3’-C), 30.2 (CH2, 2’-C), 25.1 (CH2, 3’’-C), 22.5 (CH2, 4’-C), 29.6 (CH2, 4’’-C), 14.1 
(CH3, 5’-C). HREIMS m/z 250.1382 (calculated for C15H22OS 250.1391) 
 
9-(5-pentylthiophene-2-yl)-
non-8-yn-1-ol (5.15). - 2-Iodo-
5-pentylthiophene (5.5) (151.0 
mg, 0.5 mmol), Pd(PPh3)4 (34.6 mg, 5%) and CuI (9.5 mg, 10%) were degassed several 
times and backfilled with argon. Pyrrolidine (10 mL) was subsequently added. After 
addition, the mixture was stirred for two minutes at RT. A solution of non-8-yn-1-ol 
(4.33) (151.1 mg, 1.1 mmol) in pyrrolidine was added dropwise, and the mixture was 
stirred overnight. Petroleum ether was added to the resulting mixture and the precipitate 
was removed by filtration on silica using a mixture of EtOAc and petroleum spirit (1:1). 
Organic layer was washed with NH4Cl, followed by NaCl and water, dried over Na2SO4 
and concentrated under reduced pressure, yielding 9-(5-pentylthiophene-2-yl)-non-8-yn-
1-ol (5.15) (87%) as a clear orange liquid. Rf (0.48, EtOAc:petroleum spirit 1:1) IR vmax 
3355 (br), 2927 (s), 2856 (m), 2219 (w), 1590 (w), 780 (m). 
1
H NMR (400 MHz, 
CDCl3): δ 6.92 (1 H, d, J = 3.5, 3-H), 6.58 (1 H, d, J = 3.5, 4-H), 3.65 (2 H, t, J = 6.6, 
1’’-H), 2.74 (2 H, t, J = 7.6, 1’-H), 2.40 (2 H, t, J = 7.0, 7’’-H), 1.62-1.31 (12 H, m, 2’, 
6’’, 5’’, 4’’, 3’’, 2’’-H), 0.89 (3 H, t, J = 4.8, 5’-H) 13C NMR (CDCl3, 100 MHz) δ 
146.7 (5-C), 130.8 (CH, 3-C), 123.8 (CH, 4-C), 93.5 (2-C), 63.0 (8’’-C), 53.4 (9’’-C), 
32.7 (CH2, 1’’-C), 31.2, 31.1, 30.1, 28.9, 28.8, 28.5, 25.6 (CH2, 1’-C), 25.6, 22.4, 19.7, 
14.0 (CH3, 5’-C). EIMS m/z: [M]·+ 292 (53), 235 (27), 193 (100), 163 (27), 135 (33), 
91 (15). HREIMS m/z 292.1858 (calculated for C18H28OS 292.1861) 
 
12-(5-Pentylfuran-2-yl) 
dodec-11-yn-1-ol (5.12). - 2-
Iodo-5-pentylfuran (4.28) 
(99.6 mg, 0.4 mmol), 
Pd(PPh3)4 (23.0 mg, 5%) and CuI (7.6 mg, 10%) were degassed several times and 
backfilled with argon. Pyrrolidine (6 mL) was subsequently added. After addition a 
solution of dodec-11-yn-1-ol (5.9) (240.5 mg, 1.3 mmol) in pyrrolidine was added 
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dropwise, and the mixture was stirred overnight. Petroleum ether was added to the 
resulting mixture and the precipitate was removed by filtration on silica using a mixture 
of EtOAc and petroleum spirit (1:1). Organic layer was washed with NH4Cl, followed 
by NaCl and water, dried over Na2SO4 and concentrated under reduced pressure, 
yielding 12-(5-Pentylfuran-2-yl)-dodec-11-yn-1-ol (5.12) (89%) as a clear orange 
liquid. UV (MeOH) ) λmax (log ε) 254 (3.89) nm; IR (neat) νmax 3335 (br), 2924 (sh), 
2853 (m), 1592 (w), 1537 (w) 781 (m), cm
-1
; Rf (0.28, petroleum spirit: ethyl acetate, 
(3:1)); 
1
H NMR (400 MHz, CDCl3): δ 6.36 (1 H, d, J = 3.2 Hz, 3-H), 5.92 (1 H, d, J = 
3.2 Hz, 4-H), 3.63 (2 H, t, J = 6.6 Hz, 1’-H), 2.57 (2 H, t, J = 7.6 Hz, 1’’-H), 2.41 (2 H, 
t, J = 7.08 Hz, 10’’-H), 1.66 – 1.52 (8 H, m, 3’. 4’, 2’’, 7’’-H), 1.46 – 1.39 (2 H, m, 8’’-
H), 1.29 (12 H, m, 2’, 3’’, 4’’, 5’’, 6’’, 9’’-H), 0.88 (3 H, t, J = 6.9 Hz, 5’–H). 13C NMR 
(100 MHz, CDCl3): δ 157.1 (5-C), 135.6 (2-C), 114.6 (CH, 3-C), 105.8 (CH, 4-C), 94.2 
(11’’-C), 71.3 (12’’-C), 63.0 (CH2, 1’’-C), 32.8 (CH2, 2’’-C), 31.3 (CH2, 2’-C), 29.5 
(CH2, 6’’-C), 29.4 (CH2, 5’’-C). 29.1 (CH2, 4’’-C), 28.9 (CH2, 9’’-C), 28.8 (CH2, 8’’-
C), 28.4 (CH2, 7’’-C), 28.2 (CH2, 1’-C), 27.6 (CH2, 3’-C), 25.7 (CH2, 3’’-C), 22.3 (CH2, 
4’-C), 19.5 (CH2, 10’’-C), 13.9 (CH3, 5’-C). EIMS m/z 318 [M]˙
+
 (47), 218 (54), 177 
(100), 161 (46), 147 (32); HREIMS m/z 318.2559 (calculated for C21H34O2, 318.2559). 
 
12-(5-pentylthiophene-2-yl) 
dodec-11-yn-1-ol (5.16). - 2-
Iodo-5-pentylthiophene (5.5) 
(168.7 mg, 0.6 mmol), Pd(PPh3)4 (34.6 mg, 5%) and CuI (11.4 mg, 10%) were degassed 
several times and backfilled with argon. Pyrrolidine (10 mL) was subsequently added. 
After addition, the mixture was stirred for two minutes at RT. A solution of dodec-11-
yn-1-ol (5.9) (219.3 mg, 1.2 mmol) in pyrrolidine was added dropwise, and the mixture 
was stirred overnight. Petroleum ether was added to the resulting mixture and the 
precipitate was removed by filtration on silica using a mixture of EtOAc and petroleum 
spirit (1:1). Organic layer was washed with NH4Cl, followed by NaCl and water, dried 
over Na2SO4 and concentrated under reduced pressure, yielding 12-(5-pentylthiophene-
2-yl)-dodec-11-yn-1-ol (5.16) (81%) as a clear orange liquid. Rf (0.3, EtOAc:petroleum 
spirit 1:3) IR v̅ 3334 (br), 2927 (sh), 2856 (m), 1537 (w), 780 (m). 1H NMR (400 MHz, 
CDCl3): δ 6.92 (1 H, d, J = 3.5, 3-H), 6.58 (1 H, d, J = 3.5, 4-H), 3.64 (2 H, t, J =6.7, 
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1’’-H), 2.70 (2 H, t, J = 7.6, 1’-H), 2.40 (2 H, t, J = 7.1, 7’’-H), 1.66 - 1.30 (22 H, m, 
2’–4’-H & 2’’–9’’-H), 0.89 (3 H, t, J = 6.9, 5’-H) 13C NMR (CDCl3, 100 MHz) δ 146.7 
(5-C), 130.8 (CH, 3-C), 123.7 (CH, 4-C), 121.4 (2-C), 93.6 (8’’-C), 74.1 (9’’-C), 63.1 
(CH2, 1’’-C), 32.8, 31.2, 31.2, 30.1, 29.5, 29.4, 29.4, 29.1, 28.9, 28.6 (CH2, 1’-C), 28.3, 
25.7, 22.4, 19.7, 14.0 (CH3, 5’-C). EIMS m/z [M]·+ 334 (37), 234 (60), 193 (100), 177 
(43), 163 (33), 134 (25), 121 (16), 97 (13), 41 (12). HREIMS m/z 334.2336 (calculated 
for C21H34OS 334.2330) 
 
3-(5-Pentylfuran-2-yl)-prop-2-ynal (5.17). A 
mixture of 3-(5-pentylfuran-2-yl)-prop-2-yn-1-ol 
(5.10) (113.0 mg, 0.4 mmol), TEMPO (12.8 mg, 0.1 
mmol) and BAIB (228.6 mg, 0.7 mmol) were 
vigorously stirred in DCM (20 mL) overnight until all starting material was consumed. 
An aqueous solution of 10% sodium thiosulphate was added to the mixture to quench 
the reaction and stirred for few minutes. Mixture was transferred to a separatory funnel 
and the aqueous layer was washed once with DCM. The organic layers were combined 
and washed with sodium bicarbonate, NaCl, dried over Na2SO4 and concentrated under 
reduced pressure, affording the titled compound, as a yellow oil (Rf 0.35, EtOAc:Pet 
Sp, 1:3). Product was used without further purification and/or characterisation in the 
next step. 
 
3-(5-pentylthiophene-2-yl)-prop-2-ynal (5.20). – A 
mixture of 3-(5-pentylthiophene-2-yl)-prop-2-yn-1-
ol (5.13) (128.0 mg, 0.6 mmol), TEMPO (11.3 mg, 
0.1 mmol) and BAIB (211.0 mg, 0.7 mmol) were 
vigorously stirred in DCM (25 mL) overnight. 10% sodium thiosulphate (10 mL) was 
used to quench the reaction, which was then transferred to a separatory funnel. The 
aqueous layer was washed with DCM (2 x 20 mL), and the combined organic layers 
washed with saturated NaHCO3 solution (2 x 20 mL), NaCl solution (2 x 20 mL), then 
dried with Na2SO4. After being reduced in vacuo, the title product was afforded as a 
clear yellow oil. Rf (0.58, DCM 100%) EIMS m/z [M]
·+
 206 (63), 149 (100), 121 (49), 
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77 (12), 69 (8). Product was used without further purification and/or characterisation in 
the next step. 
 
6-(5-Pentylfuran-2-yl)-hex-5-ynal (5.18). - A 
mixture of 6-(5-pentylfuran-2-yl)-hex-5-yn-1-
ol (5.11) (113.0 mg, 0.4 mmol), TEMPO 
(12.8 mg, 0.1 mmol) and BAIB (228.6 mg, 
0.7 mmol) were vigorously stirred in DCM (20 mL) overnight until all starting material 
was consumed. An aqueous solution of 10% sodium thiosulphate was added to the 
mixture to quench the reaction and stirred for few minutes. Mixture was transferred to a 
separatory funnel and the aqueous layer was washed once with DCM. The organic 
layers were combined and washed with sodium bicarbonate, NaCl, dried over Na2SO4 
and concentrated under reduced pressure, affording the titled compound, as a yellow oil 
(Rf 0.35, EtOAc:Pet Sp, 1:3). Product was used without further purification and/or 
characterisation in the next step. 
 
6-(5-pentylthiophene-2-yl)-hex-5-ynal (5.21). 
– A mixture of 6-(5-pentylthiophene-2-yl)-
hex-5-yn-1-ol (5.14) (74.5 mg, 0.3 mmol), 
TEMPO (9.3 mg, 0.1 mmol) and BAIB 
(166.0 mg, 0.5 mmol) were vigorously stirred in DCM (25 mL) overnight. 10% sodium 
thiosulphate (10 mL) was used to quench the reaction, which was then transferred to a 
separating funnel. The aqueous layer was washed with DCM (2 x 20 mL), and the 
combined organic layers washed with saturated NaHCO3 solution (2 x 20 mL), NaCl 
solution (2 x 20 mL), then dried with Na2SO4. After being reduced in vacuo, the title 
product was afforded as a clear yellow oil. Rf (0.47, EtOAc:Pet sp 1:3). Product was 
used in the next step without further purification or characterisation. 
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9-(5-pentylthiophene-2-yl)-non-8-ynal 
(5.22). A mixture of 9-(5-
pentylthiophene-3-yl)-non-8-yn-1-ol 
(5.15) (137.2 mg, 0.47 mmol, 1 Eq), TEMPO (14.6 mg, 0.092 mmol, 0.2 Eq) and BAIB 
(262 mg, 0.81 mmol, 1.73 Eq) were vigorously stirred in DCM (25 mL) overnight. 10% 
sodium thiosulphate (10 mL) was used to quench the reaction, which was then 
transferred to a separating funnel. The aqueous layer was washed with DCM (2 x 20 
mL), and the combined organic layers washed with saturated NaHCO3 solution (2 x 20 
mL), NaCl solution (2 x 20 mL), then dried with Na2SO4. After being reduced in vacuo, 
the title product was afforded as a clear yellow oil. Rf (0.50, EtOAc:Pet sp 1:3). Product 
was used in the next step without further purification or characterisation. 
 
12-(5-Pentylfuran-2-yl)-dodec-
11-ynal (5.19). - A mixture of 
12-(5-pentylfuran-2-yl)-dodec-
11-yn-1-ol (5.12) (113.0 mg, 
0.4 mmol), TEMPO (12.8 mg, 0.1 mmol) and BAIB (228.6 mg, 0.7 mmol) were 
vigorously stirred in DCM (20 mL) overnight until all starting material was consumed. 
An aqueous solution of 10% sodium thiosulphate was added to the mixture to quench 
the reaction and stirred for few minutes. Mixture was transferred to a separatory funnel 
and the aqueous layer was washed once with DCM. The organic layers were combined 
and washed with sodium bicarbonate, NaCl, dried over Na2SO4 and concentrated under 
reduced pressure, affording the titled compound, as a yellow oil (Rf 0.35 (EtOAc:Pet Sp 
1:3)). Product was used without further purification and/or characterisation in the next 
step. 
 
12-(5-pentylthiophene-2-yl)-
dodec-11-ynal (5.23). - A 
mixture of 12-(5-
pentylthiophene-2-yl)-
dodec-11-yn-1-ol (5.16) (162.7 mg, 0.5 mmol), TEMPO (15.2 mg, 0.1 mmol) and 
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BAIB (271.3 mg, 0.8 mmol) were vigorously stirred in DCM (25 mL) overnight. 10% 
sodium thiosulphate (10 mL) was used to quench the reaction, which was then 
transferred to a separating funnel. The aqueous layer was washed with DCM (2 x 20 
mL), and the combined organic layers washed with saturated NaHCO3 solution (2 x 20 
mL), NaCl solution (2 x 20 mL), then dried with Na2SO4. After being reduced in vacuo, 
the title product was afforded as a clear yellow oil. Rf (0.52, EtOAc:Pet sp 1:3). Product 
was used in the next step without further purification or characterisation. 
 
3-(5-Pentylfuran-2-yl)-prop-2-ynoic acid (5.24). - 
In a test tube with stopper were vigorously stirred 
until well mixed 0.2 parts of tert-butanol (22.6 mL), 
0.1 parts of 2-methyl-2-butene (9.8 mL, purity 
80%), 3.5 parts of sodium chlorite (395.5 mg), 2.9 parts of sodium dihydrogen 
phosphate (324.8 mg) and 0.1 parts of water (16.9 mL). Mixture was added to a 100 mL 
round bottom flask containing 3-(5-pentylfuran-2-yl)-prop-2-ynal (5.17) (113.0 mg, 1.0 
part) and stirred vigorously until no starting material was visible by TLC (3-4h). Water 
was added to the mixture and extracted with EtOAc (30 mL x 2). Combined organic 
layers were washed with NaHCO3, NaCl, dried over Na2SO4 and evaporated under 
reduced pressure. Purification by flash chromatography (25% petroleum spirit in ethyl 
acetate/ethanol 3:1) was performed to obtain the title compound as a viscous oil (64%). 
UV (MeOH) ) λmax (log ε) 283 (3.81) nm; IR (neat) νmax 3401 (br), 2926 (m), 2190 (w), 
1587 (m), 1378 (m), cm
-1
; Rf (0.13, 25% petroleum spirit in ethyl acetate/ethanol, 3:1); 
1
H NMR (400 MHz, CDCl3): δ 6.73 (1 H, d, J = 3.3 Hz, 3-H), 6.11 (1 H, d, J = 3.3 Hz, 
4-H), 2.63 (2 H, t, J = 7.5 Hz, 1’-H), 1.65 (2 H, tt, J = 7.5, 2’-H), 1.38 – 1.29 (4 H, m, 
3’,4’-H), 0.91 (3 H, J = 6.7 Hz, 5’-H). 13C NMR (100 MHz, CDCl3): δ 161.0 (5-C), 
160.1 (1’’-C), 135.5 (2-C), 120.8 (CH, 3-C), 117.7 (3’’-C), 107.9 (CH, 4-C), 72.5 (2’’-
C), 32.4 (CH2, 3’-C), 29.1 (CH2, 1’-C), 28.6 (CH2, 2’-C), 23.4 (CH2, 4’-C), 14.3 (CH3, 
5’-C). HRESI-MS m/z 229.0839 (calculated for C12H14O3 23Na, 229.0841). 
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3-(5-pentylthiophene-2-yl)-prop-2-ynoic acid 
(5.27). – In a test tube with stopper were 
vigorously stirred until well mixed 0.2 parts of 
tert-butanol (10.4 mL), 0.1 parts of 2-methyl-
2-butene (4.5 mL of 2 M in THF solution), 3.5 parts of sodium chlorite (182.2 mg), 2.9 
parts of sodium dihydrogen phosphate (149.4 mg) and 0.1 parts of water (7.3 mL). 
Mixture was added to a 100 mL round bottom flask containing 3-(5-pentylthiophene-2-
yl)-prop-2-ynal (5.20) (52.1 mg, 1.0 part) and stirred vigorously until no starting 
material was visible by TLC (3-4h). Water was added to the mixture and extracted with 
EtOAc (30 mL x 2). Combined organic layers were washed with NaHCO3, NaCl, dried 
over Na2SO4 and evaporated under reduced pressure. Purification by flash 
chromatography (25% EtOH in EtOAc/pet spirit 3:1) was performed to obtain the title 
compound as a viscous oil (65%). IR (neat) νmax 3398 (br), 2924 (m), 2187 (w), 1587 
(m), 1378 (m), cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ 7.36 (1 H, d, J = 3.7 Hz, 3-H), 6.74 
(1 H, d, J = 3.7 Hz, 4-H), 2.82 (2 H, t, J = 7.6 Hz, 1’-H), 1.68 (2 H, tt, J = 7.6, 2’-H), 
1.37 – 1.30 (4 H, m, 3’,4’-H), 0.90 (3 H, J = 6.9 Hz, 5’-H). 13C NMR (100 MHz, 
CDCl3): δ 156.0 (1’’-C), 153.8 (5-C), 137.8 (3-C), 133.3 (CH, 4-C), 125.1 (2-C), 124.1 
(2’’-C), 80.5 (3’’-C), 31.3 (CH2, 1’-C), 31.2 (CH2, 3’-C), 30.5 (CH2, 2’-C), 22.5 (CH2, 
4’-C), 14.1 (CH3, 5’-C). HRESI-MS m/z 245.0622 (calculated for C12H14O223NaS, 
245.0612). 
 
6-(5-Pentylfuran-2-yl)-hex-5-ynoic acid 
(5.25). - Following the work of Schmidt 
and co-workers the oxidation of 
aldehyde to carboxylic acid was as 
follows:
120
 In a test tube with stopper were vigorously stirred until well mixed 0.2 parts 
of tert-butanol (22.6 mL), 0.1 parts of 2-methyl-2-butene (9.8 mL, purity 80%), 3.5 
parts of sodium chlorite (395.5 mg), 2.9 parts of sodium dihydrogen phosphate (324.8 
mg) and 0.1 parts of water (16.9 mL). Mixture was added to a 100 mL round bottom 
flask containing 6-(5-pentylfuran-2-yl)-hex-5-ynal (5.18) (113 mg, 1.0 part) and stirred 
vigorously until no starting material was visible by TLC (3-4h). Water was added to the 
mixture and extracted with EtOAc (30 mL x 2). Combined organic layers were washed 
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with NaHCO3, NaCl, dried over Na2SO4 and evaporated under reduced pressure. 
Purification by flash chromatography (ethyl acetate:petroleum spirit 3:1) was performed 
to obtain the title compound as a viscous oil (70%). UV (MeOH) ) λmax (log ε) 254 
(3.98) nm; IR (neat) νmax 2956 (m), 2931 (m), 1861 (m), 1712 (s), cm
-1
; Rf (0.25, 
petroleum spirit: ethyl acetate, (1:1)); 
1
H NMR (400 MHz, CDCl3): δ 6.39 (1 H, d, J = 
3.2 Hz, 3-H), 5.94 (1 H, d, J = 3.2 Hz, 4-H), 2.60 – 2.52 (6 H, m, 1’, 2’’, 4’’-H), 1.93 (2 
H, tt, J = 7.1, 3’’-H), 1.63 (2 H, tt, J = 7.1, 2’-H), 1.33 – 1.29 (4 H, m, 3’, 4’-H) 0.89 (3 
H, t, J = 6.8 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 177.3 (1’-C), 157.4 (5-C), 
135.3 (2-C), 115.0 (CH, 3-C), 105.8 (CH, 4-C), 92.5 (5’’-C), 72.4 (6’’-C), 32.4 (CH2, 
4’’-C), 31.3 (CH2, 3’-C), 28.2 (CH2, 1’-C), 27.6 (CH2, 2’-C ). 23.3 (CH2, 3’’-C), 22.4 
(CH2, 4’-C), 18.9 (CH2, 2’’-C), 13.9 (CH3, 5’-C). HRESIMS m/z 271.1311 (calculated 
for C15H20O3 23Na 271.1310). 
 
6-(5-pentylthiophene-2-yl)-hex-5-ynoic acid 
(5.28). - In a test tube with stopper were 
vigorously stirred until well mixed 0.2 parts 
of tert-butanol (14.8 mL), 0.1 parts of 2-
methyl-2-butene (6.4 mL of 2 M in THF solution), 3.5 parts of sodium chlorite (258.6 
mg), 2.9 parts of sodium dihydrogen phosphate (212.1 mg) and 0.1 parts of water (10.3 
mL). Mixture was added to a 100 mL round bottom flask containing 6-(5-
pentylthiophene-2-yl)-hex-5-ynal (5.21) (73.9 mg, 1.0 part) and stirred vigorously until 
no starting material was visible by TLC (3-4h). Water was added to the mixture and 
extracted with EtOAc (30 mL x 2). Combined organic layers were washed with 
NaHCO3, NaCl, dried over Na2SO4 and evaporated under reduced pressure. Purification 
by flash chromatography (ethyl acetate/petroleum spirit 3:1) was performed to obtain 
the title compound as a viscous oil (75%) IR (neat) νmax 2954 (m), 2929 (m), 1858 (m), 
1710 (s), cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ 6.93 (1 H, d, J = 3.6 Hz, 3-H), 6.59 (1 H, 
d, J = 3.6 Hz, 4-H), 2.74 (2 H, t, J = 7.6 Hz, 1’-H), 2.60 – 2.52 (4 H, m, 1’’, 4’’-H), 
1.92 – 1.30 (10 H, m, 2’’, 3’’, 2’, 3’, 4’-H), 0.90 (3 H, t, J = 6.8 Hz, 5’–H). 13C NMR 
(100 MHz, CDCl3): δ 177.2 (1’’-C), 147.3 (5-C), 131.3 (3-C), 124.0 (CH, 4-C), 121.1 
(2-C), 91.9 (5’’-C), 75.3 (6’’-C), 32.6 (CH2, 2’’-C), 31.4 (CH2, 1’-C), 31.3 (CH2, 3’-C), 
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30.2, 23.7, 22.5, 19.2 (CH2, 4’’-C), 14.1 (CH3, 5’-C). HRESIMS m/z 287.1092 
(calculated for C15H20O223NaS 287.1082). 
 
9-(5-pentylthiophene-2-yl)-non-8-ynoic 
acid (5.29). - In a test tube with stopper 
were vigorously stirred until well 
mixed 0.2 parts of tert-butanol (27.2 mL), 0.1 parts of 2-methyl-2-butene (11.8 mL of 2 
M in THF solution), 3.5 parts of sodium chlorite (476.8 mg), 2.9 parts of sodium 
dihydrogen phosphate (390.9 mg) and 0.1 parts of water (19.1 mL). Mixture was added 
to a 100 mL round bottom flask containing 9-(5-pentylthiophene-2-yl)-non-8-ynal 
(5.22) (136.9 mg, 1.0 part) and stirred vigorously until no starting material was visible 
by TLC (3-4h). Water was added to the mixture and extracted with EtOAc (30 mL x 2). 
Combined organic layers were washed with NaHCO3, NaCl, dried over Na2SO4 and 
evaporated under reduced pressure. Purification by flash chromatography (EtOAc/pet 
spirit 3:1) was performed to obtain the title compound as a viscous oil (80%). IR (neat) 
νmax 2930 (m), 1708 (s), 1180 (br) 630 (m), cm
-1
; 
1
H NMR (400 MHz, CDCl3): δ 6.92 (1 
H, d, J = 3.6 Hz, 3-H), 6.59 (1 H, d, J = 3.6 Hz, 4-H), 2.74 (2 H, t, J = 7.6 Hz, 1’-H), 
2.43 – 2.34 (4 H, m, 2’’, 7’’-H), 1.70 – 1.29 (14 H, m, 2’, 3’, 4’, 3’’, 4’’, 5’’, 6’’-H), 
0.89 (3 H, t, J = 6.9 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 178.4 (1’’-C), δ 145.0 
(5-C), 131.0 (CH, 3-C), 123.9 (CH, 4-C), 121.5 (2-C), 93.4 (8’’-C), 74.4 (9’’-C), 33.8 
(CH2, 2’’-C), 31.4 (CH2, 1’-C), 31.3, 30.3, 28.7, 28.6, 28.5, 24.7, 22.5, 19.8 (CH2, 7’’-
C), 14.1 (CH3, 5’-C). HRESIMS m/z 329.1560 (calculated for C18H26O223NaS, 
329.1551). 
 
12-(5-Pentylfuran-2-yl)-
dodec-11-ynoic acid (5.26). - 
In a test tube with stopper 
were vigorously stirred until 
well mixed 0.2 parts of tert-butanol (22.6 mL), 0.1 parts of 2-methyl-2-butene (9.8 mL, 
purity 80%), 3.5 parts of sodium chlorite (395.5 mg), 2.9 parts of sodium dihydrogen 
phosphate (324.8 mg) and 0.1 parts of water (16.9 mL). Mixture was added to a 100 mL 
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round bottom flask containing 12-(5-pentylfuran-2-yl)-dodec-11-ynal (5.19) (113.0 mg, 
1.0 part) and stirred vigorously until no starting material was visible by TLC (3-4h). 
Water was added to the mixture and extracted with EtOAc 30 mL x 2. Combined 
organic layers were washed with NaHCO3, NaCl, dried over Na2SO4 and evaporated 
under reduced pressure. Purification by flash chromatography (EtOAc/pet spirit 3:1) 
was performed to obtain the title compound as a viscous oil (85%). UV (MeOH) ) λmax 
(log ε) 255 (3.68) nm; IR (neat) νmax 2928 (sh), 2855 (m), 2213 (w), 1709 (m) 785 (w), 
cm
-1
; Rf (0.5, petroleum spirit: ethyl acetate, 1:1); 
1
H NMR (400 MHz, CDCl3): δ 6.36 
(1 H, d, J = 3.1 Hz, 3-H), 5.93 (1 H, d, J = 3.1 Hz, 4-H), 2.57 (2 H, t, J = 7.6 Hz, 1’-H), 
2.41 (2 H, t, J = 7.1 Hz, 10’’-H), 2.35 (2 H, t, J = 7.6 Hz, 2’’-H), 1.64 – 1.55 (8 H, m, 
3’, 4’,  3’’, 4’’-H), 1.43 – 1.40 (2 H, m, 9’’-H), 1.29 (10 H, m, 2’, 5’’, 6’’, 7’’, 8’’-H), 
0.89 (3 H, t, J = 5.4 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 179.5 (1’’-C), 157.1 (5-
C), 135.6 (2-C), 114.6 (CH, 3-C), 105.8 (CH, 4-C), 94.2 (11’’-C), 71.3 (12’’-C), 33.9 
(CH2, 2’’-C), 31.3 (CH2, 3’-C), 29.2 (CH2, 8’’-C), 29.1 (CH2, 7’’-C). 29.0 (CH2, 6’’-C), 
29.0 (CH2, 5’’-C), 28.8 (CH2, 4’’-C), 28.4 (CH2, 1’-C), 28.2 (CH2, 9’’-C), 27.6 (CH2, 
2’-C), 24.6 (CH2, 3’’-C), 22.4 (CH2, 4’-C), 19.5 (CH2, 10’’-C), 13.9 (CH3, 5’-C). 
HRESIMS m/z 355.2248 (calculated for C21H32O323Na 355.2249). 
 
12-(5-pentylthiophene-2-yl)-
dodec-11-ynoic acid (5.30). - 
In a test tube with stopper 
were vigorously stirred until 
well mixed 0.2 parts of tert-butanol (10.8 mL), 0.1 parts of 2-methyl-2-butene (4.7 mL 
of 2 M in THF solution), 3.5 parts of sodium chlorite (188.6 mg), 2.9 parts of sodium 
dihydrogen phosphate (154.7 mg) and 0.1 parts of water (7.5 mL). Mixture was added 
to a 100 mL round bottom flask containing 12-(5-pentylthiophene-2-yl)-dodec-11-ynal 
(5.23) (53.9 mg, 1.0 part) and stirred vigorously until no starting material was visible by 
TLC (3-4h). Water was added to the mixture and extracted with EtOAc (30 mL x 2). 
Combined organic layers were washed with NaHCO3, NaCl, dried over Na2SO4 and 
evaporated under reduced pressure. Purification by flash chromatography (ethyl 
acetate/petroleum spirit 3:1) was performed to obtain the title compound as a viscous oil 
(85%). IR (neat) νmax 2930 (sh), 2857 (m), 2212 (w), 1710 (m) 787 (w), cm
-1
; 
1
H NMR 
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(400 MHz, CDCl3): δ 6.92 (1 H, d, J = 3.6 Hz, 3-H), 6.58 (1 H, d, J = 3.6 Hz, 4-H), 
2.74 (2 H, t, J = 7.6 Hz, 1’-H), 2.40 (2 H, t, J = 7.6 Hz, 2’’-H), 2.35 (2 H, t, J = 7.5 Hz, 
10’’-H), 1.68 – 1.54 (2 H, m, 2’’-H), 1.36 – 1.28 (18 H, m, 3’, 4’, 3’’, 4’’, 5’’, 6’’, 7’’, 
8’’, 9’’-H), 0.89 (3 H, t, J = 6.9 Hz, 5’–H). 13C NMR (100 MHz, CDCl3): δ 178.0 (1’’-
C), 146.9 (5-C), 130.9 (CH, 3-C), 123.9 (CH, 4-C), 121.6 (2-C), 93.7 (11’’-C), 74.2 
(12’’-C), 33.8 (CH2, 2’’-C), 31.4 (CH2, 3’-C), 31.3 (CH2, 8’’-C), 30.3 (CH2, 7’’-C). 
29.4 (CH2, 6’’-C), 29.3 (CH2, 5’’-C), 29.2 (CH2, 4’’-C), 29.2 (CH2, 1’-C), 29.0 (CH2, 
9’’-C), 28.8 (CH2, 2’-C), 24.8 (CH2, 3’’-C), 22.5 (CH2, 4’-C), 19.8 (CH2, 10’’-C), 14.1 
(CH3, 5’-C). EIMS m/z [M]
·+
 348 (40), 291 (30), 234 (55), 193 (100), 177 (48). 
HRESIMS m/z 371.2030 (calculated for C21H32O223NaS 371.2021). 
 
(Z)-6-(5-Pentylfuran-2-yl)-hex-5-enoic acid 
(5.31). - A mixture of 6-(5-pentylfuran-2-
yl)-hex-5-ynoic acid (5.25) (58.2 mg, 1.0 
Eq), and Pd/C (10% w.t.) (2.98 mg of Pd, 
0.12 Eq) in EtOAc were degassed and 
backfilled with hydrogen. This process was repeated three times. Then, ethylendiamine 
(153 µL, 9.8 Eq) was added dropwise. Reaction was once more degassed and backfilled 
with hydrogen. Process repeated three times. Mixture was then vigorously stirred for 
three hours at room temperature under an atmosphere of hydrogen. Mixture was 
vacuum filtered over celite and EtOAc layer washed with ammonium chloride, sodium 
bicarbonate and sodium chloride, dried over Na2SO4 and concentrated under reduced 
pressure, yielding the title compound (47%) as a mobile liquid. 
1
H NMR (400 MHz, 
C6D6): δ 6.19 (1 H, dt, J = 11.7, 1.7 Hz, 6’’-H), δ 6.10 (1 H, d, J = 3.2 Hz, 3-H), 5.90 (1 
H, d, J = 3.2 Hz, 4-H), 5.22 (1 H, dt, J = 11.7, 7.4 Hz, 5’’-H), 2.53 – 2.38 (4 H, m, 1’, 
4’’-H), 2.13 (2 H, t, J = 7.5 Hz, 2’’-H), 1.69 – 1.15 (8 H, m, 2’, 3’. 4’, 3’’-H), 0.83 (3 H, 
t, J = 6.84 Hz, 5’–H). 13C NMR (100 MHz, C6D6): δ 179.8 (1’’-C), δ 156.0 (5-C), 152.0 
(2-C), 139.3 (CH, 5’’-C), 118.9 (CH, 6’’-C), 110.6 (CH, 3-C), 106.9 (CH, 4-C), 31.6 
(CH2, 2’’-C), 30.2 (CH2, 3’-C), 28.8 (CH2-4’’-C), 28.4 (CH2, 2’-C), 28.1 (CH2, 1’-C). 
24.8 (CH2-3’’-C), 22.8 (CH2, 4’-C), 14.2 (CH3, 5’-C). EIMS m/z 250 [M]˙
+
 (97), 193 
(73), 177 (100), 151 (35), 133 (55); HREIMS m/z 250.1569 (calculated for C15H22O3, 
250.1569). 
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(Z)-6-(5-Pentylthiophene-2-yl)-hex-5-enoic acid 
(5.33). - A mixture of 6-(5-pentylthiophene-2-
yl)-hex-5-ynoic acid (5.28) (24.8 mg, 1.0 Eq), 
and Pd/C (10% w.t.) (1.2 mg of Pd, 0.12 Eq) in 
EtOAc were degassed and backfilled with hydrogen. This process was repeated three 
times. Then, ethylendiamine (61.3 µL, 9.8 Eq) was added dropwise. Reaction was once 
more degassed and backfilled with hydrogen. Process repeated three times. Mixture was 
then vigorously stirred for three hours at room temperature under an atmosphere of 
hydrogen. Mixture was vacuum filtered over celite and EtOAc layer washed with 
ammonium chloride, sodium bicarbonate and sodium chloride, dried over Na2SO4 and 
concentrated under reduced pressure, yielding the title compound (45%) as a mobile 
liquid. 
1
H NMR (400 MHz, C6D6): δ 6.72 (1 H, d, J = 3.6 Hz, 3-H), 6.56 (1 H, d, J = 
3.6 Hz, 4-H), 6.44 (1 H, dt, J = 11.5, 1.2 Hz, 6’’-H), δ 5.23 (1 H, dt, J = 11.5, 7.2 Hz, 
5’’-H), 2.60 (2 H, t, J = 7.6 Hz, 1’-H), 2.38 – 2.33 (2 H, m, 2’’-H), 2.11 – 2.06 (2 H, m, 
4’’-H), 1.58 – 1.13 (8 H, m, 2’, 3’. 4’, 3’’-H), 0.89 (3 H, t, J = 7.1 Hz, 5’–H). 13C NMR 
(100 MHz, C6D6): δ 179.2 (1’’-C), δ 146.5 (5-C), 143.9 (2-C), 143.2 (CH, 5’’-C), 138.7 
(CH, 6’’-C), 124.2 (CH, 3-C), 123.5 (CH, 4-C), 32.0 (CH2, 2’’-C), 31.7 (CH2, 3’-C), 
31.6 (CH2-4’’-C), 30.4 (CH2, 2’-C), 23.1 (CH2, 1’-C), 22.8 (CH2-3’’-C), 14.4 (CH2, 4’-
C), 14.2 (CH3, 5’-C). EIMS m/z 266 [M]˙
+
 (48), 207 (100), 165 (70); HREIMS m/z 
266.1341 (calculated for C15H22O2S, 266.1341). 
 
(Z)-9-(5-Pentylthiophene-2-yl)-non-8-
enoic acid (5.34). - A mixture of 9-(5-
pentylthiophene-2-yl)-non-8-ynoic acid 
(5.29) (43.6 mg, 1.0 Eq), and Pd/C 
(10% w.t.) (1.81 mg of Pd, 0.12 Eq) in EtOAc were degassed and backfilled with 
hydrogen. This process was repeated three times. Then, ethylendiamine (93 µL, 9.8 Eq) 
was added dropwise. Reaction was once more degassed and backfilled with hydrogen. 
Process repeated three times. Mixture was then vigorously stirred for three hours at 
room temperature under an atmosphere of hydrogen. Mixture was vacuum filtered over 
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celite and EtOAc layer washed with ammonium chloride, sodium bicarbonate and 
sodium chloride, dried over Na2SO4 and concentrated under reduced pressure, yielding 
the title compound (75%) as a mobile liquid. 
1
H NMR (400 MHz, C6D6): δ 6.77 (1 H, d, 
J = 3.5 Hz, 3-H), δ 6.58 (1 H, d, J = 3.5 Hz, 4-H), 6.52 (1 H, dt, J = 11.3, 1.8 Hz, 9’’-
H), 5.42 (1 H, dt, J = 11.3, 7.2 Hz, 8’’-H), 2.62 (2 H, t, J = 7.5 Hz, 1’-H), 2.44 (2 H, m, 
7’’-H), 2.03 (2 H, t, J = 7.5 Hz, 2’’-H), 1.61 – 1.04 (16 H, m, 2’, 3’. 4’, 3’’, 4’’, 5’’, 6’’-
H), 0.86 (3 H, t, J = 6.8 Hz, 5’–H). 13C NMR (100 MHz, C6D6): δ 180.1 (1’’-C), δ 146.0 
(5-C), 139.1 (2-C), 129.7 (CH, 8’’-C), 127.6 (CH, 9’’-C), 124.2 (CH, 3-C), 122.9 (CH, 
4-C), 34.1 (CH2, 2’’-C), 31.7 (CH2, 3’-C), 31.6 (CH2, 7’’-C), 30.4 (CH2, 6’’-C), 29.7 
(CH2, 5’’-C), 29.6 (CH2, 4’’-C), 29.3 (CH2, 2’-C), 29.1 (CH2, 1’-C), 24.9 (CH2-3’’-C), 
22.8 (CH2, 4’-C), 14.2 (CH3, 5’-C). EIMS m/z 308 [M]˙
+
 (55), 193 (100), 149 (70); 
HREIMS m/z 308.1811 (calculated for C18H28O2S 308.1810). 
 
(Z)-12-(5-Pentylfuran-2-yl)-
dodec-11-enoic acid (5.32). - A 
mixture of 12-(5-pentylfuran-2-
yl)-dodec-11-ynoic acid (5.26) 
(38 mg, 1.0 Eq), and Pd/C (10% 
w.t.) (1.45 mg of Pd, 0.12 Eq) in EtOAc were degassed and backfilled with hydrogen. 
This process was repeated three times. Then, ethylendiamine (75 µL, 9.8 Eq) was added 
dropwise. Reaction was once more degassed and backfilled with hydrogen. Process 
repeated three times. Mixture was then vigorously stirred for three hours at room 
temperature under an atmosphere of hydrogen. Mixture was vacuum filtered over celite 
and EtOAc layer washed with ammonium chloride, sodium bicarbonate and sodium 
chloride, dried over Na2SO4 and concentrated under reduced pressure, yielding the title 
compound (43%) as a mobile liquid. 
1
H NMR (400 MHz, C6D6): δ 6.30 (1 H, dd, J = 
11.7, 1.8 Hz, 12’’-H), δ 6.17 (1 H, d, J = 3.2 Hz, 3-H), 5.93 (1 H, d, J = 3.2 Hz, 4-H), 
5.50 (1 H, dt, J = 11.7, 7.3 Hz, 11’’-H), 2.61 – 2.46 (4 H, m, 1’, 10’’-H), 2.10 (2 H, t, J 
= 7.4 Hz, 2’’-H), 1.60 – 1.10 (18 H, m, 2’, 3’. 4’, 3’’, 4’’, 5’’, 6’’, 7’’, 8’’-H), 0.83 (3 H, 
t, J = 6.7 Hz, 5’–H). 13C NMR (100 MHz, C6D6): δ 178.3 (1’’-C), δ 155.8 (5-C), 152.4 
(2-C), 129.8 (CH, 11’’-C), 118.2 (CH, 12’’-C), 110.3 (CH, 3-C), 106.9 (CH, 4-C), 33.9 
(CH2, 2’’-C), 31.7, 30.1, 29.9, 29.84, 29.81, 29.60, 29.34, 28.5, 25.04, 22.8 (CH2, 4’-C), 
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14.2 (CH3, 5’-C). EIMS m/z 334 [M]˙
+
 (50), 277 (20), 177 (100), 107 (45); HREIMS 
m/z 334.2508 (calculated for C18H28O3, 334.2508). 
 
(Z)-12-(5-Pentylthiophene-2-yl)-
dodec-11-enoic acid (5.35). - A 
mixture of 12-(5-pentylthiophene-
2-yl)-dodec-11-ynoic acid (5.30) 
(60.4 mg, 1.0 Eq), and Pd/C (10% 
w.t.) (2.20 mg of Pd, 0.12 Eq) in EtOAc were degassed and backfilled with hydrogen. 
This process was repeated three times. Then, ethylendiamine (113.4 µL, 9.8 Eq) was 
added dropwise. Reaction was once more degassed and backfilled with hydrogen. 
Process repeated three times. Mixture was then vigorously stirred for three hours at 
room temperature under an atmosphere of hydrogen. Mixture was vacuum filtered over 
celite and EtOAc layer washed with ammonium chloride, sodium bicarbonate and 
sodium chloride, dried over Na2SO4 and concentrated under reduced pressure, yielding 
the title compound (50%) as a crude mobile liquid. 
1
H NMR (400 MHz, C6D6): δ 6.77 
(1 H, d, J = 3.5 Hz, 3-H), δ 6.58 (1 H, d, J = 3.5 Hz, 4-H), 6.54 (1 H, dt, J = 11.4, 1.9 
Hz, 12’’-H), 5.48 (1 H, dt, J = 11.4, 7.3 Hz, 11’’-H), 2.55 – 2.49 (2 H, m, 10’’-H), 2.45 
(2 H, t, J = 7.6 Hz, 1’-H), 2.12 – 2.07 (2 H, m, 2’’-H), 1.52 – 1.05 (18 H, m, 2’, 3’. 4’, 
3’’, 4’’, 5’’, 6’’, 7’’, 8’’-H), 0.83 (3 H, t, J = 6.7 Hz, 5’–H). 13C NMR (100 MHz, 
C6D6): δ 180.4 (1’’-C), 146.8 (5-C), 143.4 (2-C), 129.9 (CH, 11’’-C), 122.9 (CH, 12’’-
C), 94.0 (CH, 3-C), 75.2 (CH, 4-C), 31.9 (CH2, 2’’-C), 31.7 , 30.0 , 29.9 , 29.9, 29.7 , 
29.6, 29.2, 29.0 , 25.0 , 20.0 (CH2, 4’-C), 14.2 (CH3, 5’-C). EIMS m/z 350 [M]˙
+
 (52), 
193 (100), 167 (62), 123 (48); HREIMS m/z 350.2284 (calculated for C21H34O2S, 
350.2280). 
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Chapter Six 
The Igura Hivi  
Mushroom 
 
Photograph of an Albatrellus sp. Gray by Anson Barish (UoG) (reproduced with permission) 
 
This section describes ethnomycological and taxonomical background on Igura hivi, a 
Papua New Guinean macrofungi of the genus Albatrellus Gray. Antimicrobial guided 
isolation of its biological active constituents and their structure identification is also 
provided. 
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Chapter 6 The Igura hivi mushroom (Albatrellus sp. Gray) 
6.1 Introduction 
Igura hivi (Figure 6.1) is one of the mushrooms traditionally used by the Kiovi tribe of 
Lufa District, Eastern Highlands Province in Papua New Guinea (PNG) for its edibility 
and medicinal properties. Igura hivi in the local language of the Kiovi means bitter 
mushroom. 
 
 
Figure 6.1: Igura hivi (Albatrellacea). Photograph by Anson Barish (UoG) (reproduced with 
permission) 
 
Traditionally, this mushroom is boiled before consumption and while the water residue 
is drunk to treat stomach upsets, according to Kiovi elders, eating one of these 
mushrooms could sustain a person to go without food for a minimum of two days. 
Furthermore, elders have reported that Igura hivi was the mushroom of choice during 
periods of food scarcity brought about by tribal wars and drought. Ethmomycological 
linkages to the Kiovi reported herein gave origin to this work.  
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Biological testings performed on crude extracts of Igura hivi revealed that it was active 
against Gram (+) bacteria such as Staphylococcus aureus Rosenbach [zone of inhibition 
(ZoI) 15 mm diameter] and Staphylococcus epidermidis Evans (IC50 = 168 µg.mL
-1
). In 
addition, results from the anticancer tests performed at the Queensland Institute of 
Medical Research (QIMR) also showed strong anticancer activities through growth 
inhibitory activities against melanoma (MM96L), breast cancer (MCF7), leukaemia 
(K562) and human fibroblast (NFF) cell lines at 1/5000 dilutions. 
 
Grifolin (6.1), a known antibiotic of the Albatrellaceae family was identified as the 
main component in Igura hivi. Figure 6.2 shows the chemical structure of grifolin. Thus, 
this chapter entails an investigation of Igura hivi, the isolation and elucidation of its 
major active compound responsible for its biological activity.  
 
 
Figure 6.2: Chemical structure of grifolin 
 
6.2 The genus Albatrellus Gray and its signature compound 
The genus Albatrellus Gray (1821) has a widespread distribution especially in the 
temperate areas of the northern hemisphere.
139
 The genus Albatrellus Gray was thought 
to be a member of the Polyporaceae family, due to its porous tissue layer bearing 
structure.
140
 Although more recent phylogenetic analysis based on DNA sequences have 
suggested that its closest relatives are of the Russulaceae family, this type of fungi are 
commonly placed under the Albatrellaceae Nuss family.
141
 
 
A farnesylresorcinol derivative was originally isolated from the fruiting bodies of 
Grifola confluens (Albatrellus confluens (Alb. & Schwein.) Kotl. & & Pouzar) and 
named grifolin (6.1) by Hirata and Nakanishi
142
 in 1949. According to the disc diffusion 
assay used by these authors, grifolin appeared inactive against Gram (-) bacteria such as 
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Bacillus dysenteriae and Salmonella typhi Le Minor & Popoff. However, when grifolin 
was tested against Gram (+) organisms such as S. aureus and Bacillus subtilis, this 
farnesylresorcinol derivative appeared active and hence it was classified as an 
antibiotic.
142
  
 
Recent studies have shown that grifolin (6.1) possesses different biological properties of 
interest in medicine, such as antioxidant, anti-inflammatory and antitumoral.
143-145
 
Although grifolin (6.1) has been recognised as the signature compound amongst 
Albatrellus spp., other novel biological active compounds of interest have been isolated 
from this genus. 
 
Ishii and co-workers,
146
 on their investigations on A. confluens, isolated grifolin (6.1), 
its monomethyl ester (6.2), neogrifolin (6.3) and grifolic acid (6.4), and their structures 
are shown in Figure 6.3.
146
 Although 6.1 and 6.2 showed very similar resonances in 
their respective 
1
H NMR spectra corresponding to the isoprene derived chain, grifolin 
monomethyl ester (6.2) possessed a desymmetrised ring and was thus readily 
distinguishable. The structure of grifolic acid (6.4) was determined based on 
comparisons with existing NMR data and experimentally upon treatment with 
diazomethane, which yielded its methylester, as expected.  
 
 
Figure 6.3: Chemical structures of grifolin (6.1), grifolin monomethyl ester (6.2), neogrifolin 
(6.3) and grifolic acid (6.4) 
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Ishii and co-workers
146
 also isolated four new farnesylphenol derivatives (6.5 – 6.8) 
from Albatrellus dispansus (Lloyd) Canf. & Gilb. and their structures are depicted in 
Figure 6.4. Compounds 6.5 and 6.6 were isolated via HPLC and exhibited the same 
molecular formula C22H32O3 and specific rotation value of [α]D (± 0). In addition, NMR 
data comparisons with that for grifolin (6.1) showed several differences especially in the 
downfield region. These authors concluded that compounds 6.5 and 6.6 were racemic 
and based on the chemical shifts the orientation of the hydroxyl group on position 2’ 
was assigned as trans to the methyl group on position 3’ for 6.5 and cis for 6.6 
respectively. Compound 6.7 was found to be a methyl ether of grifolic acid (6.4). In 
addition, an isopentenylphenol methylester (6.8) was also isolated. 
 
 
Figure 6.4: Chemical structures of novel farnesylphenol derivatives (6.5 – 6.8) 
 
Nukata and co-workers,
143
 during their investigations on the antioxidaive potential of 
mushrooms also isolated grifolin (6.1), its isomer neogrifolin (6.3) and grifolic acid 
(6.4) from A. ovinus. In addition, these authors also isolated three novel neogrifolin 
derivatives (6.9 – 6.11) and their structures are shown on Figure 6.5.143 Regarding 3-
hydroxyneogrifolin (6.9), its structure was elucidated based on NMR analyses. In 
addition, methylation with MeI/K2CO3 under reflux yielded three methylethers, which 
suggested the presence of three phenolic hydroxyl groups in the molecule. The chemical 
structures of the remaining two compounds, 1-formylneogrifolin (6.10) and 1-formyl-3-
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hydroxyneogrifolin (6.11), were also elucidated based on NMR analyses. The key 
similarity between 6.10 and 6.11 was the presence of an aromatic aldehyde, and the key 
difference was that 6.10 was lacking a phenolic hydroxyl group. 
 
 
Figure 6.5: Neogrifolin derivatives isolated from A. ovinus. 
 
Nukata and co-workers
143
 used the DPPH˙ assay to compare the radical scavenging 
activity (RSA) of the three neogrifolin derivatives against the signature compounds of 
the genus Albatrellus Gray (grifolin (6.1)). Although grifolic acid (6.4) was practically 
inactive (RSA < 10%), grifolin (6.1) and neogrifolin (6.3) showed a RSA of 30% - 40%. 
However, when the number of substituents increased around the benzene ring, as for the 
neogrifolin derivatives, the RSA was almost double the RSA reported for neogrifolin 
(6.3) alone. 3-Hydroxyneogrifolin (6.9) and 1-formyl-3-hydroxyneogrifolin (6.11) 
(RSA 68% - 75%) were more active in the DPPH˙ assay than the antioxidant used as a 
positive control (α-tocopherol, RSA = 45%). 
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In 2006, Quang and co-workers,
144
 in the course of investigating new biologically active 
compounds, isolated two novel farnesyl phenol derivatives, namely grifolinone A (6.12) 
and grifolinone B (6.13), their chemical structures are depicted in Figure 6.6.
144
  
 
Both grifolinones (6.12 and 6.13) were able to inhibit nitric oxide production stimulated 
by lipopolysaccharides in murine leukemia virus cells (RAW 264.7), suggesting that 
both compounds might have the potential of being used in the treatment of 
inflammation. 
 
 
Figure 6.6: Grifolinones A and B (6.12 and 6.13) isolatetd from A. caeruleoporus. 
 
Recently in 2012, whilst screening mushroom extracts used by the Kiovi tribe from 
PNG, as reported in 0 section 2.6.6 (Table 2.5), the antibacterial effect of several 
mushroom extracts was tested against S. epidermidis and E. coli β(-) ATCC 25922.  
 
Amongst the mushroom extracts tested was Igura hivi (Albatrellus sp. Gray), which 
appeared inactive against the Gram (-) strain tested, but active against S. epidermidis 
(IC50 = 168 µg.mL
-1
). These findings led to the identification and characterisation of the 
compound responsible for the biological activity exhibited by Igura hivi (Albatrellus sp. 
Gray) – grifolin (6.1). 
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6.3 Characterisation of Igura hivi and isolation of grifolin 
The macrofungus used in this study was collected from the forest area that surrounds 
the Kiovi village, Lufa District, Eastern Highlands Province, Papua New Guinea (PNG). 
See map on Figure 2.1 for location of study area. 
 
Ethanolic extracts of this fungus possessed antibacterial activity against the Gram (+) S. 
epidermidis and thus its taxonomy and chemistry were further pursued. Morphological 
comparisons between Igura hivi with mushroom samples of known taxonomy kept, as 
vouchers, at the Centre for Natural Resources Research and Development (CNRRD) at 
the University of Goroka (UoG), provided indication that Igura hivi belongs to the 
Albatrellaceae family. 
 
After initial extraction, as described in 0, section 2.6.1, ethanolic extracts of Igura hivi 
(Albatrellus sp. Gray) were partitioned under a modified Kupchan scheme to obtain five 
new extracts (Figure 6.7): hexane (Hex), dichloromethane (DCM), ethyl acetate 
(EtOAc), n-butanol (n-BuOH) and aqueous. 
 
 
Figure 6.7: Modified Kupchan solvent partition.
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Kupchan extracts were re-assayed using the turbidity-MTT assay described in Chapter 
2, section 2.9.6. Results from the antimicrobial assay suggested activity in the DCM 
fraction and hence it was chosen to continue with the isolation of the active metabolites. 
 
The DCM fraction was further partitioned via size exclusion chromatography, using 
sephadex LH-20 in MeOH as the mobile phase. A total of 40 fractions each containing 
about 10 mL of eluent were collected and pooled into four major fractions on the basis 
of their thin layer chromatography (TLC) profiles, 
1
H NMR spectra, GC-MS 
experiments and comparisons with crude extracts of Igura hivi (Albatrellus sp. Gray). 
 
These fractions were re-assayed for their antibacterial potential with the turbidity-MTT 
method. Fraction two was active against the Gram (+) strain used and hence subjected 
to further purification. The active LH20 fraction was fractionated on silica gel 60 (230 – 
400 mesh) column using 100% DCM as the mobile phase. A total of 25 fractions of 
approximately 5 mL of eluent were collected and pooled into three fractions with 
fraction one containing the major active compound, identified according to 1D and 2D 
NMR, MS experiments and comparisons with existing data, as grifolin. 
 
6.4 Elucidation of grifolin 
 
 
Figure 6.8: Grifolin (6.1) 
 
HRESIMS suggested a molecular formula of C22H32O2 through the appearance of a 
deprotonated molecule [M – H]- of m/z 237.2324 (calculated for C22H31O2 , 237.2324). 
This molecular formula implied seven degrees of unsaturation, as per Equation 3, 
shown in Chapter 3. 
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Moreover, the 
1
H NMR spectrum (Figure 6.9) displayed ten resonances with five 
distinctive methyl groups. One methyl resonance was relatively more deshielded (E,  
2.21 ppm) than the rest (F – I) suggesting the presence of an aromatic ring. The 
appearance of a singlet (A) at  6.24 ppm in the 1H NMR spectrum integrating for two 
protons was characteristic of a benzene ring with symmetry.  
 
Two distinctive resonances in the 
1
H NMR spectrum comprised an AM2 spin system 
(B) and a singlet (C), both integrating for a total of three olefinic protons between  5.0 
-  5.3 ppm. In addition, a clear “methylene envelope” between  1.9 -  2.2 ppm and an 
A2M spin system (D,  3.39 ppm) deshielded due to its proximity to the paramagnetic 
region of the benzene ring. 
 
 
Figure 6.9 
1
H NMR (300 MHZ, CDCl3) spectrum of grifolin (6.1) 
 
The 
13
C NMR spectrum displayed 20 discrete resonances and with HSQC analysis, 
allowed the confirmation of a number of proton-carbon assignments. Carbons on 
positions 1 and 3 on the benzene ring (Figure 6.8) had the same chemical shift (154.9). 
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In addition, carbons on positions 4 and 6 also on the benzene ring appeared with the 
same chemical shift (109.2), which suggested symmetry in the aromatic ring 
effectively bringing a total of 22 carbons assigned matching the molecular formula 
(C22H31O2) calculated based on HRESIMS experiments. Finally, HMBC correlations 
allowed the elucidation of grifolin. Because grifolin is not a new compound, data was 
also compared against that of Ishii and co-workers.
146
 A summary of 
1
H and 
13
C NMR 
correlations and a comparison with that of the literature can be seen in Table 6.1. 
 
Table 6.1: 
1
H and 
13
C NMR correlations for grifolin (6.1) 
Position 
1
H-NMR 
δ (ppm), |J| (Hz) 
13
C-NMR 
δ (ppm) 
HMBC 
1
H - 
13
C 
1
H-NMR 
(Literature)
146
 
13
C-NMR 
(Literature)
146
 
1  154.9   154.6 
2  110.6   111.0 
3  154.5   154.6 
4 6.24 (s) 109.2 C3, C5, C7 6.20 (s) 109.3 
5  137.6   137.2 
6 6.24 (s) 109.2 C1, C5, C7 6.20 (s) 109.3 
7 2.21 (s) 21.2 C4, C5, C6 2.18 (s) 21.0 
1’ 3.39 (d, 7.1) 22.3 C1, C2, C2’ 3.37 (d, 7.0) 22.3 
2’ 5.27 (t, 7.1) 121.8 C1’, C3’ 5.26 (t, 7.0) 122.0 
3’  139.0   138.4 
4’ 1.87 – 2.10 (m) 39.8  1.90 - 2.10 (m) 39.7 
5’ 1.87 – 2.10 (m) 26.5  1.90 - 2.10 (m) 26.7 
6’ 5.09 (s) 123.7  5.06 (m) 123.7 
7’  135.7   135.4 
8’ 1.87 – 2.10 (m) 39.8  1.90 - 2.10 (m) 39.7 
9’ 1.87 – 2.10 (m) 26.8  1.90 - 2.10 (m) 26.7 
10’ 5.09 (s) 124.5  5.06 (m) 124.5 
11’  131.4   131.0 
12’ 1.68 (s) 25.8  1.66 (s) 25.7 
13’ 1.60 (s) 17.8  1.57 (s) 17.7 
14’ 1.59 (s) 16.4  1.57 (s) 16.1 
15’ 1.82 (s) 16.2  1.80 (s) 16.0 
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6.5 Conclusion 
Investigation of the major isolated compound of the mushroom Igura hivi (Albatrellus 
sp. Gray), collected in the Eastern Highlands Province of Papua New Guinea and used 
traditionally by the Kiovi tribe as medicine, led to the discovery of a known antibiotic 
named Grifolin. 
 
6.6 Experimental 
For general information on instrumental methods used for the characterisation of 
grifolin, see experimental section in Chapter 3, section 3.8.1 to 3.8.6. 
 
6.6.1 Metabolite data 
Grifolin (6.1): 
1
H NMR (CDCl3, 400 MHZ); and 
13
C NMR (CDCl3, 100 MHZ) see 
Table 6.1. HRESIMS m/z 237.2324 [M – H]- (calculated for C22H31O2 , 237.2324). 
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Appendix 1: Mushrooms used by the Kiovi 
 
Specimens and 
collection code 
Species 
(Family) 
Local name 
(English name) 
Uses 
 
Kiovi-MSp1 
Entoloma sp. 
(Bull.) P. Kumm. 
(Entolomataceae) 
Jokoni  Inedible mushroom 
 Regarded as potentially 
poisonous 
 
Kiovi-MSp2 
Cantharellus sp. 
Adans. ex Fr. 
(Cantharellaceae) 
Lamana hivi  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp3 
Xylaria sp. Hill ex 
Schrank 
(Xylaraceae) 
Kula avara  Situated at soil level 
 Inedible mushroom 
 Regarded as potentially 
toxic 
 
Kiovi-MSp4 
Missing data Cofy candy  Edible mushroom 
 Grows on grounds next to 
coffee plants 
 
Kiovi-MSp5 
Missing data Mamu hivi  Edible mushroom 
 Grows on soil 
 Used as a food source 
 
Kiovi-MSp6 
Lactarius sp. Pers. 
(Russulaceae) 
Dagaidy 
 
 Large fleshy mushroom 
 Could be edible if marinated 
before cooking 
 
Kiovi-MSp7 
Russula sp. Pers. 
(Russulaceae) 
Kokai 
 
 Strong red coloured cap and 
white gills 
 Hot in taste 
 Regarded as potentially 
poisonous 
 
Kiovi-MSp8 
Ramaria sp. Fr. Ex 
Bonord. 
(Gomphaceae) 
Dekeja-hava 2 
 
 Edible mushroom 
 Boiled and then cooked in 
oil before eating 
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Kiovi-MSp9 
Ramaria sp. Fr. Ex 
Bonord. 
(Gomphaceae) 
Dekeja-hava 3 
 
 Edible mushroom 
 Boiled and then cooked in 
oil before eating 
 
Kiovi-MSp10 
Missing data Kaudi klodi  Edible mushroom 
 Cooked in oil before eating 
 
Kiovi-MSp11 
Ramaria sp. Fr. Ex 
Bonord. 
(Gomphaceae) 
Dekeja-hava 1 
 
 Edible mushroom 
 Club shape 
 Grows on grounds 
 
Kiovi-MSp12 
Albatrellus sp. 
Gray 
(Albatrellaceae) 
Fagotave hivi  Edible mushroom 
 Used medicinally to treat 
stomach complaints 
 
Kiovi-MSp13 
Albatrellus sp. 
Gray 
(Albatrellacea) 
Nupa duguripa  Edible mushroom 
 Used medicinally to treat 
stomach complaints 
 
Kiovi-MSp15 
Amanita sp. Pers. 
(Amanitaceae) 
Fulaga dive 
 
 Edible mushroom 
 Grows on soil 
 Used as a food source 
 Kiovi people particularly 
reported that eating this 
mushroom makes them feel 
well 
 
Kiovi-MSp16 
Amanita sp. Pers. 
(Amanitaceae) 
Opoiya  White cap with fleecy spots 
 Inediblee 
 Regarded as potentially 
poisonous 
 
Kiovi-MSp17 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Dugulipa2  Edible mushroom 
 Given specially to pigs for 
fattening 
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Kiovi-MSp18 
Missing data Kumurere hivi  Edible mushroom 
 Kiovi use this mushroom as 
fertiliser 
 
Kiovi-MSp19 
Missing data Kegigoma hivi  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp20 
Boletus sp. L. 
(Boletaceae) 
Nenekova  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp21 
Boletus sp. L. 
(Boletaceae) 
Yage-hivi  Edible mushroom  
 Used as a food source 
 
Kiovi-MSp22 
Boletus sp. L. 
(Boletaceae) 
Kegigoma hivi  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp23 
Tricholoma sp. 
Fries 
(Tricholomataceae) 
Lemu-hivi  Inedible mushroom 
 Regarded as potentially 
poisonous 
 
Kiovi-MSp24 
Missing data Lemu hivi  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp25 
Missing data Indova  Edible mushroom 
 Used as a food source 
 
Missing data Fanu hava  Edible mushroom 
 Used as a food source 
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Kiovi-MSp26 
 
Kiovi-MSp27 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Yausivi1  Edible mushroom 
 Boiled in water before eating 
 
Kiovi-MSp29 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Unale kaula  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp30 
Boletus sp. L. 
(Boletaceae) 
Nimi-hove  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp31 
Missing data Kanaravo  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp32 
Boletus sp. L. 
(Boletaceae) 
Nama-hove  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp33 
Boletus sp. L. 
(Boletaceae) 
Demose  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp34 
Missing data Fetotive  Edible mushrooms 
 Used as a food source 
 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Yausivi3  Edible mushroom 
 Boiled in water before eating 
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Kiovi-MSp35 
 
Kiovi-MSp36 
Albatrellus sp. 
Gray 
(Albatrellaceae) 
Dugulipa1  Edible mushroom 
 Used medicinally to treat 
stomach complaints 
 
Kiovi-MSp37 
Trametes sp. L. 
(Polyporaceae) 
Yausivi2  Edible mushroom 
 Boiled in water before eating 
 
Kiovi-MSp38 
Leccinum sp. Gray 
(Boletaceae) 
Agajowa1  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp40 
Missing data Agajowa2  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp41 
Missing data Fu-aulga dive  Edible mushroom 
 Used as a food source 
 
Kiovi-MSp42 
Missing data Fanu  Edible mushroom  
 Used as a food source 
 
Kiovi-MSp43 
Albatrellus sp. 
Gray 
(Albatrellacea) 
Igura hivi 
 
 Edible mushroom 
 Grows on dead trunks 
 Kiovi people use this 
mushroom medicinally to 
treat stomach upset 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
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Appendix 2: Mushrooms used by the Waefo 
 
Specimens and 
collection code 
Species (Family) Local name 
(English name) 
Uses 
 
Waefo-MSp1 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Holipa lua hefola 
 
 Edible mushroom 
 Grows on dead trunks 
 Associated with mosses 
under moist conditions 
 Cooked in wooden drums 
before eating 
 
Waefo-MSp2 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Yomba lua mulita 
 
 Inedible mushroom 
 Grows on dead trunks  
 Associated with mosses and 
lichens 
 Short-medium stipe 
 Grey, brown and white 
colours in circular intervals 
on cap 
 
Waefo-MSp3 
(Sclerodermataceae) Nokondi agamula lua 
(scrotum of the nature 
man) 
 
 Inedible mushroom 
 Waefo believes this 
mushroom protects the 
forest 
 Grows on dead logs and 
branches 
 
Waefo-MSp4 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Heleme lua 
 
 Edible mushroom 
 Grows on soil 
 Waefo made emphasis on 
the good taste of this 
mushroom 
 
Waefo-MSp5 
Missing data He lua 
 
 Edible mushroom 
 Grows on the bark of 
specific living trees 
 Culturally of great value as 
it is specially given to pigs 
to fatten them 
 
Waefo-MSp6 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Mamona lua homulege 
 
 Edible mushroom  
 Grows on dead trunks 
 Associated with high 
moisture 
 Raw mushroom induces 
vomiting 
 Cooked before eating 
 
Waefo-MSp7 
Amanita sp. Pers. 
(Amanitaceae) 
 
Fiona fululu lua 
(slippery/waxy) 
 
 Edible mushroom 
 Grows on soil and on dead 
trunks 
 Mushroom is cooked before 
eating 
 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Nege lua fana 
 
 Inedible mushroom 
 Grows on dead logs and 
fallen branches 
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Waefo-MSp8 
 
Waefo-MSp9 
(Ganodermataceae) Holipa lua namba 
 
 Inedible mushroom 
 Grows on dead logs 
 
Waefo-MSp11 
(Auriculareaceae) Hoinomba lua lafa 
(red roster’s comb) 
 
 Edible mushroom 
 Grows on decomposing 
dead logs 
 Waxy surface and brown in 
colour 
 
Waefo-MSp12 
(Polyporaceae) Nege lua lina 
 
 Inedible mushroom 
 Grows on fallen logs 
 Porous cap on underside 
 
Waefo-MSp13 
(Polyporaceae) Ya lua 
 
 Inedible mushroom 
 Grows on dead trunks 
 
Waefo-MSp14 
 Hopa lua 
 
 Inedible mushroom 
 Grows on dead trunks 
 
Waefo-MSp15 
Auricularia sp. 
(Dicks.) Pers. 
(Auriculareaceae) 
Hoinomba lua feke 
(white rooster’s comb) 
 
 Edible mushroom 
 Grows on dead trunks 
 Associated with mosses and 
lichens 
 
Waefo-MSp16 
(Fistulinaceae) Yafo welahuluma lua 
(pig’s tongue) 
 
 Edible mushroom 
 Cooked twice before eating 
 Regarded as poisonous 
 Grows on the bark of living 
trees 
 
Waefo-MSp17 
Polyporus sp. P. 
Micheli ex Adans. 
(Polyporaceae) 
Lambi lua 
 
 Inedible 
 Grows on dead logs 
 
Waefo-MSp18 
(Ganodermataceae) Holipa lua muliti 
 
 Inedible 
 Grows on dead logs 
 
Boletus sp. L. 
(Boletaceae) 
Lua horu 
 
 Edible mushroom 
 Cooked or smoked on fire 
before eating 
 Sprouts from where the soil 
is rich in decomposed 
matter 
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Waefo-MSp19  Found in grasslands 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
 
Appendix 3: Mushrooms used by the Kopanka 
Specimens and 
collection code 
Species (Family) Local name 
(English name) 
Uses 
 
Tapiaku-MSp1 
Ramaria sp. Fr. Ex 
Bonord. 
(Ramariaceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
Tapiaku-MSp2 
Ramaria sp. Fr. Ex 
Bonord. 
(Ramariaceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
 
Tapiaku-MSp3 
Clavaria sp. Vaill. 
ex L. 
(Clavariaceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
 
Tapiaku-MSp4 
Ramaria sp. Fr. Ex 
Bonord.  
(Ramariaceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
 
Tapiaku-MSp5 
Ramaria sp. Fr. Ex 
Bonord. 
(Ramariaceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
 
Tapiaku-MSp6 
Thelephora sp. 
Ehrh. ex Willd. 
(Thelephoraceae) 
Ombnantskim 
(Sugar cane 
skin) 
 
 Edible mushroom 
 Used as an analgesic 
 
 
Tapiaku-MSp7 
Tricholoma sp. 
Fries 
(Tricholomataceae) 
Makbunde 
(Ground 
mushroom) 
 Edible mushroom 
 Eaten cooked, boiled or 
fried 
 Source of food and also, 
used as a fertilizer 
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Tapiaku-MSp8 
Hygrocybe sp. (Fr.) 
P. Kumm. 
(Hygrophoraceae) 
Amto 
(Breast milk) 
 Edible mushroom  
 Eaten cooked or raw  
 Given to lactating mothers 
for breast milk stimulation  
 
Tapiaku-MSp9 
Auricularia sp. 
(Dicks.) Pers. 
(Auriculariaceae) 
Koikamuk 
(Rat ears)  
 Edible mushroom 
 Eaten cooked or boiled 
 Given to mothers post-
partum for womb healing 
 
Tapiaku-MSp10 
Rugosomyces sp. 
L. 
(Tricholomataceae) 
Kombsar 
(Lightning) 
 Edible mushroom 
 Mushroom only appears 
after lightning strikes 
 Kopanka believes that this 
mushroom provides them 
with protection from 
lightning  strikes during the 
wet season 
 
Tapiaku-MSp11 
Macrocystidia sp. 
Joss. 
(Marasmiaceae) 
Kopi nonda 
(coffee 
mushroom) 
 Edible mushroom 
 Grows on soil next to coffee 
plantations 
 Eaten cooked 
 
Tapiaku-MSp12 
Echinoderma sp. 
(Pers.) Bon 
(Agaricaceae) 
Nakents 
(baby faeces) 
 Edible mushroom 
 Grows on soil 
 Given to babies as anti-
diarrhoeal 
 
Tapiaku-MSp13 
Missing data Komugtai 
(Mushroom 
madness) 
 Edible mushroom 
 Eaten raw 
 Makes consumers go crazy 
 Men want to show their 
strengths/fighting 
capabilities 
 Kopanka reported taking 
this mushroom in time of 
war with other tribes 
 
Tapiaku-MSp14 
Missing data Kalap nonda 
 
 Edible mushroom 
 Cooked in oil before eating 
 
Tapiaku-MSp15 
Missing data Kalap 
 
 Inedible mushroom  
 Used as medicine topically 
to treat skin growths 
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Tapiaku-MSp16 
Amanita sp. Pers. 
(Amanitaceae) 
Tokangi 
(Swollen body) 
 Edible mushroom 
 Eaten cooked 
 Used medicinally as anti-
inflammatory remedy 
 
Tapiaku-MSp17 
Missing data Gesu 
 
 Edible mushroom 
 Kopanka reported that 
eating this mushroom it 
makes them strong and gives 
them confidence 
 
Tapiaku-MSp18 
Microporus sp. P. 
Beauv. 
(Polyporaceae) 
Willikimik 
 
 Edible mushroom 
 Grows on dead trunks 
 Used for the treatment of 
pimples and scar removal 
 
Tapiaku-MSp19 
Microporus sp. P. 
Beauv. 
(Polyporaceae) 
Willi-toli 
(Strong) 
 Edible mushroom 
 Kopanka does not eat it 
because it is  very hard and 
dry, hence its name “strong” 
 
Tapiaku-MSp20 
Missing data Dange 
 
 Edible mushroom 
 Eaten cooked 
 Given to women post-
partum to aid with the 
removal of scars associated 
with delivery 
 
Tapiaku-MSp21 
Morchella sp. (L.) 
Pers 
(Morchellaceae) 
Kipenembik 
(devil’s penis) 
 
 Edible mushroom 
 Grows on garden soil 
 Eaten cooked and used as a 
food source 
 
Tapiaku-MSp22 
Missing data Dukdedek 
(Eye water)  
 Inedible mushroom 
 Sap is extracted and rub on 
eyes for conjunctivitis (used 
topically) 
 
Tapiaku-MSp23 
Missing data Tuarbik 
(Dog’s tongue) 
 Edible mushroom 
 Sour taste 
 
Tapiaku-MSp24 
Russula sp. Pers. 
(Russulaceae) 
Dekmindemp 
(Earth worm) 
 Edible mushroom  
 Used to boost up their 
immune system 
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Tapiaku-MSp25 
Missing data Binge bang 
(Red) 
 Inedible mushroom  
 Boiled and water is drank,  
 Used as emetic and body 
cleanser (potentially toxic) 
 
Tapiaku-MSp26 
Russula sp. Pers. 
(Russulaceae) 
Binge 
 
 Edible mushroom 
 Used as a food source 
 
Tapiaku-MSp27 
Missing data Bongnengs 
 
 Edible mushroom 
 Grows on soil 
 Eaten cooked 
 Given to babies to prevent 
diseases and to grow healthy 
 
Tapiaku-MSp28 
Missing data Angen-muk 
 
 Edible mushroom 
 Highly valuable for 
Kopanka 
 Given to pigs as a fattening 
source 
 
Tapiaku-MSp29 
Missing data Kupsik-kupsik 
 
 Edible mushroom 
 Sour in taste 
 Induce individuals to sweat 
when eaten. 
 
Tapiaku-MSp30 
Missing data Kupsik nonda 
 
 Edible mushroom 
 Does not make you sweat 
 Nonda added to differ from 
Kupsik-kupskik 
 
Tapiaku-MSp31 
Boletus sp. L. 
(Boletaceae) 
Kirmapik 
(Bat mushroom) 
 Edible mushroom 
 Eaten cooked or raw 
 Sour in taste 
 It is believe that bats bring 
this mushroom to the village 
 
Tapiaku-MSp32 
Russula sp. Pers. 
(Russulaceae) 
Kaimuk 
(Bird’s egg) 
 Edible mushroom 
 Used as a food source 
 
Tapiaku-MSp33 
Missing data Mos-1 
 
 Inedible mushroom 
 Regarded as potentially 
toxic 
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Tapiaku-MSp34 
Missing data Mos-2 
 
 Edible mushroom 
 Used as a food source 
 Gills must be removed 
before cooking 
 Gill regarded as potentially 
toxic 
 
Tapiaku-MSp35 
Schizophyllum sp. 
(Schizophyllaceae) 
Kombas 
(Skin dust) 
 
 Edible mushroom 
 Used medicinally as internal 
cleansing 
Mushroom photographs by Anson Barish (UoG). Reproduced with permission 
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Appendix 4: Supporting information: 
1
H and 
13
C NMR spectra for 
synthesis of F-acids and T-acids 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 5-pentylfuran (4.26) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 5-pentylthiophene (5.4) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 2-iodo-5-pentylfuran (4.28) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 2-iodo-5-pentylthiophene (5.5) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 2-(prop-2-yn-1-yloxy)-tetrahydro-2H-pyran 
(4.30) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of hex-2-yn-1-ol (5.6) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of non-2-yn-1-ol (4.32) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of dodec-2-yn-1-ol (5.7) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of hex-5-yn-1-ol (5.8) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of non-8-yn-1-ol (4.33) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of dodec-11-yn-1-ol (5.9) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 3-(5-pentylfuran-2-yl)-prop-2-yn-1-ol 
(5.10) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 3-(5-pentylthiophene-2-yl)-prop-2-yn-1-ol 
(5.13) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 6-(5-pentylfuran-2-yl)-hex-5-yn-1-ol (5.11) 
in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 6-(5-pentylthiophene-2-yl)-hex-5-yn-1-ol 
(5.14) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 9-(5-pentylfuran-2-yl)-non-8-yn-1-ol (4.34) 
in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 9-(5-pentylthiophene-2-yl)-non-8-yn-1-ol 
(5.15) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 12-(5-pentylfuran-2-yl)-dodec-11-yn-1-ol 
(5.12) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 12-(5-pentylthiophene-2-yl)-dodec-11-yn-
1-ol (5.16) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 3-(5-pentylfuran-2-yl)-prop-2-ynoic acid 
(5.24) in CD3OD 
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1
H and 
13
C NMR (400/100 MHz) spectra of 3-(5-pentylthiophene-2-yl)-prop-2-ynoic 
acid (5.27) in CD3OD 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 6-(5-pentylfuran-2-yl)-hex-5-ynoic acid 
(5.25) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 6-(5-pentylthiophene-2-yl)-hex-5-ynoic 
acid (5.28) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 9-(5-pentylfuran-2-yl)-non-8-ynoic acid 
(4.36) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 9-(5-pentylthiophene-2-yl)-non-8-ynoic 
acid (5.29) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of 12-(5-pentylfuran-2-yl)-dodec-11-ynoic 
acid (5.26) in CDCl3 
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1
H and 
13
C NMR (400/100 MHz) spectra of 12-(5-pentylthiophene-2-yl)-dodec-11-
ynoic acid (5.30) in CDCl3 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of (Z)-6-(5-pentylfuran-2-yl)-hex-5-enoic acid 
(5.31) in C6D6 
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1
H and 
13
C NMR (800/200 MHz) spectra of (Z)-6-(5-pentylthiophene-2-yl)-hex-5-enoic 
acid (5.33) in C6D6 
 
 
 
1
H and 
13
C NMR (800/200 MHz) spectra of (Z)-9-(5-pentylfuran-2-yl)-non-8-enoic acid 
(3.1)in C6D6 
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1
H and 
13
C NMR (400/100 MHz) spectra of (Z)-9-(5-pentylthiophene-2-yl)-non-8-enoic 
acid (5.34) in C6D6 
 
 
 
1
H and 
13
C NMR (400/100 MHz) spectra of (Z)-12-(5-pentylfuran-2-yl)-dodec-11-enoic 
acid (5.32) in C6D6 
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1
H and 
13
C NMR (400/100 MHz) spectra of (Z)-12-(5-pentylthiophene-2-yl)-dodec-11-
enoic acid (5.35) in C6D6 
 
 
 
